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Abstract
The Family Study o f Myopia is a research project aiming to discover genetic loci 
causing susceptibility to high myopia. As part of this investigation, the heritability of 
refractive error and other ocular components was estimated for a large Irish-Welsh 
multi-generational pedigree using variance components analysis software, SOLAR. 
Heritabilities of 0.39 (p=6.92 x 10'5, S.E.=0.14), 1.00 (p=1.84 x 104, S.E.=0.22) and
0.30 (p=0.13, S.E.=0.33) were found for refractive error, mean comeal curvature and 
axial length, respectively. Heritability of refractive error was also calculated using 
within-family regression and a Markov Chain Monte Carlo method producing 
estimates of between 0.12 and 0.73. This high heritability o f ocular refraction 
suggests the potential for finding susceptibility loci for the control and development 
of refractive error. To pinpoint these loci, areas of chromosomes which have 
previously been suggested to harbour genes controlling refractive error were 
investigated to determine whether linkage was present within this family. DNA was 
extracted from mouthwashes and linkage analysis was performed. SOLAR revealed 
no significant linkage to the loci tested, reinforcing the theory that myopia is a highly 
heterogenous disease. The maximum twopoint LOD score was within the MYP6 
locus at marker D22S1176 (LOD=1.19). Multipoint analysis showed the maximum 
LOD score at the MYP3 locus, between markers D12S1605 and D12S354 (LOD 
=1.37).
In a separate study of 96 families containing a highly myopic child and the two 
parents, the involvement of a candidate gene encoding the protein myocilin (MYOC) 
was examined using an association analysis. There was weak evidence o f over­
transmission of allele 3 of MYOC 1, a marker in the 5’ untranslated region of the 
gene, and under-transmission of allele 4 of that same marker (both p<0.05). This 
suggests MYOC may play a small role in the causation of high myopia development 
but a larger sample is needed to establish this conclusively.
Table of Contents
T a b l e  o f  C o n t e n t s ....................................................................................................................................... 5
F ig u r e s ................................................................................................................................................................. 9
T a b l e s ..................................................................................................................................................................11
Eq u a t io n s .........................................................................................................................................................11
A b b r e v ia t io n s ................................................................................................................................................ 12
C h a p t e r  s u m m a r y  a n d  a im s ...................................................................................................................14
1. LINKAGE ANALYSIS IN HIGH MYOPIA-AN INTRODUCTION.............................. 15
1.1. M y o p i a ........................................................................................................................................................15
1.1.1. R e f r a c t iv e  E r r o r .......................................................................................................................... 15
1.1.2. O c u l a r  C o m p o n e n t s ..................................................................................................................... 17
1.1.3. A e t io l o g y  a n d  a ss o c ia t io n s  w it h  m y o p ia ......................................................................18
1.1.3.1. M yopia and near w ork ......................................................................................................................18
1.1.3.2. M yopia and other associations.......................................................................................................24
1.1.3.3. M yopia and association with system ic and ocular disease................................................... 24
1.1.4. A n im a l  M o d e l s  o f  M y o p i a .....................................................................................................27
1.2. G e n e t ic  A n a l y s is ..............................................................................................................................29
1.2.1. D N A  SEQUENCES, CONSTITUENTS AND FUNCTION WITH RELATION TO GENETIC 
ANALYSIS..............................................................................................................................................................29
1.2.1.1. D N A ........................................................................................................................................................30
1.2.1.2. Protein Synthesis................................................................................................................................ 30
1.2.1.2.1. Replication........................................................................................................................................30
1.2.1.2.2. Transcription.................................................................................................................................... 30
1.2.1.2.3. Translation........................................................................................................................................31
1.2.1.3. Genes and a lleles................................................................................................................................ 31
1.2.1.4. M icrosatellite Genotyping............................................................................................................... 34
1.2.1.4.1. Polymerase Chain Reaction........................................................................................................34
1.2.1.4.2. Primer design...................................................................................................................................35
1.2.1.4.3. Identification o f genotypes........................................................................................................... 35
1.2.2. In h e r it a n c e .........................................................................................................................................36
1.2.3. L in k a g e  A n a l y s is .............................................................................................................................38
1.2.3.1. Assumptions made for linkage analysis..................................................................................... 39
1.2.3.2. Methods o f  linkage analysis........................................................................................................... 40
1.2.3.2.1. Parametric Linkage Analysis......................................................................................................40
1.2.3.2.2. Non parametric linkage analysis..............................................................................................42
1.2.4. ASSOCIATION.........................................................................................................................................43
1.2.5. H e t e r o g e n e it y ................................................................................................................................. 44
1.2.6. Ex p e r im e n t a l  D e s ig n ....................................................................................................................45
1.2.6.1. Phenotype classification.................................................................................................................. 45
1.2.6.1.1. Quantitative and dichotomous traits........................................................................................45
1.2.6.2. H eritability...........................................................................................................................................47
1.2.6.3. P ow er.....................................................................................................................................................47
1.2.6.4. Populations and Pedigree Structure............................................................................................ 48
1.3. M y o p ia  a n d  L in k a g e  A n a l y s is ................................................................................................. 50
2. FA M IL Y  ST U D Y  O F M Y O PIA : SU B JEC T  R E C R U IT M E N T ........................................54
2.1. In t r o d u c t io n .........................................................................................................................................54
2.1.1. A sso r t a t iv e  M a t i n g ..................................................................................................................... 56
2.2. M e t h o d s .................................................................................................................................................... 57
2.2.1. E t h ic a l  A p p r o v a l ........................................................................................................................... 57
2.2.2. R e c r u it in g ............................................................................................................................................57
2.2.2.1. Recruiting via Optom etrists............................................................................................................57
222 .2 . Recruiting by Databases...................................................................................................................58
2.2.23. Recruiting by the Internet............................................................................................................... 58
2.2.2.4. Recruiting by Word o f  Mouth........................................................................................................58
2.2.3. A s s o r t a t iv e  M a t i n g ..................................................................................................................... 59
2.3. R e s u l t s .......................................................................................................................................................60
2.3.1. P r o b a n d  R e c r u it m e n t ................................................................................................................. 60
2.3.2. Fa m il y  R e c r u it m e n t .....................................................................................................................63
2.3.3. R e c r u it in g  M e t h o d s ..................................................................................................................... 64
2.3.4. C h a r a c t e r is t ic s  f o r  p r o b a n d s  a n d  f a m il ie s ................................................................ 65
2.3.5. T r a it  d is t r ib u t io n s ........................................................................................................................67
2.3.6. A s so r t a t iv e  M a t i n g ..................................................................................................................... 69
2.4. DISCUSSION.................................................................................................................................................71
3. HERITABILITY.......................................................................................................................................73
3.1. In t r o d u c t io n ..........................................................................................................................................73
3.1.1. D e f in it io n ............................................................................................................................................. 73
3.1.2. Tw in  St u d ie s ........................................................................................................................................ 74
3.1.3. A s s u m p t io n s ..........................................................................................................................................75
3.1.4. M e t h o d s  o f  c a l c u l a t in g  h e r it a b il it y ..............................................................................76
3.1.4.1. Within Family Regression........................................................................................... 76
3.1.4.2. Variance Components Method..................................................................................... 77
3.1.4.3. Markov Chain Monte Carlo (Gibbs sampling) methods..............................................77
3.1.3. H e r it a b il it y  a n d  R e f r a c t iv e  E r r o r .................................................................................. 79
3.1.4. O c u l a r  C o m p o n e n t s  a n d  H e r it a b il it y ..............................................................................81
3.2. M e t h o d s ..................................................................................................................................................83
3.2.1. R e c r u it m e n t .......................................................................................................................................83
3.2.2. H e r it a b il it y  E s t im a t e s .............................................................................................................. 83
3.2.2.1. Within Family Regression...........................................................................................84
3.2.2.1.1. Midparent-offspring regression................................................................................84
3.2.2.1.2. Sibling-sibling regression.........................................................................................84
3.2.2.2. Variance Components Method.....................................................................................85
3.2.2.3. Markov Chain Monte Carlo (Gibbs sampling) methods............................................. 86
3.3. R e s u l t s .......................................................................................................................................................87
3.3.1. R e c r u it m e n t .......................................................................................................................................87
3.3.2. T r a it  C h a r a c t e r is t ic s ................................................................................................................ 87
3.3.3. H e r it a b il it y  e s t im a t e s ............................................................................................................... 91
3.4. D is c u s s io n ..............................................................................................................................................97
4. EVALUATION OF QUALITY AND QUANTITY OF DNA EXTRACTED FROM 
MOUTHWASHES.....................................................................................................................100
4.1. In t r o d u c t i o n .............................................................................................................................................100
4.1.1. M o u t h w a s h e s ......................................................................................................................................... 100
4.1.2. W h o l e  G e n o m e  A m p l if ic a t io n  (WGA).................................................................101
4.2. M e t h o d s .........................................................................................................................................................104
4.2.1 Sa m p l e  C o l l e c t i o n ............................................................................................................................ 104
4.2.2. DNA E x t r a c t io n  f r o m  M o u t h w a s h e s ................................................................................. 104
4.2.3. Q u a n t if ic a t io n  o f  DNA Y ie l d  a n d  Q u a l it y  b y  S p e c t r o p h o t o m e t r y  105
/4.2.4. In v e s t ig a t io n  o f  o r ig in  o f  D N A .............................................................................106
4.2.4.1. SYBR® Green I human genomic DNA a ssa y ..............................................................106
4.2.5. W h o l e  G e n o m e  A m p l i f i c a t i o n ...............................................................................107
4.3. R e s u l t s ...................................................................................................................................................108
4.3.1. S p e c t r o p h o t o m e t r y ................................................................................................................... 108
4.3.2. SYBR® GREEN I HUMAN DNA ASSAY...................................................................................................1 10
4.3.3. W h o l e  G e n o m e  A m p l if ic a t io n ............................................................................................ 112
4.3.4. A g e  a n d  t o t a l  h u m a n  DNA y i e l d ............................................................................................ 114
4.4. D is c u s s i o n ..........................................................................................................................116
5. LINKAGE ANALYSIS FOR MYOPIA IN THE MULTI-GENERATIONAL IRISH- 
WELSH PEDIGREE.................................................................................................................121
5.1. In t r o d u c t io n .......................................................................................................................................121
5.1.1. L in k a g e  A n a l y s is ...........................................................................................................................121
5.1.1.1. Power and SLIN K ............................................................................................................................ 121
5.1.1.2. Variance Components Linkage A nalysis................................................................................. 122
5.1.1.2.1. SOLAR...............................................................................................................................................123
5.1.2. G e n o t y p in g .........................................................................................................................................124
5.1.2.4. Genotyping Errors..........................................................................................................................124
5.1.2.4.1. Description and Sources o f Error........................................................................................... 124
5.1.2.4.2. PEDCHECK ...................................................................................................................................126
5.1.3. EXCLUSION LOCI................................................................................................................................. 127
5.1.4. Ca n d id a t e  G e n e s .............................................................................................................................127
5.1.4.1. M yopia candidate gen es................................................................................................................. 128
5.2. M e t h o d s ...................................................................................................................................................130
5.2.1. P o w e r  c a l c u l a t io n s  a n d  S L IN K .......................................................................................... 130
5.2.2. G e n o t y p in g .........................................................................................................................................131
5.2.2.1. Preparation for genotyping analysis........................................................................................... 132
5.2.3. C h e c k in g  f o r  M e n d e l ia n  e r r o r s ........................................................................................136
5.2.4. L in k a g e  a n a l y s is : S O L A R .........................................................................................................136
5.3. R e s u l t s ..................................................................................................................................................138
5.3.1. P e d ig r e e  a n d  p h e n o t y p e  s t a t is t ic s .................................................................................. 138
F ig u r e  5.3. F r e q u e n c y  d is t r ib u t io n  o f  m a r r ie d - in  i n d i v i d u a l s  (n = 2 4 ) .........................139
5.3.2. P o w e r ..................................................................................................................................................... 139
5.3.3. G e n o t y p in g .........................................................................................................................................143
5.3.3.1. Genotyping procedures.................................................................................................................. 143
5.3.3.1.1. Genotyping success rates: subjects........................................................................................ 143
5.3.3.1.2. Genotyping success rates: WGA samples............................................................................144
5.3.3.1.3. Genotyping success rates: loci.................................................................................................145
5.3.3.2. PE D C H EC K ................................................................................................................................... 146
5.3.4. ALLELE FREQUENCIES......................................................................................................................147
5.3.5. L in k a g e  a n a l y s is : S O L A R ........................................................................................................ 152
5.3.5.1. Syndromic L oci.................................................................................................................................152
5.3.5.2. N on syndromic lo c i......................................................................................................................... 152
5.4. D is c u s s io n ........................................................................................................................................... 168
5.4.1. G e n o t y p in g ........................................................................................................................................ 168
5.4.2. M a r r ie d - in in d iv id u a l s .............................................................................................................168
5.4.3. L in k a g e  A n a l y s is ...........................................................................................................................169
5.4.3.1. Syndromic lo c i.................................................................................................................................. 169
5.4.3.2. Non syndromic lo c i..........................................................................................................................169
5.4.3.3. A llele frequencies and trait description.....................................................................................170
5.4.4. Su m m a r y ............................................................................................................................................170
6. ASSOCIATION ANALYSIS OF MYOCILIN WITH HIGH MYOPIA 172
6.1. In t r o d u c t io n ................................................................................................................... 172
6.1.1. T r a n s m is s io n  D ise q u il ib r iu m  T e s t .....................................................................................173
6.1.2. TDTEX.............................................................................................................................. 174
6.1.3. F a m il y  B a se d  A s so c ia t io n  T e s t ...........................................................................................176
6.1.4. P o w e r  a n d  s a m p l e  s i z e ...............................................................................................................177
6.1.5. H a r d y -W e in b e r g  E q u il ib r iu m ............................................................................................. 177
6.1.6. A s so c ia t io n  a n d  M y o p i a ...........................................................................................................179
6.1.7. MYOCILIN..........................................................................................................................180
6.2. M e t h o d s ............................................................................................................................................... 182
6.2.1. A s so c ia t io n  a n a l y s is .................................................................................................................. 182
6.2.2. Sa m p l e  p r e p a r a t io n  f o r  DNA S e q u e n c in g ................................................................... 183
6.3. R e s u l t s ................................................................................................................................................. 184
6.3.1. A s s o c ia t io n  A n a l y s i s .................................................................................................................184
6.3.1.1 Transmission Disequilibrium T est.............................................................................................. 184
6.3.1.2. T D T E X ................................................................................................................................................185
6.3.1.3. Family Based Association T est....................................................................................................187
6.3.2. PBAT POWER CALCULATIONS....................................................................................... 190
6.3.3. C a s e -c o n t r o l  s t u d y ..................................................................................................................... 191
6.3.4. H a r d y -W e in b e r g  E q u il ib r iu m ..............................................................................................195
63.5. Se q u e n c in g  r e s u l t s ....................................................................................................................195
6.4. D is c u s s io n ...............................................................................................................................................197
7. FINAL DISCUSSION........................................................................................................... 199
7.1. O v e r v ie w ................................................................................................................................................. 199
7.2. F u t u r e  w o r k ........................................................................................................................................ 201
APPENDICES............................................................................................................................203
A p p e n d ix  1.................................................................................................................................. 203
A p p e n d ix  II ................................................................................................................................ 209
A p p e n d ix  III............................................................................................................................... 217
R e f e r e n c e s .....................................................................................................................................................231
W e b sit e  B ib l io g r a p h y ............................................................................................................................244
Figures
Figure 1.1. Frequency distribution o f refractive error 15
Figure 1.2. Ocular components o f refractive error 17
Figure 1.3. Example o f typical recessive and dominant inheritance 36
Figure 1.4. The additive genetic biometrical model 37
Figure 1.5. Allele sharing 43
Figure 1.6. Applying an affection threshold to a quantitative trait 46
Figure 2.1. Flow chart summarising the recruiting process. A small proportion of the responding 
probands were excluded due to clinical factors. 61
Figure 2.2. Number o f first contact questionnaires (PQ1) sent out and returned between October 
2002 and October 2005. 62
Figure 2.3. Response rate for PQ1 s from October 2002 to October 2005. 62
Figure 2.4. Number o f family member questionnaires (PQ2) sent out and returned between 
October 2002 and October 2005. 63
Figure 2.5. Response rate for PQ2s from October 2002 to October 2005. 63
Figure 2.6. Recruiting methods for all three different pedigree types used in the study 64
Figure 2.7. Cumulative measure o f the number o f optometrists involved in the study between
October 2002 and October 2005. 65
Figure 2.8. Trait distribution o f right eye, least minus meridian (dioptres) for subjects within ASP 
and MG families. 67
Figure 2.9. Trait distribution o f right eye, least minus meridian (dioptres) for subjects within ASP 
and MG families, not including probands. 68
Figure 2.10. Trait distribution o f right eye, least minus meridian (dioptres) for probands within 
ASP and MG families. 69
Figure 2.11. Proband spectacle prescriptions (Rx, RE LMM, dioptres) plotted against that o f their 
spouses. 70
Figure 3.1. Showing the values o f spherical equivalent refractive error o f the left eye for twin 1 
plotted against twin 2 for monozygotic and dizygotic twins 68
Figure 3.2. Pictorial representation o f Markov Chain. 71
Figure 3.3. Regression o f spectacle prescription against autorefraction 81
Figure 3.4. Distribution o f refractive error, RE LMM (D), in the multigenerational Irish-Welsh 
pedigree 82
Figure 3.5. Female and male trait distributions o f refractive error. 83
Figure 3.6. Frequency distribution o f RE mean corneal curvature (D), in the multigenerational 
Irish-Welsh pedigree 83
Figure 3.7. Frequency distribution o f RE axial length (mm), in the multigenerational Irish-Welsh 
pedigree 84
Figure 3.8. Midparent-offspring regression. 85
Figure 3.9. Sibling-sibling regression o f refractive error 85
Figure 3.10. Correlation between refractive error and mean corneal curvature 89
Figure 4.1. Yield o f DNA from separate mouthwashes from Irish-Welsh family. 108
Figure 4.2. Total yield o f mouthwashes (sum o f two mouthwash samples) from Irish-Welsh 
family. 108
Figure 4.3. Yield o f DNA from separate mouthwashes from Family Study o f Myopia subjects. 109
Figure 4.4. Total yield o f DNA from mouthwashes from the Family Study o f Myopia subjects. 110
Figure 4.5. Agarose gel image. 110
Figure 4.6. Total yields o f human gDNA from SYBR® green I human gDNA assay. I l l
Figure 4.7. Total human DNA yield for Irish-Welsh family including samples which underwent 
WGA. 112
Figure 4.8. Flowchart o f the sample preparation pre-genotyping process using a human genome 
DNA assay and multiple displacement amplification 113
Figure 4.9. Age and total human genomic DNA yield for Irish-Welsh family. 114
Figure 4.10. Age and total DNA yield for FSM subjects. 115
Figure 4.11. Yield distributions for spectrophotometry and human gDNA yields. 116
Figure 4.12. Mean yield o f those samples undergoing WGA 117
Figure 4.13. Human DNA yield in females and males 118
Figure 4.14. Human DNA yield in females and males 118
Figure 4.15. DNA yields in males and females measured by spectrophotometry. 119
Figure 4.16. Distribution o f DNA yields in males and females measured by spectrophotometry 119
Figure 5.1. Example o f a gel for testing primers prior to genotyping 131
Figure 5.2. Frequency distribution o f traits ql and q2 138
Figure 5.3. Frequency distribution o f married-in individuals. 139
Figure 5.4. Reduced pedigree for power calculation 141
Figure 5.5. Reduced pedigree for power calculation (Stambolian model). 142
Figure 5.6. Success rates o f subjects 144
Figure 5.7. Comparing the genotype success rate produced by subjects using DNA from the
original mouthwash and those using WGA DNA 145
Figure 5.8. Success rates o f groups o f markers at the candidate loci investigated. 146
165
166 
174 
191 
193 
196 
196 
196
Figure 5.9i. SOLAR Multipoint scores for syndromic loci 
Figure 5.9ii. SOLAR Multipoint results for non syndromic loci 
Figure 6.1. Example o f scoring for TDT contingency tables. 
Figure 6.2. MYOC1 allele frequencies in cases and controls 
Figure 6.3. MYOC2 allele frequencies in cases and controls 
Figure 6.4. Sequence trace for MYOC1, allele 2 
Figure 6.5. Sequence trace for MYOC1, allele 3 
Figure 6.6. Sequence trace for MYOC1, allele 4
Tables
Table 1.1. Patient, study characteristics and outcomes o f randomized clinical trials 23
Table 1.2. Summary o f mapped MYP loci 52
Table 2.1. Characteristics o f probands 66
Table 2.2. Characteristics o f all individuals recruited for the Family Study o f Myopia 66
Table 3.1. Calculation of heritability estimates (h2) based on regression and correlation of the 
phenotypes o f relatives 76
Table 3.2. Summary o f heritability estimates o f refractive error. 79
Table 3.3. Heritability estimates o f ocular refractive components. 82
Table 3.4. Characteristics o f biometry measurements in the multigenerational Irish-Welsh 
pedigree. 94
Table 3.5. Right and left eye characteristics of traits. 94
Table 3.6. Heritability estimates for refractive error using within-family regression and 95
correlation methods.
Table 3.7a. Heritability estimates for refractive components using SOLAR for all subjects 95
Table 3.7b. Heritability estimates for refractive components using SOLAR for male and female
subjects separately 96
Table 3.8. Heritability estimates for refractive error using MCMC methods. 96
Table 5.1. PCR programmes 131
Table 5.2. Marker, primer and PCR product descriptions. 133
Table 5.3. SLINK LOD score production using models described by Stambolian and colleagues 140 
Table 5.4a-l. Allele frequencies calculated from founders and married in individuals. 148
Table 5.5. Summary o f SOLAR twopoint analysis 155
Table 6.1. TDT results for MYOC1. 184
Table 6.2. TDT results for MYOC2. 184
Table 6.3. TDTEX contingency table for MYOC1 alleles. 185
Table 6.4. TDTEX contingency table for MYOC2 alleles 185
Table 6.5. Summary of TDTEX results 186
Table 6.6. Results determining specifically which allele has increased or decreased transmission 
for MYOC 1. 187
Table 6.7. FBAT results for MYOC1, allelic mode 187
Table 6.8. FBAT results for MYOC2, allelic mode 188
Table 6.9. FBAT results for MYOC1, genotype mode. 188
Table 6.10. FBAT results for MYOC2, genotype mode. 189
Table 6.11. HBAT results showing only those haplotypes with more than 10 informative families. 190
Table 6.12. MYOC1 allele frequencies in cases and controls. 191
Table 6.13. MYOC1 case-control genotype frequencies 192
Table 6.14. MYOC1 case-control study results. 192
Table 6.15. MYOC2 allele frequencies for cases and controls. 193
Table 6.16. MYOC2 case-control genotype frequencies 194
Table 6.17. MYOC2 case-control study results. 194
Equations
Equation 1.1. Heterozygosity. 32
Equation 1.2. Odds ratio 38
Equation 1.3. Logarithm o f odds ratio. 39
Equation 1.4. Relative risk to siblings 48
Equation 3.1. Narrow sense heritability (h2) 74
Equations 4.1. DNA Concentration Yield Calculation. 105
Equations 4.2. DNA Yield Calculation 105
Equation 6.1. Test statistic for TDT. 174
Equation 6.2. Curtis’ method o f testing for association for polymorphic markers. 175
Equation 6.3. Hardy Weinberg equilibrium. 178
Equation 6.4. Extension o f Hardy-Weinberg theory for polymorphic markers. 179
Abbreviations
A adenosine
ASP affected sibling pair
Bp base pairs
C cytosine
CLAMP contact lens and myopia progression trial
cM centi-morgan
COMET correction of myopia evaluation trial
D dioptres
DC cylindrical dioptres
DNA deoxyribonucleic acid
dNTP deoxynucleotide-triphosphate bases
DS spherical dioptres
DZ dizygotic twins
EDTA ethylenediaminetetraacetic acid
ETDT Extended Transmission/Disequilibrium Test
FBAT Family Based Association Test
G guanine
GC guanine-cytosine content
gDNA genomic deoxyribonucleic acid
H2 broad sense heritability
h2 narrow sense heritability
H2r residual heritability
H2ql heritability due to the specified quantitative trait locus
HBAT (haplotype) Family Based Association Test
HC1 hydrochloric acid
hLOD heterogeneity logarithm of odds ratio
HW Hardy Weinberg
HWE Hardy Weinberg equilibrium
IBD identity by descent
IBS identity by state
K keratometry reading of corneal curvature
KC1 potassium chloride
KOH potassium hydroxide
L.E. left eye
LINKAGE Linkage analysis software
LMM least minus meridian
LOD logarithm of odds ratio
Mar The Centre for Medical Genetics, Marshfield Clinic
MCMC Markov Chain Monte Carlo
MDA multiple displacement amplification
MG multi-generational family
MgCl2 magnesium chloride
MLE maximum likelihood estimate
MMM most minus meridian
mRNA messenger ribonucleic acid
MSE mean spherical equivalent
MZ monozygotic twins
NaCl sodium chloride
(NH4 )2 SC>4 ammonium sulphate
OMIM online Mendelian inheritance in man
PAL progressive addition lenses
PBAT Power calculation of Family-Based Association Tests
PCR polymerase chain reaction
PEDCHECK Pedigree error checking software
QTL quantitative trait locus
R.E. right eye
RGP rigid gas permeable
RNA ribonucleic acid
Rx refractive error
S.A.G.E. Statistical Analysis for Genetic Epidemiology
SDS sodium dodecyl sulphate
Sib sibling
SLINK Linkage simulation software
SLRP small leucine-rich proteoglycans
SNP single nucleotide polymorphism
SOLAR Sequential Oligogenic Linkage Analysis Routines (variance
components linkage analysis)
T thymine
TDT Transmission/Disequilibrium Test
TDTEX TDT software
TE tris-ethylenediaminetetraacetic acid buffer
Tm melting temperature
TNE tris-sodium- ethylenediaminetetraacetic acid buffer
tSNP haplotype tagging single nucleotide polymorphism
U uracil
VA additive genetic variance
VP phenotypic variance
WGA whole genome amplification
WTAC 42nd Wellcome Trust Advanced Course. Human Genetic Analysis:
Genetic Analysis of Multifactorial Disease.
A* sibling recurrence risk ratio
0 recombination fraction
Chapter summary and aims
Chapter one provides an overview of the basic principles involved in this thesis. The 
background describes the trait under investigation- refractive error- concentrating on 
one extreme of the condition; high myopia. An overview of inheritance and the tools 
used to construct inheritance patterns is provided and a discussion of the alternative 
methodologies is presented.
For any genetic study, a cohort of subjects needs to be recruited. The methods and 
results of the recruitment process used are presented in chapter two, along with a 
description and summary of the cohort and their trait characteristics.
Chapter three investigates the trait characteristics of the large Irish-Welsh pedigree 
and the heritabilities thereof using several different methods. The higher the 
heritability o f the trait, the stronger the genetic basis, so providing a measure of 
potential success o f locus mapping for that trait.
Genotypes of the subjects’ samples provide the raw data for the genetic analysis. In 
order to avoid the limitations present for epidemiological studies requiring DNA 
samples in the form of blood, mouthwashes have been used to increase sample size 
and also ease of collection. Chapter four presents arguments in favour of this method 
of DNA sample collection and also investigates the benefits o f the method of whole 
genome amplification to overcome the limitations brought about by sample depletion. 
Quality and quantity of DNA from the Irish-Welsh family samples are investigated.
Chapter five presents a background of different genetic analysis methods along with 
the basics of molecular biology related to genotyping and DNA. Genotyping results at 
loci previously linked to myopia provide the raw data to perform the linkage analysis. 
The presented results of the analysis will indicate the presence or absence o f linkage 
to previously identified high myopia loci for this Irish-Welsh pedigree.
Using the cohort o f trios recruited, an association study was performed for the MYOC 
gene, which encodes the protein myocilin and has previously been found to be 
associated with high myopia in a Hong Kong population. Chapter six presents a 
description of the methodological basis provided and the results of three association 
study strategies.
Chapter seven is a summary o f the findings and general discussion of the work 
undertaken.
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1. Linkage Analysis in High Myopia-An Introduction.
1.1. Myopia
1.1.1. Refractive Error
Refractive error is a quantitative trait and has a continuous distribution within the 
population (Bear, 1991). The frequency distribution of ocular refraction is 
leptokurtotic rather than normal and is skewed towards myopia (Sorsby et al., 1957). 
Figure 1.1. shows the frequency distribution of refractive error in a population 
attending optometric practice, n=88048. This data is taken from a database of patients 
attending optometric practice in the North-West of England and Scotland, courtesy of 
Conlons Opticians Ltd.
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Figure 1.1. Frequency distribution o f  refractive error o f  the right eye (RE) in the least minus meridian 
(LMM) in dioptres (D).
Myopia is defined as a refractive condition in which parallel rays of light are focused 
in front of the retina with relaxed accommodation. This occurs due to the eye having 
either a vitreous chamber depth that is too great for the refractive power of the eye or
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an ocular refractive power that is too great for the vitreous depth of the eye 
(Grosvenor and Goss, 1999) (figure 1.2.).
High myopia (generally classified as a refractive error o f -6.00D or over) is typically 
the result of abnormal lengthening of the vitreous chamber. It is associated with a 
higher risk of glaucoma, cataracts, macular degeneration and retinal detachments 
(Saw et al., 2005) and is, therefore, one o f the major causes o f blindness in the U.K. 
working age population.
Severity is often used as a threshold for myopia classification in myopia studies, 
either by dichotomising the trait (section 1.2.6.1.1) or dividing it into several sub­
categories o f magnitude i.e. mild, moderate and marked.
Alternative ways to classify myopia include age of onset (Grosvenor, 1987). The 
suggestion that all myopia can be divided into: congenital, youth onset, early adult 
onset and late adult onset removes any assumptions of causation which can be implied 
when using other classification systems. One such system is based on ocular 
components (axial or refractive myopia) whereas another alternative is that based on 
signs of disease within the eyes: physiologic or pathological myopia.
Curtin (Curtin, 1985) stated that 27-33% of the myopic population are high myopes. 
The prevalence o f the condition varies between populations. For example, in Taiwan, 
Hong Kong and Singapore 60-80% o f young adults have myopia, 15-20% having 
high myopia. In the U.S.A., Europe and Australia only 20-30% of the population are 
myopic and 2-3% are highly myopic (Choo, 2003; Gilmartin, 2004).
The clinical implications and potential consequences of high myopia and the 
increasing prevalence within the population (Gilmartin, 2004) emphasises the need to 
identify the underlying mechanisms of this disease.
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1.1.2. Ocular Components
The refractive system of the human eye is made up of several individual refractive 
components (figure 1.2). The first surface, the cornea, is a convex refracting surface 
with a power of approximately +42.00D. The light then passes through the anterior 
chamber to reach the crystalline lens, which has an accommodative facility allowing a 
changeable focus. The equivalent power is approximately +20.00D in its weakest 
form. The light is focused onto the retina after passing through this optical system, the 
retina being on average 24mm behind the cornea, this distance is known as the axial 
length (Tunnacliffe, 1993). In emmetropic eyes, the corneal power and axial lengths 
are well correlated and it is the breakdown of the correlation between these refractive 
components which occurs in an ametropic eye (Sorsby et al., 1957). With increasing 
ametropia, extreme values are apparent in the axial length rather than with the corneal 
power. This, along with the observations that lens power varies little and anterior 
chamber depth appears to be only loosely related to axial length and refractive error, 
suggests that axial length is the primary determining component of refractive error.
Lens
Anterior Chamber Depth
Vitreous Chamber Depth
Radius of Corneal Curvature
Axial Length
Figure 1.2. Ocular components o f refractive error. In an emmetropic eye the light is focused onto the 
retina (solid line). In a myopic eye, the light entering the refractive system will be focused in front o f 
the retina (dashed line).
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1.1.3. Aetiology and associations with myopia
1.1.3.1. Myopia and near work
There is strong evidence for the contribution of non-genetic factors to myopia 
development including age, occupation, ethnicity, intelligence and near work. Studies 
have reported that associations can be found with near work but not necessarily 
causation (Rosenfield and Gilmartin, 1998).
Evidence for this comes from examining the change in prevalence o f myopia within 
different populations with changing or different near work demands. In populations 
such as precontact Africans, Eskimos and Australian Aborigines where the mode of 
life involves hunting and gathering, reduced visual acuity was very uncommon as this 
would put individuals at a selective disadvantage (Bear, 1991). In Native American 
populations in Alaska and northern Canada, low myopia has increased in prevalence 
since World War Two, coinciding with the introduction of compulsory formal 
education and therefore an increase in exposure to prolonged periods o f near work. It 
has also been found that myopia is much rarer in illiterate compared to literate 
populations (Lithander, 1999).
Studies have also shown that within groups of individuals who have occupations or 
lifestyles in which a lot of near work is required, the prevalence o f myopia is higher 
(Goldschmidt, 1968; Curtin, 1985; Bear, 1991; Shimizu et al., 2003).
There are several ways in which near work may induce myopia. One such theory 
comes from animal studies which have shown that defocus of the retinal image due to 
light focusing behind the retina induces myopia (section 1.1.4.). On correcting myopia 
in the distance with spectacle or contact lenses, the eye is required to focus on near 
objects by altering the curvature of the eye’s natural lens, known as accommodation. 
Generally, individuals do not accommodate accurately, producing less 
accommodative effort than is required, this is known as the accommodative lag and is 
quantified by measuring the difference between the required accommodative demand 
and the actual accommodative response (Gwiazda et al., 2003). This accommodative
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lag causes the image to be positioned behind the retina. Myopes particularly have 
been found to accommodate significantly less than emmetropes (Gwiazda et al.,
1993), especially early onset myopes (Nakatsuka et al., 2005).
Clinical studies have been based on these findings and have attempted to slow myopia 
progression by the use of multifocal spectacle lenses to ensure that the image is 
focused clearly on the retina at all viewing distances and so compensates for the lag of 
accommodation. Lenses used are either: 1. a bifocal lens with the top portion
correcting the vision in the distance and the lower portion with a shorter focal length 
to correct vision for near distances, such as for reading, or
2. a progressive addition lens (PAL) 
which has a smoother progression from the distance correction to the near. These 
multifocal lenses reduce the amount of accommodation required to place the image at 
near onto the retina.
Reduced accommodation has been found to be associated with a shift in heterophoria 
towards esophoria (Fulk et al., 2000; Gwiazda et al., 2003). That is, when the eyes are 
dissociated, they move out of alignment to rest at their natural position and realign 
when viewing objects binocularly. In esophoria the natural resting position of the eyes 
is slightly converged. Therefore in order for the esophore to maintain binocular single 
vision at near, the accommodation must be relaxed to reduce the accommodative- 
convergence to overcome the esophoria and so increasing the lag of accommodation. 
The treatment with multifocal lenses is, therefore, more applicable to this sub-section 
of myopes. In a single vision versus PAL study, the myopia in esophoric subjects 
corrected with single vision lenses progressed more than twice as much as the non 
esophores (Brown et al., 2002). The Correction of Myopia Evaluation Trial (COMET) 
(Gwiazda et al., 2003) found that the children with larger accommodative lags 
developed significantly more myopia than those with smaller lags. Those children 
with larger lags and increased near work had a larger treatment effect of the myopia 
progression with PALs than the children with smaller lags or more myopia. Fulk and 
colleagues (Fulk et al., 2000) also found a reduction in myopia progression in myopic 
esophores who were treated with bifocal lenses compared to single vision lenses of 
0.25D over 30 months.
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Other clinical studies have found treatment effects, including a reduction of myopia 
progression of 0.50D in a cohort of Chinese children wearing PALs compared to 
single vision lenses over two years (Leung and Brown, 1999). The results cannot, 
however, support or reject the accommodative theory if the accommodative functions 
of the cohort are not measured but the results are nevertheless useful in gaining a 
more informative picture of the possible aetiology of myopia progression. Other 
studies have found similar effects, but not necessarily statistically significant results.
An alternative trial method includes the attempt to slow progression of myopia by the 
use of contact lenses. Theories behind using this method of refractive correction to 
reduce myopia progression include the possibility that the image on the retina is of 
higher quality and so reducing any blur stimulus for myopia inducement. Also, due to 
its mechanical properties, particularly for rigid gas permeable lenses, the contact lens 
may flatten the cornea slightly and therefore cause a temporary reduction in myopia. 
A recent finding showed that in a study population of school age Singapore children, 
no evidence was found that wearing rigid gas permeable contact lenses significantly 
reduced the progression of myopia (Katz et al., 2003). Changing from a correction of 
spectacles to soft contact lenses was associated with an increase in myopia 
progression in a study which initially corrected the subjects with either bifocals or 
single vision lenses, the rate of progression being slower in the bifocal wearer’s group 
in the first year but remaining the same for both groups in the following two years 
(Fulk et al., 2003).
The Contact Lens and Myopia Progression study (CLAMP) compared the progression 
of myopia in children wearing soft and rigid gas permeable contact lenses over a three 
year period. Initially the children went through a preparatory stage of contact lens 
wear. Those completing this stage with no aversions to the lens wear were randomised 
into two groups of the different lens types. Baseline measurements of refraction and 
ocular component dimensions were taken and the children were followed up at regular 
intervals. Over the three years the RGP wearers’ myopia progressed less than the soft 
lens wearers’ (-1.56 D compared to -2.19D respectively). This reduction of myopia 
progression was limited to only the first year of the trial, possibly due to the change of 
corneal curvature induced by the lens. The comeal curvature steepened more in soft
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lens wearers by 0.26D but there was no statistically significant difference in axial 
length between the two groups (Walline et al., 2004).
Under correction of myopia, that is the prescribing o f spectacle lenses that are less 
than the power required for a clear retinal image at distance, but closer to that required 
for near with a non-accommodating eye, was assessed in a two year study of 
Malaysian myopes aged between 9-14 years. The children were randomised into one 
group o f fully corrected spectacle wearers and one wearing spectacles with an 
undercorrection of +0.75D. This resulted in the under-corrected group showing a 
greater axial length elongation than the fully corrected group, suggesting under­
correction as an ineffective and unwarranted method of myopia control (Chung et al., 
2002).
A recent study looked at the effect of correcting children by monovision in an attempt 
to reduce accommodative lag and therefore myopia progression (Phillips, 2005). A 
cohort of 18 children was prescribed a distance prescription for their dominant eye 
and a near correction of approximately +2.00D difference for their non-dominant eye. 
The results of which found that the children were accommodating over their distance 
prescriptions and using their dominant eyes to read. However, there was a significant 
difference in myopia progression (0.36D per year) and vitreous chamber depth 
(0.13mm per year) between the two eyes suggesting differing optical consequences 
for uni- and bilateral undercorrection and that the myopic retinal defocus experienced 
by the undercorrected eye counteracted the abnormal axial elongation.
In the same way that clinical studies have used multifocal lenses to reduce the 
accommodation required, other studies have trialled pharmaceutical agents to do the 
same in an attempt to reduce myopia progression. Accommodation is controlled by 
the activity o f the ciliary muscle which is connected to the lens by zonules. As the 
ciliary muscle contracts, the tension in the zonules is released and the lens changes 
shape to focus the image at near. When the eye is relaxed, the zonules resume their 
tension and the lens returns to its thinner, less curved shape. Paralysing the ciliary 
muscle will prevent accommodation and is known as cycloplegia. This is done by 
targeting the muscarinic receptors o f the ciliary muscle with pharmaceutical agents. In 
one double-masked randomized trial, a progression o f only 0.42D of myopia over 18
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months was found in a group of children treated with the non-specific anti-muscarinic 
agent atropine with multi-focal lenses compared to 1.19D in the multi-focal lens 
wearers without atropine and 1.40D in the single-vision lens, placebo control group 
(Shih et al., 2001). Pirenzipine has a similar muscarinic antagonistic action to 
atropine, but acts selectively on the Ml receptors thereby reducing effects of 
cycloplegia and mydriasis (dilation of the pupil). It also has fewer side effects and is a 
less toxic drug. A 2% gel formulation was found to reduce myopia progression by 
approximately 50% over a one year period (Tan et al., 2005). Due to the specificity of 
the target receptor sites o f this drug and its reduced cycloplegic action, these findings 
support that of animal work suggesting that myopia development is independent of 
the accommodation mechanism (Tan et al., 2005).
So far these studies have not been able to find a system of clinical management of 
myopia which will reduce its progression (Table 1.1). Whilst some studies show 
significant treatment effects (Leung and Brown, 1999; Fulk et al., 2000; Shih et al., 
2001; Fulk et al., 2003; Gwiazda et al., 2003; Walline et al., 2004; Tan et al., 2005), 
especially for near-esophoric myopes, a clinically significant effect to change the 
prescribing guidelines for clinicians has yet to be produced. If an effective treatment 
is proposed there are many effects that could have a major influence on the reliability 
and success o f this treatment. When prescribing multifocal lenses to children there is 
the increased cost o f the lenses and the potential problems of adaptation to consider as 
well as the social implications for the child. Contact lenses also have a factor o f non- 
compliance due to hygiene and care issues. The increased number o f after-care visits 
as well as increased cost and increased risk of health complications would be issues to 
tackle. Side effects of pirenzipine would pose problems such as a degree of mydriasis 
and cycloplegia, although these would be reduced compared to atropine (Tan et al., 
2005). Compliance would also be a major difficulty to this treatment. This option 
does seem, however, the most likely source of a potential treatment due to the success 
of the trials (Tan et al., 2005). Table 1.1 shows a summary of some of these and oher 
trials, the strong evidence and potential of treatment appears to be with the 
pharmaceutical agents.
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Table 1.1. Patient, study characteristics and outcomes of randomized clinical trials taken from (Saw et al., 2002)
Study Country Methods Masking Total
Randomized
Intervention Follow up 
(years)
Group rates 
(Dioptre/year)
Evidence
Yen 1989 Taiwan Parallel RCT 
Baseline similar
No 247 1% atropine 
l%cyclopentolate 
Normal saline*
l -0.22 (0.54) 
-0.58 (0.49) 
-0.91 (0.58)
B,I
Shih 1999 Taiwan Parallel RCT 
Baseline similar
Single 200 0.5% atropine 
0.25% atropine 
0.1% atropine 
0.5% tropicamide*
2 -0.04 (0.63) 
-0.45 (0.55) 
-0.47 (0.91) 
-1.06(0.61)
B,I
Shih 2000 Taiwan Parallel RCT (central 
office)
Baseline similar
Double 227 0.5% atropine 
Multifocals 
Single vision*
1.5 -0.28 (0.05) 
-0.79 (0.05) 
-0.93 (0.06)
B,I
Schwartz 1981 USA Parallel RCT in twins 
Baseline similar
Single
(assessor)
26 pairs 1% tropicamide 
Single vision*
3.5 Paired analysis c,i
Grosvenor 1987 USA Parallel RCT (random 
number table). Baseline 
similarity unknown
No 207 Bifocals +2.00D 
Bifocals +1.00D 
Single vision*
3 -0.32
-0.34
-0.32
c,i
Parssinen 1989 Finland Parallel RCT (sealed 
envelopes)
No 240 Bifocals +1.75D 
Single vision (distance 
only)
Single vision*
3 -0.56 (0.3) 
-0.59 (0.3)
-0.49 (0.3)
C,I
Jensen 1991 Denmark Parallel RCT 
Baseline similar
No 150 Bifocals +2.00D 
Single vision + 0.25% 
timolol 
Single vision*
2 -0.48 (0.28) 
-0.59 (0.30)
-.57 (0.36)
C,I
Fulk 1996 USA Parallel RCT (sealed 
envelopes)
Baseline similarity 
unknown
Single 32 Bifocals +1.25D 
Single vision*
1.5 -0.39 (0.12) 
-0.57(0.11)
C,I
Fulk 2000 USA Parallel RCT 
Baseline similar
Double 82 Bifocals +1.50D 
Single vision*
2.5 -0.40 (0.27) 
-0.50 (0.26)
C,I
Homer 1999 USA Parallel RCT 
Baseline similar
Single 175 Soft contact lenses 
Single vision*
3 -0.36 (0.03) 
-0.30 (0.03)
C,II
* Control group; D Dioptres; RCT Randomized Clinical Trial
B = moderately important information; C = relevant but not critical recommendation; I = strong evidence supporting recommendation; II = substantial evidence supporting 
recommendation but lacking some qualities required for strong support.
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1.1.3.2. Myopia and other associations
Myopia has been found to have an association with a number of other factors, for 
example ethnicity (section 1.1.1.) and IQ (Saw et al., 2004b). A retrospective study by 
Chong and colleagues investigated the prevalence o f myopia in children who were 
breastfed and in those who were not. The results showed that 62.0% of breast fed 
children were myopic, compared to 69.2% of children who were not breast fed, giving 
an odds ratio of 0.73 and therefore a protective effect. The authors speculated that this 
was due to the increased levels of docosahexaenoic acid passed to the child in the 
mother’s milk, which is beneficial for neurodevelopment (Chong et al., 2005).
A study o f a Japanese population found an association of myopia with higher 
education and management based occupations in men. For women, an association 
with high income and clerical based occupations was found (Shimizu et al., 2003). 
The clerical work and education associations support the hypothesis that increased 
near work may be associated with myopia.
Subjects bom prematurely are at a higher risk of developing myopia than babies bom 
at full term, the incidence increasing with decreasing gestational age and incidence of 
retinopathy o f prematurity (Fledelius, 1996; Snir et al., 2004).
Other studies have investigated such factors as diet (Edwards, 1996), night lighting 
(Gwiazda et al., 2000; Zadnik et al., 2000) and parental smoking (Saw et al., 2004a) 
but found no clinically significant association.
1.1.3.3. Myopia and association with systemic and ocular disease.
Myopia is manifested in a number o f rare, monogenic disorders (reviewed by (Curtin, 
1985)).
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Albinism is caused by a pigment deficiency and mainly affects the skin and hair, but 
primarily structures o f the eye. A study by Edmunds and colleagues in 1949 found a 
high myopia prevalence of 12% in a group o f albino subjects (Edmunds, 1949).
Stickler syndrome causes skeletal abnormalities producing premature degeneration of 
the joints. Ocular associations of Stickler’s syndrome include high myopia, anterior 
chamber abnormalities and secondary glaucoma. It can be defined as type I (Online 
Mendelian Inheritance in Man (OMIM) #120140) or type II (OMIM #604841), this 
classification depending on the gene within which the mutation occurs which, in turn, 
gives rise to a different vitreous phenotype. A mutation in COL2A1, which codes for 
the ai chain o f type II collagen, produces a membranous vitreous phenotype. 
Approximately two thirds o f families affected by Stickler syndrome are linked to this 
gene (Richards et al., 1996). Less common is a mutation in COL11 A l, which codes 
for the aj chain o f the collagen type XI molecule, producing a type II vitreous 
phenotype described as “beaded” (Martin et al., 1999). There are other phenotypic 
differences between the two classifications o f individuals. Subjects with the type I 
Stickler syndrome commonly have the additional ocular complications o f retinal 
detachment and vitreous degeneration whereas these signs are seldom seen in subjects 
with type II. However, hearing loss is quite common in type II Stickler syndrome but 
not in type I. An alternative mutation has also been shown to be linked to Stickler 
syndrome with the gene COL11A2 but this shows no ocular involvement (Richards et 
al., 1996).
In Marfan syndrome (OMIM #154700) a prevalence of myopia o f 83% has been 
found (Curtin, 1985). The main characteristics of this disease include elongation and 
thinning o f the long bones. Cardiac, pulmonary and renal problems are also often 
associated. Ocular abnormalities include upward subluxation o f the lens, a higher 
incidence o f cataract and abnormalities of the trabecular meshwork and outflow 
system. All cases o f Marfan syndrome appear to be due to a mutation in the gene 
FBN1 which codes for fibrillin which is found in the connective tissues. Mutations of 
this gene also cause Weill-Marchesani syndrome (OMIM #608328), another 
connective tissue disorder associated with high myopia.
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Homocystinuria (OMIM +236200) is a metabolic disorder and is mainly associated 
with ocular complications of ectopia lends as well as myopia.
The prevalence o f high myopia is approximately 27%  in subjects with Down 
Syndrome (OMIM #190685) but there is also a high prevalence o f keratoconus 
(OMIM #605020, #608932, #608586, #609271) of approximately 15% (Shapiro and 
France, 1985; Van Allen, Fung and Jurenka, 1999) which is also associated with 
myopia.
Other ocular complications associated with myopia include congenital stationary 
night blindness, nystagmus, retinitis pigmentosa and cataracts. Cataracts particularly 
have a high association, especially with high myopia. The association with cataracts 
has also been found in a number o f studies based on different types o f cataracts 
although care has to be taken to avoid including those individuals with index myopia; 
the cataract therefore causing the myopia (Weale, 2003). A study carried out in the 
Blue Mountains, Australia revealed a high risk of developing posterior sub-capsular 
cataract for high myopes (OR=5.5) compared to an inversely related association with 
hyperopes (OR=0.6). The risk was greater with increasing myopic refraction (Lim et 
al., 1999). This same Blue Mountains’ study population was used to investigate the 
associations o f myopia with glaucoma. The results showed that myopic subjects had a 
two-to-threefold greater risk o f developing glaucoma than emmetropes (Mitchell et 
al., 1999). This result was supported by the Beijing Eye Study, which found an odds 
risk ratio of 7.56 of high myopes developing glaucoma compared to non-myopes (Xu 
et al., 2006).
The association of high myopia with systemic diseases was investigated in a 
community based population of children. It suggested 56% of highly myopic children 
had no systemic disease association but 19% had associations with Stickler’s 
syndrome, Weill-Marchesani syndrome or homocystinuria. Ocular abnormalities such 
as amblyopia or retinal dystrophies were found in 25% of the children (Logan et al., 
2004). A separate study based in a hospital ophthalmology department found only 8% 
of highly myopic children had no underlying systemic or ocular association, the 
difference in prevalence of this association with the previous study may be due to the 
population base, the hospital department being a more likely situation in which to see
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a high concentration o f complex cases than in community based clinics. Systemic 
associations as above including Down’s syndrome and prematurity were found in 
54% of the children and the remaining 38% had ocular problems, similar to those 
mentioned and including lens subluxation and coloboma (Marr et al., 2001).
Even though the associations are common within these cohorts, high myopia is still 
found in only a small section of the population, approximately 2%. In children this 
number is much smaller. A cohort of 7600 school children aged seven had a myopia 
prevalence (more than -1.00D) of only 1.1% (Barnes et al., 2001). Conditions such as 
Stickler and Marfan syndrome are even rarer having a prevalence o f only 0.0001% 
and 0.005% respectively in the general population and as there is an age dependency, 
this will be even smaller in children.
These syndromic disorders are relatively rare conditions and, although a genetic study 
of a cohort of families with myopia associated with one of these will provide greater 
power than non-syndromic myopia due to the increased genetic homogeneity, it will 
not identify those genetic risk factors applicable to the general population. Therefore 
any condition which causes or is associated with myopia acts as an exclusion criterion 
for contributing to a genetic study that aims to investigate genetic risk factors for a 
general population. These ocular or systemic associations can be identified either by 
observing clinical signs or by genetic screening and will ensure the basis o f the 
disease is not confounded by these factors.
1.1.4. Animal Models of Myopia
Inducing myopia in animal models such as tree shrews, chickens and monkeys 
enables investigations into the mechanisms controlling the development of myopia. 
Form deprivation is a commonly used method, degrading the retinal image by adding 
a frosted lens in front o f the eye. Many studies found this causes axial elongation, 
primarily of the vitreous chamber (Irving et al., 1992).
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Eye length is controlled during post-natal development, in order to keep the focused 
image on the retina by using visual feedback. During a critical period of development, 
myopia can be induced by simulating an innate refractive error, e.g. by fitting a lens 
of known power in front of the eye. When an eye is fitted with a positive lens this will 
induce myopic blur, causing distant objects to be blurred. Over a period of days or 
weeks, the retina will be moved towards the focal point o f the image by reducing the 
rate of axial elongation and increasing the choroidal thickness. The opposite will 
happen when the eye is fitted with a negative lens, the hyperopic blur causing the rate 
of axial elongation to increase and the choroid to reduce in thickness (Zhu et al., 
2003).
Chick studies have shown that not only will the eye attempt to emmetropise, but 
suggest that the sign of blur can be distinguished and therefore guide the growth 
towards emmetropia (Park et al., 2003). More investigations have looked at the effect 
of blur exposure time on lens compensation (Winawer and Wallman, 2002; Zhu et al., 
2003) which found that brief periods of myopic defocus may contribute to a 
protective effect, reducing the rate o f myopia progression which implies the amount 
of defocus is not summed linearly for myopic or hyperopic defocus. Whether these 
principles may be useful for human eyes remains to be seen. Winawer (Winawer et 
al., 2005) has suggested that the total time spent on near work not taking into account 
the time spent looking into the distance and the defocus produced, cannot predict the 
degree o f myopia.
The precise aetiology o f myopia progression is, as yet, unknown. It is likely that this 
trait is under the control o f a number o f factors, including environmental and genetic 
influences. Clinical and experimental studies along with genetic studies will provide 
an insight into possible mechanisms of refractive error development.
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1.2. Genetic Analysis
Linkage analysis is a tool used to identify areas of a chromosome which cosegregate 
along with a trait and therefore may contain a causative gene. A background to 
linkage analysis and its underlying principles are described below.
1.2.1. DNA sequences, constituents and function with relation to 
genetic analysis
An organism’s complement o f deoxyribonucleic acid (DNA) is called the genome. 
The human genome is made up of 23 paired chromosomes, each o f which consists of 
a chain of genes. Genes are long sequences of DNA, variants o f which are called 
alleles. The human genome contains around three billion base pairs o f DNA which 
codes for approximately 30 000 genes.
Genes have several functions. Firstly, replication is necessary in order to maintain the 
continuation of the species. Secondly, genes contain information regarding a specific 
protein and therefore a specific function. This function being either as a structural 
component o f the cell or involvement in a chemical process within the cell, enabling 
the cell, and therefore the organism, to function.
Considering these 30 000 genes and approximately 100 000 proteins that are present 
within the human body, it is extremely unlikely that each gene is responsible for only 
one function alone. Each gene will code for a different number o f proteins due to 
alternative splicing or post-translational modifications. It is the interaction between 
these different proteins produced and expressed along with environmental factors that 
determine the trait rather than there being a direct relationship between DNA 
sequence, protein expression and functionality.
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1.2.1.1. DNA
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DNA consists o f two intertwining chains of nucleotides, the nucleotides themselves 
comprising a phosphate, a pentose sugar and one of four bases: guanine, cytosine (the 
purines), adenine or thymine (the pyrimidines). The nucleotides are joined together to 
form a polynucleotide chain with a phosphate backbone. The two polynucleotide 
chains are held together by hydrogen bonds joining complementary bases together. 
Specifically adenine will bind exclusively to thymine and cytosine only to guanine. 
The complementary nature o f the base pairs and the hydrogen bonds between them 
maintains the double helical structure and therefore the stability o f the molecule.
1.2.1.2. Protein Synthesis
The synthesis o f protein is required to maintain the constituents and the viability of a 
cell during its renewal and the growth and development of an organism. There are 
three steps in this process: replication, transcription and translation. If the protein 
synthesis is inaccurate, changes occur within the sequence and may alter the function.
1.2.1.2.1. Replication
During replication o f the DNA the two polynucleotide chains will separate and each 
will act as a template for new strands composed of complementary bases. Once 
replicated each strand can, once again, separate from its template and so act as a new 
template for further replication.
1.2.1.2.2. Transcription
The sequence of DNA bases represents a code for synthesising proteins, the order and 
content of the gene in turn defining the function (of which there may be one or more 
within the system). During the process of transcription, the DNA sequence is
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replicated with complementary bases and a ribose sugar in place of the deoxyribose 
sugar to produce a single strand of ribonucleic acid (RNA). This is similar in structure 
to DNA, the difference, along with the alternative sugar, is the replacement of 
thymine with a different nitrogenous base, uracil. RNA molecules which code for 
proteins- messenger RNA (mRNA) - leave the nucleus of the cell and transfer to the 
cytoplasm where protein synthesis occurs.
1.2.1.2.3. Translation
The next step o f this process is translation, in which the sequence o f mRNA bases is 
decoded. The mRNA sequence is read three bases (a codon) at a time. Each codon 
binds to a specific amino acid, which is attached by means of a transfer RNA 
molecule, a complementary three base sequence attached to the amino acid. As the 
complementary bases attach to the RNA, an amino acid chain is built up to form the 
protein, the structure o f which is regulated by its sequence. If this sequence is altered, 
the structure of the protein is altered which can potentially affect its function. 
Malfunctioning genes may be unable to maintain the organism’s chemical processes 
and so can lead to the expression of a disease phenotype.
1.2.1.3. Genes and alleles
A gene is made up a sequence of DNA which comprises of areas which will 
transcribe proteins, exons, and interspersed sequences which do not perform this 
function, introns. Marking the gene’s boundaries are a promoter region to which 
proteins bind and initiate the transcription and, at the other end, an area marking the 
end point o f transcription.
Genes are connected in a linear fashion to produce chromosomes of which humans 
have 23 pairs. The nucleus o f most cells of the human body will contain all of these 
chromosomes. Gametes will, however, only have one of each pair o f chromosomes 
and therefore offspring only inherit half o f their genetic information from one parent
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and half from the other, described as Mendel’s first law. A point on a chromosome, a 
locus, will be paired with its homologous chromosome, the other one in the pair, and 
the two gene variants (alleles, see below) at that locus will describe that individual’s 
genotype.
Microsatellite markers are tandem repeats of nucleic acid bases mostly found within 
introns, for example, a dinucleotide repeat of CA. Each allele (i.e. a variant form of a 
gene or specific polymorphic site (Terwilliger and Goring, 2000)) is represented by a 
different number of repeats, i.e. a sequence of three repeats may be allele 1, and four 
repeats may be allele 2. Considering a pair of homologous chromosomes, there will 
be two alleles for each marker, i.e. a genotype. Linkage analysis makes use of these 
variations in DNA sequences within genes, to investigate the cosegregation of a trait 
and specific areas o f a chromosome.
Each marker locus has a specific number of alleles. The higher the possible number of 
alleles of a marker, the more likely it is that an individual will be heterozygous at that 
locus: that is, they will have a different allele on each of their homologous 
chromosomes. When tracing the inheritance o f an allele through a pedigree, a more 
definite pattern o f which parent the allele has been inherited from can be made if the 
individuals are heterozygous and therefore the more informative the genotypes are for 
linkage analysis. This measure of informativeness is known as the heterozygosity 
(equation 1.1.) and should be considered when choosing the most efficient and 
informative markers to use when genotyping individuals within a genetic study.
H=l- £  Pi2
i=l
Equation 1.1. Heterozygosity. Where H is the heterozygosity, p  is the frequency o f the ith allele at the 
locus and n is the number o f alleles
Chapter 1. Linkage analysis in high myopia: Introduction 33
Another consideration is the spacing of the markers and the genetic distance the 
analysis will cover. A genome scan will space markers, on average, approximately 
lOcM apart whereas investigating a targeted region o f chromosome requires a denser 
distribution. A centimorgan is the genetic distance based on the recombination rate, 0. 
Two points on a chromosome lcM apart will have a 1% chance o f having a 
recombination occurring between them. The denser the spacing of markers across a 
chromosomal region, the more information is obtained. However, for linkage analysis, 
spacing o f markers o f lcM  will give 100% information content and increasing the 
density will not significantly increase the power to detect linkage (Ulgen and Li,
2005).
A vital tool for genetic analysis is the knowledge of recombinations within 
chromosomes. During meiosis, at the prophase I stage in cell division, the 
chromosomes may come together and exchange homologous parts. This 
recombination or “crossing over” results in a different sequence o f DNA on the 
offspring’s chromosome compared to that of the parents. Recombination will happen, 
on average, once between each chromosome pair per meiosis. The further apart any 
two loci are on a chromosome, the more likely a crossing over will occur between 
them and so it is less likely that alleles at these loci will be inherited together. The 
recombination fraction, 0, defines the genetic distance between two loci and is a 
function o f the probability that a crossing over will occur between the two loci. It can, 
therefore, be used to map the position o f a locus on a chromosome. The 
recombination fraction will not exceed 0.5, this occurring when there is no linkage 
since the probability that an allele will be inherited from either parent by chance is 
50%.
For a genetically based trait, the genotype at one or more loci will determine the 
phenotype o f the individual. For a dichotomous trait, a particular allele at a locus may 
determine whether that individual is affected with the disease o f interest. For a 
quantitative trait it may determine the value or extent to which the individual is 
affected.
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Molecular biology methods are used to identify genotypes of individuals at specific 
pre-designated loci for use in linkage analysis.
1.2.1.4. Microsatellite Genotyping
This process involves identifying the genotype at each locus under investigation by 
differentiating between the size of the fluorescently labelled polymerase chain 
reaction products and therefore between alleles. The techniques involved are 
described below.
1.2.1.4.1. Polymerase Chain Reaction
This is a method of amplifying a specific sequence o f DNA. A “master mix” is 
prepared which contains all o f the required ingredients for the amplification. The 
master-mix is added to the DNA template and includes a buffer to optimise the 
chemical conditions for the reaction. Magnesium chloride ions are used as a cofactor 
for the enzyme, Taq DNA polymerase which is stable at high temperatures and 
initiates the amplification. Deoxynucleotide-triphosphate bases are used to extend 
from the primer strand and create the new sequence producing a new complementary 
strand o f DNA. The primers are short sequences of DNA designed to be 
complementary to sequences surrounding the target section o f DNA. They are 
designed to work optimally under the chosen PCR thermal cycling parameters in that 
they should have a specific melting temperature (Tm, approximately 50-65°C) and 
guanine and cytosine content (GC content between 40-50%). The initial stage of the 
PCR denatures the template DNA by separating the double stranded helix. Due to 
their complementarity, primers attach to sites on the sequence strands surrounding the 
section of DNA to be amplified, the amplimer. This process is known as annealing 
and the temperature that this occurs at during the cycling procedure can be tailored to 
optimise the efficiency o f the reaction. The dNTP bases are taken from the mastermix 
and are joined to the primer creating a new complementary strand and so a new 
double stranded DNA molecule. In the second cycle of the reaction, this double
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stranded molecule is again denatured and a new primer attaches at the complementary 
strand. This procedure continues until all of the ingredients are depleted and the 
reaction is saturated, or the number of cycles requested has been completed, resulting 
in PCR product o f the specified sequence and length. Genotyping subjects at specific 
loci where microsatellite markers exist within the amplimer requires use of this 
technique, specifically using fluorescently labelled primers in the PCR to recognise 
alternatively sized molecules and so differentiate between alleles.
1.2.1.4.2. Primer design
Primers are specifically designed to be compatible with the PCR cycling parameters, 
by considering Tm and GC content (section 1.2.1.4.1.). Due to the required specificity 
of genotyping the procedure must be exactly complementary and amplimers must be 
amplified accurately. Certain primers may encourage the addition o f an extra 
adenosine base to the product. In order to eliminate the potential genotyping errors 
produced by the uncertainty of the presence of this extra base, a “PIGtail” can be 
added to the 5’ end o f the primer which will encourage the addition o f an adenosine 
molecule. A GTTTCT PIGtail has been suggested which results in nearly complete 
adenylation (Brownstein et al., 1996) and so eliminates this inconsistency and this 
source o f potential genotyping error.
1.2.1.4.3. Identification o f  genotypes.
Once the PCRs have been performed, the reaction products are run on a DNA 
sequencer. This machine uses an electrophoresis based method to separate the 
differentially sized PCR products and is able to specify exact sizes of each of the 
products and therefore both alleles, in base pairs, using comparisons to a size standard 
and the detection of the fluorescence given out by the labelled forward primer. Each 
sequence length is assigned an allele number and so genotypes are produced.
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When genotyping several loci, to reduce the number of genotype reactions run on the 
sequencer, the markers can be pooled into sets. These should be designed so that each 
set includes markers which have differing product sizes which are not over-lapping. 
Those in close proximity to each other should use a different label from their 
neighbours, these labels being determined by that attached to the forward primer.
1.2.2. Inheritance
How the alleles inherited affect the phenotype of the offspring is dependent on the 
mode o f inheritance of the trait.
Mendelian diseases are inherited dominantly or recessively. In dominant inheritance 
only one copy of a disease allele is required in order to express the phenotype in an 
individual, whereas two copies are needed for a recessive autosomal disease to be 
expressed. A typical, rare dominantly inherited disease will show affected offspring at 
a ratio of 2:1 when one parent is affected. If both parents are unaffected and there is 
an affected offspring the disease must not be inherited dominantly. A recessive 
inheritance pattern shows unaffected heterozygous parents with only one o f four 
offspring to be affected (figure 1.3.).
Dd dd
■ ■
Dd Dd dd dd 
Dominant inheritance
Dd
O
Dd
1
DD Dd Dd dd 
Recessive inheritance
Figure 1.3. Example o f typical recessive and dominant inheritance patterns where D is the dominant 
allele and d is the recessive allele. In the example for dominant inheritance the individual requires only 
one dominant disease allele (D) for the individual to be affected. For recessive inheritance the 
individual is considered affected if the disease allele (d) appears twice in the genotype.
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A phenotype can exist which is different from the homozygous phenotypes and occurs 
for a heterozygote. Here, the locus is said to be codominant and the inheritance model 
additive. This is an important type of inheritance when investigating quantitative traits 
and is based on the biometrical model (figure 1.4.). This model defines a quantitative 
trait in terms of the allele frequencies and genotypic values o f each causative locus 
(Camp and Cox, 2002) and describes the effect produced due to a quantitative trait 
locus (QTL). For example, the additive effect of the alleles may produce a phenotype 
equivalent to an additive value, a. Homozygous genotypes will produce the minimum 
and maximum phenotypes o f -a  and a and the heterozygote will produce a phenotype 
somewhere between these, dependent on the dominance effects; the closer the 
heterozygous trait value is to the midpoint of the homozygous values, the smaller the 
dominance effects of either allele present in the homozygote.
AjAi 0 AjA2 A2A2
d^------- ---------- p
a
-a
Figure 1.4. The additive genetic biometrical model (taken from (Camp and Cox, 2002)) where Aj and 
A2 are the alleles, a is the additive genetic value and d is the dominance deviation.
An additional form o f non-Mendelian inheritance occurs through mitochondria. In 
this case the mutation is generally passed to the offspring by the mother. Mutations in 
the DNA may cause functional problems which most commonly manifest as muscle 
disorders (Weaver and Hedrick, 1997). A strong pattern of offspring affected with the 
disease when the mother is affected is shown due to only a negligible amount of 
mitochondrial-DNA being passed on by the father.
Relating the inheritance of the disease to the actual inheritance of marker alleles is 
achieved by the application o f linkage analysis methods.
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1.2.3. Linkage Analysis
Linkage is present when two loci on the same chromosome are inherited together 
more often than expected by chance. For linked loci the two syntenic loci are close 
enough to each other that recombination during meiosis is uncommon enough for 
their segregation to be detectable within families (Camp and Cox, 2002). Linkage 
analysis is a method which allows the examination of how a particular trait is 
transmitted through a family. If a particular marker allele is transmitted along with the 
phenotype it may be that this allele and the disease pre-disposing allele are linked.
The likelihood that these loci are linked can be calculated by the ratio o f the 
likelihood that they are linked compared to that of not being linked, known as the 
odds ratio (equation 1.2.). For simple pedigrees, this can be calculated by hand, 
identifying the number o f recombinations occurring within the pedigree, having the 
knowledge of the phenotypes and the genotypes at the locus. The logarithm o f this 
odds ratio calculation is taken as the standard measure (LOD score, equation 1.3.) of 
the evidence in favour o f linkage. As the pedigree structure increases in complexity or 
the identification o f the recombinants becomes less apparent due to unknown phase of 
the parental chromosomes (i.e. being unable to identify which o f the offspring’s 
chromosomes were inherited from which parent), the calculation becomes more 
complex and computer based calculations are required.
Odds Ratio = likelihood the disease locus and marker are linked
likelihood the disease locus and marker are not linked
Equation 1.2. Odds ratio
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LOD SCOre — lo g io  [ (1 —0 ) n r.0 r/ ( l / 2 ) n] where n -  number of offspring
r = number of recombinant offspring 
6 = recombination fraction = r/n 
where parental phase is known
Equation 1.3. Logarithm o f odds ratio.
A LOD score o f 3 or more is usually taken as significant evidence for linkage and a 
value of over 2 is suggestive o f linkage. This former value has been shown to be
y
roughly equivalent to a conventional significance level of p=l x 10' and a LOD score 
of less than -2 excludes linkage from that locus (Sham, 1998).
A “twopoint analysis” is performed when linkage is assessed between a trait and each 
marker locus, separately. In general, the higher the LOD score, the closer the marker 
is located to the disease locus. Multipoint analysis uses all o f the markers genotyped 
along a section of chromosome and the position of the disease locus is varied. The 
probability of the locus segregating with the marker taking into account the location 
of the other markers is examined producing multipoint LOD scores. The advantage of 
using multipoint analysis over twopoint is the increase in information gained by use 
of haplotypes for linkage analysis. Haplotypes are the representation o f the genotypes 
along the chromosome. Tracing the inheritance of a haplotype as opposed to an allele 
allows fewer assumptions to be made as any missing data can be allowed for within 
the section, conditional on whether the neighbouring genotypes are present.
1.2.3.1. Assumptions made for linkage analysis 
Linkage analysis involves a number of assumptions:
1. The assumption o f Hardy-Weinberg equilibrium states that the genotype 
frequencies between generations are not changed (see also chapter 6).
2. Linkage equilibrium is also assumed; that is, that genotype frequencies at 
one locus are independent o f those at a second. In reality this is not the case, some 
alleles on the same chromosome are frequently inherited together, i.e. they are in
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linkage disequilibrium. This occurs when the allele is so close to the disease allele on 
the chromosome that there has not been a recombination between them to separate the 
inheritance of the two. The stronger the linkage disequilibrium the more likely the two 
loci are linked (Terwilliger and Goring, 2000).
3. Random mating is assumed. Non-random mating, the mating of two 
phenotypically similar individuals, (chapter 2) will alter the genotype frequencies.
4. No epistasis, i.e. no interaction between alleles at different loci is assumed.
1.2.3.2. Methods of linkage analysis.
There are many different methods involved in genetic analysis. For linkage analysis 
those methods can be classified into two main groups, parametric and non-parametric 
linkage analysis. The preferred method depends on a number of factors, including 
those based on the definition o f the phenotype, the ability to define parameters 
associated with the phenotype and the structure o f the pedigrees collected or to be 
recruited.
1.2.3.2.1. Parametric Linkage Analysis.
Parametric linkage analysis requires a model to be described, so defining the 
relationship between the phenotype and the genotype. Pedigree and genotypic data are 
then fitted to it. In general, the model requires the specification o f the following 
parameters:
■ disease gene frequency,
■ the mode o f inheritance, for example, dominant or recessive,
■ the disease penetrance: the probability o f an individual being affected 
with the disease given the genotype,
■ the phenocopy rate: the probability of being affected by the disease but 
having an alternative genotype,
■ marker allele frequencies and
■ the rate of mutation.
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The actual observed data, i.e. the genotypes at a specific locus within a pedigree, can 
then be compared to the model and the likelihood of linkage is calculated, assuming 
the model is correct. The process relies on a low level of recombination between the 
marker and the trait loci. It also assumes that the locus has a major effect on the 
phenotype and that a defined Mendelian pattern of inheritance is segregating within 
families (Camp and Cox, 2002).
As described above, the model used for the analysis is chosen based on a number of 
factors including the disease allele frequency, the transmission probability and the 
relationship between the unobserved genotypes and phenotype (Camp and Cox,
2002). Providing the model specified is correct, this method is more powerful than 
non parametric analysis, resulting in a lower type I error rate. It will also provide an 
estimate of the recombination fraction, therefore information about the location of the 
disease locus. Mis-specification of the model, however, will lead to a loss in statistical 
power to detect linkage. Specifically, mis-specifying the disease mode o f inheritance 
will have a large impact on the LOD score as will incorrect marker allele frequencies 
especially when a lot of genotypic data is missing. Mis-specifying the penetrance and 
disease allele frequency has little effect on the LOD score (Haines and Pericak-Vance, 
1998).
Although parametric analysis is extremely powerful when correctly specifying the 
model, the method is sensitive to bilineality. When the “affected” phenotype occurs in 
the family in both parents, or in two or more founders of a pedigree, different genes 
may act to produce the same phenotype therefore confounding the analysis. This 
arouses concern because the analysis occurs within pedigrees, not across pedigrees, 
therefore not allowing for this potential heterogeneity.
In general, the chromosomal area linked to the trait may be mapped efficiently, but 
the localized interval will usually be greater than 1 Mb wide, relying on 
recombination events having occurred within the pedigree. Therefore further analysis 
of additional pedigrees is usually required to refine the interval. However, as 
described above, with the correct model specified, the tests are powerful and can 
provide an accurate significance level. There are also many well developed marker 
sets for this purpose.
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1.2.3.2.2. Non parametric linkage analysis
The alternative to parametric linkage analysis is non parametric linkage analysis 
which does not require the specification of model parameters. It is based on 
examining which alleles or sections of chromosomes are shared by affected 
individuals within pedigrees. The concept behind this being that for a genetically 
controlled trait, relatives that closely resemble each other phenotypically, will 
resemble each other genotypically. By sharing alleles or sections o f chromosomes 
more often than expected by chance, it is possible that these regions will have some 
effect on the phenotype. The shared alleles can be classed as identical by descent 
(IBD), where the alleles are inherited from a common ancestor, or identity by state 
(IBS), where the alleles are the same but have not necessarily been transmitted from a 
common ancestor.
Affected sib pair analysis uses families with at least two affected siblings and 
examines the number of alleles shared IBD. By chance they will share 0, 1 or 2 alleles 
at a locus 25, 50 and 25% of the time respectively.
For example, in figure 1.5., sibling 1 has the genotype A C. Considering the parental 
genotypes, sibling 2 has four possible genotypes, one which shares both alleles and is 
therefore genotypically identical to sibling 1, two out of the four possible genotypes 
(i.e. 50% o f the time) show the siblings having only one allele in common. The final 
possible genotype shows the siblings sharing no alleles, sibling 2 inheriting the two 
alternative alleles from the parents. If the proportion of shared alleles is significantly 
larger or smaller than the 25, 50 and 25% proportions in affected sib pairs, it indicates 
that a gene at that locus is linked to the trait. This approach has been used in many 
genetic analyses including the investigation of insulin dependent diabetes mellitus 
(Davies et al., 1994) as a dichotomous trait. Success for QTL mapping using this 
method is not as common. Other affected relative methods can be used: the likelihood 
of excess sharing between more distant affected family members by chance is 
decreased and therefore, if  excess sharing does occur, it is more likely to be the cause 
of the phenotype.
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Figure 1.5. Allele sharing, adapted from (Strachan and Read, 1999)
Variance components methods provide a mechanism for partitioning observed 
phenotypic variance into component parts (see also chapters 4 and 5) and is 
particularly successful for the analysis of quantitative traits. IBD probabilities, i.e. the 
probabilities that alleles are shared IBD between relatives, are calculated from marker 
data of a pedigree. In a similar way to parametric LOD score calculations, two 
alternative models are then fitted, the first where the major gene effect is hypothesised 
to be 0 (i.e. null hypothesis of no linkage to that locus) and the alternative model 
where an estimation of the size of the gene effect is made (i.e. alternative hypothesis 
o f linkage). The two models are fitted at regular intervals along the chromosome and 
compared so that the log likelihood ratio is calculated at each point. The most likely 
position of the quantitative trait locus can then be found based on the significance of 
the LOD scores (Camp and Cox, 2002).
1.2.4. Association
Association investigates the over-representation or under-representation of a specific 
allele in diseased individuals compared to control subjects (Baur and Knapp, 1997) 
(chapter 6). Association tests are commonly used after linkage analysis has identified 
a region harbouring a possible disease gene. The probability of causal action by a 
candidate gene within the linked region is investigated by studying the association
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between the frequency of alleles at polymorphic loci and the presence or absence of 
the phenotype.
Two major strategies can be used in association studies. In case-control studies, the 
allele frequencies o f a population affected with the trait under investigation are 
compared to those o f a matched control population. In family based tests the 
transmission of parental alleles to affected offspring is compared to those alleles not 
transmitted. The preferential transmission of an allele to the affected offspring is 
suggestive o f association.
1.2.5. Heterogeneity
It is possible that several different loci control a particular phenotype, known as locus 
heterogeneity. For example, one locus could control a trait in a particular population 
but in another population, that locus may be unrelated to the trait and an alternative 
locus is responsible for that phenotype. This could be due to differences in the genetic 
background or environmental conditions between populations. Locus heterogeneity 
can confound genetic analyses especially in the case of bilineality.
To include possible locus heterogeneity into the analysis, heterogenous LOD scores 
(hLOD) can be implemented which test the hypothesis of allowing a certain 
proportion of pedigrees within the study population to be linked. This proportion, a, is 
varied, producing a range of possible LOD scores. This increases the power of the 
study as it attempts to eliminate the possibility of, for example, excluding a locus 
which may be linked in some of the families and not in the others. This is because 
some of the families may produce a high LOD score and those not linked will have a 
negative value. The summation of these values may decrease the LOD score so that it 
is below the significant value.
In contrast to locus heterogeneity, in allelic heterogeneity two different alleles at the 
same point cause the same phenotype. Linkage analysis is insensitive to this
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phenomenon but it can have a major influence in association studies, generally 
causing a reduction in power.
1.2.6. Experimental Design
There are a number o f factors to consider when designing a genetic study: the 
definition of the phenotype under investigation, its likely genetic basis and the overall 
power of the study including consideration of the number and structure of pedigrees 
to collect.
1.2.6.1. Phenotype classification
The phenotype is the observed condition of a subject. For example, if  the trait under 
observation is a disease, the phenotype would be either the extent o f that disease, or 
simply if  that individual has the disease or not. Therefore, there are two different ways 
in which a phenotype can be described: as a dichotomous (binary) value, or as a 
quantitative measure. In binary traits there are only two options and so the phenotype 
is either “affected” or “not affected”. However, continuous traits such as refractive 
error may provide the investigator with more information. A quantitative measure 
potentially provides a greater power, especially if  the genotype-to-phenotype 
relationship is direct.
1.2.6.1.1. Quantitative and dichotomous traits
As mentioned above, a dichotomous trait is one in which there are only two 
possibilities for the phenotype. This affectation status defines whether the individual 
is affected or unaffected with the disease. If the measured trait is quantitative, a 
threshold approach can be applied (figure 1.6.). A certain value, x, is defined as the 
threshold value, any value above this stated phenotype is classified as affected, below 
this as unaffected. This is the case in some studies of high myopia. For example,
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taking a refractive error of -6.00D as the threshold value and classifying those 
individuals more myopic than this as affected. Although this approach can be 
successful, it has limitations. For example, it assumes that those individuals who have 
a refractive error o f -5.75D are unaffected and therefore in the same group as those 
who are hyperopic.
affectedunaffected
xTrait value
Figure 1.6. Applying an affection threshold to a quantitative trait. Any individual with a trait value 
falling in the area defined by that threshold value x and the area under the curve is classed as affected.
Some clinical phenotypes have a dichotomous basis; however they may have a 
strongly related quantitative risk factor. Although this may not describe the disease 
accurately, it may provide more information by quantifying it. If  the disease under 
investigation is age related, it may allow earlier identification o f the proband, even 
allowing for parental information to be included. However, this would require a direct 
genotype-to-phenotype relationship and would be limited to specific diseases.
Quantitative traits have a continuous distribution and suggest polygenic inheritance. 
Such traits could be controlled by a few quantitative trait loci each with a large effect 
or more QTLs each with a small effect. The individual genes will generally act in an 
additive manner, but there may be interactions between them, known as epistasis.
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Clinical phenotypes are often in the form of quantitative measures and so give a more 
informative measure o f the trait. For example, the additive effects of a number of 
“high risk alleles” may increase the quantitative trait value. For a dichotomous 
measure, it may require a certain number of these alleles to push the trait value above 
the affection threshold mark.
1.2.6.2. Heritability
Heritability estimates will give an indication of phenotypic variation due to genetic 
factors (chapter 3). The lower the heritability value, the less genetic factors will affect 
the trait and therefore the larger the size of the cohort of subjects needed to detect 
linkage.
1.2.6.3. Power
The power o f a linkage study is its likelihood to detect linkage, given that it is present. 
A type I error occurs when the null hypothesis is incorrectly rejected. A type II error 
occurs when a false null hypothesis is not rejected. Power is therefore defined as (1-p) 
where P is the type II error rate. Power depends on a number of factors including the 
required significance level, the specification o f the alternative hypothesis and the 
sample size.
Based on these factors and the assumptions made about the mode of inheritance and 
the model’s parameters, power calculations can be performed to calculate the sample 
size required to produce power to detect linkage at the required level. When 
inheritance patterns are known, power calculations are generally reliable. However, 
the results can be misleading if the mode of inheritance is specified incorrectly. This 
is particularly true for complex diseases, where assumptions about locus 
heterogeneity, phenocopy rate, recombination between marker and disease locus and 
marker allele frequencies have to be made.
Chapter 1. Linkage analysis in high myopia: Introduction 48
For complex diseases, an indication of the power to detect disease loci can be 
obtained by considering the relative risk to relatives, X (equation 1.4.). This describes 
the genetic contribution to a trait. For siblings, the X value (A*) is calculated as 
follows:
Xs= trait risk for siblings of an affected individual 
trait prevalence of the general population
Equation 1.4. Relative risk to siblings.
In general, the higher the X$ value, the greater the power to detect disease-carrying 
loci. Unfortunately, even diseases with a high X$ may not be amenable to linkage 
analysis if numerous susceptibility genes contribute to the phenotype. Each locus (i) 
will import its own risk (A«i) with their sum (£A*j) being equal to the overall A*, 
assuming additive effects.
1.2.6.4. Populations and Pedigree Structure
Pedigree structure also plays a part in the sample size calculations. The power of a 
study is increased if  the sample population is enriched with affected individuals. This 
is why the recruitment of subjects for a linkage analysis study targets affected 
probands and their families.
Many linkage analysis studies concentrate on the affected sib pair design, the 
methodology o f which is based on the ability to identify those alleles inherited IBD 
compared to that expected by chance (section 1.2.3.2.2.). This is partly due to the 
relative ease of ascertainment o f this pedigree type; often small nuclear families are 
more in abundance than larger extended families. The ideal type of pedigree to 
ascertain depends on the underlying genetic basis of the disease. For example, for a 
disease controlled by a single gene, extended pedigrees may be more useful but for a
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more complex disease, sib pairs are often more efficient (Haines and Pericak-Vance, 
1998).
If the study is using an association study design, alternative pedigree structures are 
required (chapter 6) dependent on the exact strategy to be used. A case-control study, 
comparing the allele frequencies of affected individuals to a matched population of 
controls, requires only individual subjects. A family based design requires a 
population enriched for the trait, generally small families with at least one affected 
offspring. In some strategies families with or without parents and including additional 
siblings, affected or not, are collected.
Due to the possibility o f heterogeneity, mentioned previously, ideally the subjects 
recruited for the study would be of similar genetic background. This would reduce the 
possibility of locus and allelic heterogeneity. Bilinear families would also be best 
avoided in case the disease susceptibility loci are different in the two sides of the 
family although this may reduce the sample size and therefore the power. This is, 
however, difficult to detect unless it occurs directly from members o f the phenotyped 
pedigree. It is entirely possible that bilineality goes undetected if the phenotypes of 
extended family members are not collected.
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1.3. Myopia and Linkage Analysis.
Despite the ongoing nature versus nurture debates for myopia, as well as associations 
with near work and environmental factors, linkage studies have found a number of 
loci linked to refractive error and myopia (summarised in Table 1.2. up until summer
2006).
The first locus, MYP1, was mapped as Bornholm Eye Disease to Xq28 in 1990 
(Schwartz et al., 1990). Analysis of an additional family resulted in a narrowing of 
this region from 34.4cM to 6.8cM (Young et al., 2004a). However, differing colour 
vision anomalies between the two families suggests separate mutations for the 
observed phenotypes.
The MYP2 locus was described in 1998 following a genome scan in four 
multigenerational families (Young et al., 1998b). By defining high myopia as a 
dichotomous trait, the cut-off point being -6.00D in the most minus meridian (MMM) 
of the right eye, and using a model based method of linkage analysis, an area of 
linkage was highlighted within 18p. By fine mapping an additional four families and 
using the same model o f autosomally dominant inherited high myopia (susceptibility 
gene frequency 0.0133, 100% penetrance) a LOD score of 8.30 (0=0.001) at a marker 
D18S63 was produced, suggesting strong evidence of linkage. The critical interval of 
7.6cM at the location 18pl 1.31 was between markers D18S59 and D18S1138. This 
was later refined to a much smaller interval of only 0.8cM, flanked by markers 
D18S63 and D18S52 (Young et al., 2001a).
Following on from this study, MYP3 was mapped by the same laboratory using the 
same analysis method but in one large Italian-German family (Young et al., 1998a). 
The critical interval o f 30.1 cM was found between markers D12S1684 and 
D12S1603.
Twenty-one French and two Algerian families, each containing at least one high 
myope, were recruited by Naiglin and colleagues in 2002 (Naiglin et al., 2002). 
Negative LOD scores were found for the loci on 12q and 18p therefore, excluding
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linkage to these regions and indicating the heterogeneity of this disease. A genome 
scan provided suggestive evidence of linkage on chromosome seven from marker 
D7S798 to D7S2423 with a multipoint LOD score of 2.81 (two-point LOD score of 
1.87 at 0=0). A recombination event aided the narrowing of this interval to 11.7cM, 
from D7S798 to the telomeric end of the chromosome. This analysis was based on an 
autosomal dominant model of inheritance (susceptibility gene frequency 0.013, 58.4% 
penetrance) and was named MYP4.
A large English-Canadian family was analysed by Paluru and colleagues (2003) and 
the MYP2-4 loci were excluded. A linkage peak with a LOD score o f 3 was found, 
however, on chromosome 17 (Paluru et al., 2003). The critical interval was narrowed 
to 7.7lcM  between markers D17S787 and D17S1811 and named MYP5.
A study o f an isolated population of Ashkenazi Jews led to the linkage o f a locus on 
chromosome 22 to common myopia (Stambolian et al., 2004) (MYP6). Forty families 
were phenotyped for common myopia. Those subjects with a refractive error of 
-1.00D or more were classed as affected and those with myopia o f less than this, 
emmetropes and hypermetropes were classed as unaffected, with some allowances for 
age also involved in the phenotypic classification. Linkage analysis was performed 
using a range o f models based on autosomal dominant inheritance with a gene 
susceptibility frequency o f 0.0133 (penetrances 90, 80 and 58.4%, phenocopy rates 0, 
5, 10 and 15%). The 12q and 18p loci were excluded for linkage, but the genome scan 
produced a linkage peak localised to 22ql2 (hLOD=3.56, NPL=4.62). The same 
cohort also produced a high linkage peak from a genome scan when considering the 
trait quantitatively, on chromosome 1 (LOD=9.5, p=0.065 for ocular refraction and 
LOD=8.7, p<0.005 for log transformed refraction) (Wojciechowski et al., 2006). This 
QTL for refractive error lies in an 11Mb region flanked by markers D1S552 and 
D1S1622.
MYP7-10 were found in a twin based study (Hammond et al., 2004). A cohort of 
unselected twin pairs underwent a genome scan using refractive error as a continuous, 
quantitative trait. This indicated four areas which had evidence of linkage: 1 lp l 3 
(LOD=6.1, MYP7), 3q26 (LOD=3.7, MYP8), 4ql2  (LOD=3.3, MYP9) and 8p23 
(LOD=4.1, MYP10). It was noted that the gene PAX6, having a major contributory
Chapter 1. Linkage analysis in high myopia: Introduction 52
role in eye development, is mapped to within the 1 lp l3 region. An association study 
was then performed with SNPs adjacent to the PAX6 gene but, despite the strong 
linkage signal, no association was found.
More recently, another new locus has been found within a 2.22cM region at 
chromosome 2q37.1 (Paluru et al., 2005). This study involved a large pedigree 
consisting of 32 family members in four generations, 14 of whom were highly 
myopic. The family were based in the U.S.A. and were o f Northern European 
extraction. Using a model o f autosomally dominant inherited high myopia (myopia 
gene frequency o f 0.01, 90% penetrance and 10% phenocopy rate) and phenotype 
classification -6.00D or more, RE MMM as affected, a genome scan with two-point 
linkage analysis highlighted three areas as providing suggestive evidence o f linkage. 
Further multipoint analysis excluded two of the loci but supported the evidence for 
linkage with a maximum multipoint LOD score o f 4.75 for the area 2q37. Haplotype 
analysis further refined the interval to between markers D2S1279 and D2S2205.
On chromosome four, a Chinese family was found to be linked to a 20.4cM region 
surrounding marker D4S1564 giving a two-point LOD score o f 3.11 at 0=0 (Zhang et 
al., 2005).
Table 1.2. Summary o f mapped MYP loci.
Name Chromosome 
and locus
Trait used Population mapped in
MYP1 Xq28 High myopia 1 MG Danish pedigree
MYP2 18pl 1.31 High myopia 4 MG pedigrees
MYP3 12q21-q23 High myopia 1 MG Italian-German 
pedigree
MYP4 7q36 High myopia 21 French & 1 Algerian 
pedigree
MYP5 17q21-q22 High myopia 1 large English-Canadian 
pedigree
MYP6 22ql2 Common myopia 40 MG Ashkenazi Jewish 
pedigrees
MYP7 1 lp l 3 Refractive error (quant) Unselected twin pairs
MYP8 ~3q26 Refractive error (quant) Unselected twin pairs
MYP9 4ql2 Refractive error (quant) Unselected twin pairs
MYP10 8p23 Refractive error (quant) Unselected twin pairs
MYP11 4q22-q27 High myopia 1 MG Chinese pedigree
MG= multigenerational, quant = quantitative value
Chapter 1. Linkage analysis in high myopia: Introduction 53
Considering the loci found to date, this provides strong evidence of major 
heterogeneity o f this disease. Farbrother and colleagues attempted to replicate linkage 
to MYP2, 3 and 4 (Farbrother et al., 2004b). They found in excess of 25% of the 
families in their cohort were linked to MYP3 therefore further suggesting locus 
heterogeneity. Ibay and colleagues also excluded MYP2 and MYP3 as being linked to 
common myopia using the Ashkenazi Jew cohort (Ibay et al., 2004).
As yet, no candidate genes have been found to be causative o f high or common 
myopia within these regions. Several, including lumican, fibromodulin and TGIF-p 
have been excluded along with others (Paluru et al., 2004; Scavello et al., 2004; 
Scavello et al., 2005). To actually name a causative gene for myopia is proving 
difficult due to a number o f factors. Firstly, the disease is known to be highly 
heterogenous. Once linkage is found, the candidate genes under test have to be 
picked accurately from those known genes within the locus. They may be chosen due 
to their biological function but this also relies on knowing that function and relating it 
to the trait. The disease causing polymorphism or a polymorphism in linkage 
disequilibrium also has to be identified and could be within sections o f the gene or 
that of the promoter or another controlling area of the gene domain. Myopia is often 
described as a polygenic disease and therefore it may be that these candidate genes are 
providing only a small and therefore difficult to detect effect on the phenotype. As 
with other diseases, the quest for genes and QTL is ongoing and benefits from 
specific adaptations to study designs and analysis methods with regard to the exact 
trait characteristics.
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2. Family Study of Myopia: Subject Recruitment
2.1. Introduction
The Family Study o f Myopia was set up in 1999, aiming to recruit families for genetic 
analysis o f high myopia. Initially, only families containing affected sibling pairs were 
sought, but this criteria was expanded to include trios, a highly myopic proband (the 
member o f the family who is the primary contact) with two parents, and 
multigenerational families containing at least one high myope (MG families).
For the purposes of the study high myopia was defined as having a refractive error of 
at least -6.00D in both eyes in the least minus meridian. Taking the least minus 
meridian allows for the most conservative estimate of refractive error thereby 
ensuring a lower false positive error rate.
Probands also had to meet additional criteria. They were excluded if  they were bom 
prematurely as these subjects are more at risk of having significant refractive errors 
(Larsson et al., 2003; Snir et al., 2004). Any subject who has a systemic or ocular 
disease associated with myopia was excluded from the study; for example, Stickler’s 
syndrome and Marfan’s syndrome (Chapter 1). Any subjects with lens opacities were 
not excluded, but when obtaining phenotypic details, a pre-cataract spectacle 
prescription was specifically requested. As 80% of 75 to 85 year olds show some 
signs of age-related cataracts (Tunnacliffe, 1993), excluding those subjects with lens 
opacities would decrease the information about the pedigrees, the benefits of 
excluding any subjects with cataracts and therefore possible related myopia will be 
overshadowed by the major decrease in power shown by the reduction in pedigree 
size.
To reduce heterogeneity, as discussed in the previous chapter, the ideal cohort would 
be of the same ethnic background. At this stage of recruiting the ethnicity of a 
pedigree is not a limiting factor in the inclusion criteria because the aim is to obtain a
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large number o f highly myopic families and to build a database of willing participants 
for possible future analysis.
Family studies can use varying methods to ascertain their cohort of families. These 
include referrals from support groups and organisations or health care professionals, 
or through public databases and the internet (Haines and Pericak-Vance, 1998). 
Referral from specialists will ensure the participants are within the clinically defined 
study criteria but rely heavily on the participation of the professional. Using an 
advertising campaign may increase the response rate but may also include a small 
number of those subjects outside the criteria. Considering these advantages and 
disadvantages, the subjects for the Family Study of Myopia were recruited in a 
number of ways (section 2.2.2.).
It is important to recruit families with specific structures for genetic analysis. 
Specifically, the type of pedigree to ascertain is based on previous knowledge of the 
disease inheritance and the phenotype. For example, if  it is suspected that one major 
gene controls the phenotype, extended multigenerational families are more powerful 
for linkage whereas affected sibling pairs may be more advantageous for a highly 
complex, polygenic disease (Haines and Pericak-Vance, 1998).
Other myopia studies have varying approaches to their pedigree ascertainment. 
Selecting for two affected siblings gives an advantage of using allele sharing linkage 
analysis methods, but it can be difficult to recruit the sample required. Collecting a 
number of large multigenerational families with multiple affected family members 
allows for various other methods of linkage analysis but the higher the number of 
affected family members and the more generations included will further increase the 
power. MYP1, MYP3 and MYP5 were discovered by linkage analysis using only one 
large multigenerational family (Schwartz et al., 1990; Young et al., 1998a; Young et 
al., 2001b). MYP2 used a cohort of four multigenerational families (Young et al.,
1998b) whereas MYP4 and MYP6 had much larger cohorts consisting of 24 and 40 
smaller families, respectively, containing one or more affected subjects (Naiglin et al., 
2002; Stambolian et al., 2004). MYP7-10 were discovered based on a population 
sample of twins (Hammond et al., 2004). There are a number of advantages and 
disadvantages to recruiting the various types of families which is discussed further in
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Chapter 5. The ascertainment criteria were extended to any family type in this study 
so that a database o f myopia pedigrees in the British Isles can be maintained and 
subjects included for future analyses.
2.1.1. Assortative Mating
Random mating within a population is generally assumed and is essential for the 
validity of many types of genetic analysis. Assortative mating suggests that more 
often than expected, mating occurs with like-for-like individuals. Assortative mating 
can occur in several ways and can be influenced by factors such as location, familial 
expectations and social implications. One type of assortative mating occurs between 
relatives. Consanguineous matings may influence the incidence o f inherited disease 
based on the fact that relatives will already share a proportion of their genes. Another 
type occurs within subgroups of populations e.g. ethnic groups. This will, eventually, 
increase the genetic differences between these subgroups (Vogel and Motulsky,
1996).
In this study, the information required to test the presence of assortative mating is 
how often is the spouse o f a high myope also a high myope and does this occur more 
often than expected based on the phenotype prevalence. If it does, this situation within 
a population selected for genetic analysis will increase the heterogeneity of the sample 
particularly within a specific pedigree (bilineality) therefore decreasing the power to 
detect linkage.
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2.2. Methods
2.2.1. Ethical Approval
Ethical approval was sought for and gained from the Human Science Ethical 
Committee, Cardiff University.
r
2.2.2. Recruiting
2.2.2.1. Recruiting via Optometrists
Families for the Family Study of Myopia were ascertained by participating 
optometrists who identified high myopes willing to join the study. Probands were 
given an information sheet and a questionnaire, PQ1, (Appendix I) which asked them 
to indicate the name and address of their optometrist, the age they began to wear 
spectacles, any ocular surgery or treatment and any systemic conditions. Once a high 
myope had been contacted and their consent form and questionnaire returned, their 
optometrist was contacted again to obtain the spectacle prescription and ocular history 
of that subject. Other family members were invited to participate by sending them a 
“PQ2” questionnaire (Appendix I). Family members’ spectacle prescriptions and 
ocular history details were obtained in the same way. Once a suitable family had been 
identified, mouthwashes were requested from each individual.
When optometrists mentioned on a returned PQ1 or PQ2 form were contacted to 
request the patient’s details (forms OP1 and OP2, Appendix I), they were also sent a 
recruitment pack and information on the study to pass on to any other highly myopic 
patient they might see, ensuring an accumulation of optometrists recruiting patients. 
They were also sent a Family Study of Myopia occluder, for use in their day-to-day 
clinical practice, with the contact details and recruitment criteria on it to serve as a 
constant reminder. Information packs were also distributed at local optical continuing 
education meetings.
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An optometrist based in Carmarthen approached the Family Study of Myopia with 
information about his own family, who are mainly living in Ireland. Approximately 
190 members o f this family were contacted (PQIW, Appendix II) and asked to 
provide details o f spectacle wear and, again, details of their optometrists, from whom 
we could obtain ocular history details. A “family get together” was arranged for this 
family to obtain further information, ocular measurements and DNA samples (chapter 
3).
t
22.2.2. Recruiting by Databases
A large proportion of the highly myopic probands recruited were included in a 
database o f patients who attended a group o f optometric practices based in the North 
West of England and Scotland, Conlon & Sons (Opticians) Ltd. These individuals 
were contacted directly with a PQI, consent form and covering letter explaining the 
research project (Appendix I). Their relatives were contacted with PQ2s as mentioned 
above. An alternative database containing those patients seen at the Cardiff University 
Eye Clinic was also utilised.
2.2.2.3. Recruiting by the Internet
The Family Study o f Myopia has its own website containing information about the 
study and also an email address and contact details through which interested parties 
can request information or offer to participate.
2.2.2A Recruiting by Word of Mouth
The final way probands were recruited was simply by word of mouth. These probands 
included, for example, those who were optometry students within the university and 
high myopes known to one of the research study group.
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2.2.3. Assortative Mating
To investigate assortative mating, all probands who were not recruited specifically for 
a family history of myopia were encouraged to provide contact details of their spouse. 
The spouse was also contacted and their spectacle prescription and ocular history 
details were collected from their own optometrist.
The sample included only those not specifically recruited for a family history of 
myopia to avoid any bias and provide an appropriate random sample representative of 
the general population.
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2.3. Results
The recruiting process is summarised in figure 2.1.
2.3.1. Proband Recruitment
Between October 2002 and October 2005, a total of 30 families with affected sib 
pairs, 55 families containing at least one high myope and 98 trios were identified. A 
total of 1968 PQ ls were sent out and 250 were returned. The response rates ranged 
from 0 to 45% per month, averaging 12.7% (figures 2.2 and 2.3). Two different 
methods were tested for recruiting high myopes through the database. For most 
subjects in the database, a questionnaire, consent form, information sheet and freepost 
return envelope were sent and follow up questionnaires were sent to family members 
if  consent was given. A sample of 200 subjects were sent a variation on this theme, 
comprising a shortened questionnaire, a card with details about the study and a tick 
box section to return if  they would like to take part or just require further information. 
Those subjects who returned the card were then sent a full questionnaire, as 
previously, by their chosen method of communication (PQ1C, Appendix I). This 
approach ensures only interested parties would receive the information and increase 
the response rate from the questionnaires. From the 200 cards sent, 17 replies were 
received, (figure 2.3, highlighted region). The 8.5% response rate was not 
significantly different from the previous method. Furthermore, due to either a lack of 
response from these probands’ families or from those probands themselves, only one 
suitable family was ascertained using this approach. Therefore the success rate was 
5.9%. This compares to the original method (a mixture of sending out questionnaires 
to people in the database and recruiting by optometrist, where there were 101 PQls 
leading to a family useful for genetic analysis) in which a success rate of 5.1% was 
estimated. Due to the benefits in terms of time-investment, the original method was 
used.
Chapter 2. Family Study o f Myopia: Subject Recruitment 61
Databases Optoms Website Other
Abroad (3) 
Keratoconic (1)
PQls sent
(1968)
Accepted
(241)
Excluded
Returned
(250)
C Trios 198) ~)
( MG families (55))  
C ASP (30) ')
PQ2s sent
(1083)
Premature (4)
Oculocutaneous 
albinism (1)
i
Returned
(599)
F igure 2.1. Flow chart summarising the recruiting process. A small proportion o f  the responding 
probands were excluded due to clinical factors.
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Figure 2.2. Number o f  first contact questionnaires (PQI) sent out and returned between October 2002 
and October 2005. The highlighted region represents the time period in which the alternative method of 
using a shortened questionnaire and card was used in an attempt to increase the response rate.
month of recruiting
Figure 2.3. Response rate for P Q ls from October 2002 to October 2005. Highlighted region as 
described above.
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2.3.2. Family Recruitment
Once a PQI was returned, PQ2s were sent to family members of the proband. Out of 
1083 PQ2s sent out, a cumulative total of 599 were returned (figure 2.4) with a 
response rate of 55.3%. The monthly response rates were also increased compared to 
the PQls (figure 2.5).
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Figure 2.4. Number o f family member questionnaires (PQ2) sent out and returned between October 
2002 and October 2005.
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Figure 2.5. Response rate for PQ2s from October 2002 to October 2005.
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2.3.3. Recruiting Methods
Probands were recruited by a variety of methods as shown in figure 2.6.
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Figure 2.6. Recruiting methods for all three different pedigree types used in the study.
The largest proportion of affected sibling pairs and multigenerational families were 
recruited using the Conlons’ database. The most successful method for recruiting trios 
seems to be via optometrists.
Optometrists played a vital role in the recruiting process. During the first stage of 
recruitment undertaken between 1999 and 2002, a total of 479 optometrists were 
actively involved in the recruitment (Farbrother, 2003). From October 2002, a further 
323 were contacted and invited to help, giving a total of 802 optometric practices 
within the UK and Ireland potentially distributing information about the study to their 
highly myopic patients (figure 2.7).
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Figure 2.7. Cumulative measure o f the number o f optometrists involved in the study between October 
2002 and October 2005.
2.3.4. Characteristics for probands and families.
Tables 2.1. and 2.2. show the characteristics of probands and family members of the 
three family types. Subjects were aged between 7 and 89, and were mostly of White 
European descent. More females than males participated. By investigating only those 
subjects who were recruited by the Conlon’s database and comparing those who 
agreed to participate and those who did not, there appears to be supporting evidence 
of a gender bias towards females willing to participate 0^=1 1.49, p=7.01xl0’4). 
However, there is no significant difference in severity of myopia (Mann Whitney, 
p=0.01) nor with age (Mann Whitney, p=0.01).
By looking at the affected and unaffected members of the recruited families there was 
no obvious pattern of inheritance of myopia indicated.
Table 2.1. Characteristics of probands.
Type o f family Mean age in yrs 
(range)
Ethnicity Gender Mean Rx (RE LMM), 
dioptres (range)
Total
ASP 38 (14 to 71) 93.3% White European 
3.3% Asian 
3.3% Euro-Caribbean
30% Male 
70% Female
-9.58 (-20.00 to -6.00) 30
MG 34 (14 to 67) 100% WTiite European 23.6% Male 
76.4% Female
-8.83 (-20.50 to -6.00) 55
Trios 29 (14 to 58) 98.0% White European 
1% Asian 
1% European-African
27.6% Male 
72.4% Female
-8.85 (-27.50 to -6.00) 98
Table 2.2. Characteristics of all individuals recruited for the Family Study of Myopia
Type o f family Mean age, yrs (range) Ethnicity Gender Mean Rx (RE LMM), 
dioptres (range)
Total
ASP 41 (7 to 80) 97.5% White European 
1.2% Asian 
0.65% Euro-Caribbean 
0.65% Unknown
40.4% Male 
59.6% Female
-5.03 (-27.50 to +6.00) 161
MG 49 (7 to 89) 98.4% White European 
1.6% Unknown
41.8% Male 
58.2% Female
-3.47 (-25.00 to +3.50) 318
Trios 42 (14 to 85) 98.0% White European 
1% Asian 
1% European-African
42.5% Male 
57.5% Female
-5.09 (-27.50 to +6.00) 294
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2.3.5. Trait distributions
Refractive error (RE LMM) distribution is not normally distributed. Considering the 
family members in the ASP and MG families, there is an apparent bimodal 
distribution (figure 2.8). This maximum around -6.00D is due to the ascertainment 
criteria. Removing the probands from this analysis reduces this peak, but not 
completely as the ascertainment criteria for the ASP families will increase the amount 
of high myopes (figure 2.9). The trait distribution of probands only (figure 2.10.) 
shows the majority of probands being within the lower end of the limits. Generally, 
refractive error is leptokurtosed at emmetropia and skewed towards myopia (Sorsby et 
al., 1957), this is also reflected in the distribution of the study subjects.
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Figure 2.8. Trait distribution of right eye, least minus meridian (dioptres) for subjects within ASP and 
MG families.
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RE LMM (D)
Figure 2.9. Trait distribution o f  right eye, least minus meridian (dioptres) for subjects within ASP and 
MG families, not including probands.
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Figure 2.10. Trait distribution o f right eye, least minus meridian (dioptres) for probands within ASP 
and MG families.
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2.3.6. Assortative Mating
Due to the strict inclusion criteria for this particular analysis, results were collected 
for just 36 probands and their spouses. Other probands were from families known to 
have a high number o f affected individuals, some probands did not have a spouse, and 
some spouses did not participate in the study. There was no statistically significant 
correlation between spectacle prescriptions of proband and spouse (Spearman’s rank 
r=-0.075, p=0.663). The most myopic spouse refractive error was -5.75D therefore 
there was no evidence for assortative mating for high myopes (p=0.5, Fisher’s exact 
test). Considering myopia in general, 12 spouses have a refractive error o f greater 
than -0.50D, which is 33.3%, higher than the estimated prevalence in the UK 
population, but not significantly different (p=0.302, Fisher’s exact test). This suggests 
that this population is not enriched for myopes due to the recruiting criteria.
If this investigation was extended to consider not only the randomly ascertained 
probands but probands and spouses of those families not recruited unselectively, there 
is still no statistically significant correlation between proband and spouse (Spearman’s 
rank r=-0.077, p=0.612, n=46). However, there are now two highly myopic spouses, 
4.3%, which is higher than the expected value of 2% (assuming a population 
prevalence of 2% and random mating) but not statistically significant (p=0.5, Fisher’s 
exact test). There is a slight enrichment of myopes, increasing to 41.3% explained by 
the selective recruitment criteria, again not significantly difference to the expected 
value (p=0.093, Fisher’s exact test).
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Figure 2.11. Proband spectacle prescriptions (Rx, RE LMM, dioptres) plotted against that o f their 
spouses.
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2.4. Discussion
The recruiting process relies not only on subjects being willing to participate 
themselves but also on them having family members who are also willing to help and, 
in the case of finding affected sibling pairs, being highly myopic. This therefore limits 
the number of families who can be ascertained using the methods employed in this 
study.
Nevertheless, 183 families suitable for genetic analysis were recruited between 
October 2002 and 2005, increasing the number involved in the Family Study of 
Myopia to over 240 (including all family types). The subjects for this project were 
mainly recruited via database-based recruiting and by optometrists. The subjects vary 
in age and had a gender split biased towards females. The majority o f the families 
were of White European ethnicity which suggests the population will be highly 
homogenous, thereby increasing the power to detect linkage within the study. 
Including a mixture of ethnicities into the pedigrees to be analysed can increase the 
possible heterogeneity and therefore decrease the power to detect linkage (Ott, 1991). 
All of the trios were included into the association analysis (chapter 6) as there was 
only a small percentage of different ethnicities. If an effect was found it would be 
possible to repeat the analysis with sub-sections of different ethnicities or remove 
individuals from the analysis to create a homogenous population.
A study undertaken in Australia found that participation of probands seems to 
increase with the proband’s perception of disease severity (Garoufalis et al., 2005). 
This was not found to be the case for these probands, only 25% of the sample 
representing extreme myopia (over -10.00D, RE LMM) compared to 56% in the 
Australian study, although these two studies did differ in study design and selection 
criteria. There did not appear to be any other significant pattern involving specific 
characteristics o f families and their likelihood to participate although this analysis is 
limited as only specific information was obtained from those individuals who were 
only invited to take part and declined compared to those who agreed.
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Optometrists appeared to play a vital role in the recruitment of probands and their 
families. They provide a valuable position in that they are qualified to recognise 
suitable candidates by including relevant questions into their detailed history taking 
along with having the specific inclusion and exclusion details in information sheets 
provided to them. This allows the numbers involved in the study to be massively 
increased compared to the situation in which one optometrist were to examine all 
patients individually with no decrease in the quality o f the data collected.
Only nine probands were excluded from the study and only six o f these were excluded 
due to clinical issues; the other three were excluded due to difficulties in obtaining 
phenotypes and DNA samples due to them living abroad. Out o f those six probands, a 
premature birth was the main reason for exclusion. One person was keratoconic and 
one had oculocutaneous albinism which prevented them from being involved in this 
genetic study as they would increase the genetic heterogeneity o f the sample and 
allow some possible confounding factors as to the basis of the myopia.
There is a wide range of refractive errors within the probands and it is possible that a 
high myope of -6.00D has a different clinical phenotype than one with a much higher 
refractive error of -22.00D. However, with the obtained clinical information from the 
optometrists any abnormalities, systemic or ocular, allow the exclusion of these 
individuals from the analysis. There is considerable current interest in sub-classifying 
complex disease phenotypes in order to improve linkage power which could be 
adapted to be used in the Family Study of Myopia (Hauser et al., 2004; Gordon et al., 
2006).
There appears to be no evidence of assortative mating. However, the small number of 
spouses involved in the study suggests that the power to detect such an effect would 
have been low.
The following analyses did not make use of all of the families recruited within this 
time period but this recruitment process added to a large and unique database of 
pedigrees willing to participate with future genetic analysis projects investigating 
myopia within the UK and Irish population.
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3. Heritability
3.1. Introduction
Whilst recruiting families to take part in the Family Study o f Myopia, an optometrist 
based in Carmarthen approached the study to offer the participation of his own family, 
a large seven generational pedigree consisting of 294 contactable members within 
three generations (IW pedigree, Appendix III). Due to the size o f the family and a 
reportedly high prevalence of myopia, they were considered an ideal cohort for 
linkage analysis. Initial efforts concentrated on calculating a heritability estimate in 
order to give an indication of the potential for mapping refractive error susceptibility 
loci responsible for the control and development of refractive error for this family.
3.1.1. Definition
Heritability is the proportion of observed phenotypic variance attributed to genetic 
variance (Camp and Cox, 2002). This broad sense heritability (H2) therefore describes 
both additive and dominance effects on the phenotype and also any interactions. The 
broad sense heritability can be calculated using a twin study (section 3.1.2.). Narrow 
sense heritability, h , is more commonly used. The genotypic variance is partitioned 
into separate components of additive and dominance effects, the narrow sense 
heritability being the ratio of additive genetic variance to phenotypic variance in a 
specific population (equation 3.1.) (Falconer, 1996). It is a quantitative value 
representing the effect of genetic factors upon a trait and can be estimated from the 
degree of resemblance between relatives. Specifically, heritability is the observed 
correlation as a proportion of the correlation that would be found if  the character were 
completely inherited (Falconer, 1996).
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1i2=V a/V p. where Va is the additive genetic variance and Vp is the 
phenotypic variance
Equation 3.1. Narrow sense heritability (h2)
It is vital to be aware of the heritability of a trait before starting a genetic study. The 
estimate calculated may not only govern the choice of ascertainment scheme or study 
design but also reinforce the hypothesis of the likelihood of identifying a quantitative 
trait locus for that trait (Camp and Cox, 2002).
3.1.2. Twin Studies
An alternative method to investigating the degree of resemblance between relatives is 
a twin study, comparing the concordance of the trait in monozygotic twins to that of 
dizygotic twins, for example see figure 3.1. The increased correlation of phenotypic 
values from the monozygotic twins compared to the dizygotic twins suggests a highly 
genetic influence and therefore a high heritability value. Twins are ideal subjects for 
heritability studies as the genetic and, generally, the environmental factors of 
monozygotic twins are the same from conception onwards, whereas for dizygotic 
twins it is purely the genetic factors that will differ in most cases. However, this 
shared environment may inflate the heritability estimate; therefore the value must be 
regarded with these limitations in mind and will show the upper limit of the 
heritability. This is also true of sibling-sibling methods.
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Figure 3.1. Taken from (Hammond et al., 2001) showing the values o f spherical equivalent refractive 
error (D) of the left eye for twin 1 plotted against twin 2 for monozygotic (MZ) and dizygotic (DZ) 
twins.
For twin studies, when comparing the traits o f monozygotic and dizygotic twins, the 
assumption of equal environmental effects is made and also that the genetic variance 
is equal in both types o f twins. This may not always be the case due to factors 
including gene-environment interaction, competition between twins in utero and 
parental treatment (Falconer, 1996).
3.1.3. Assumptions
Heritability calculations rely on several assumptions. This estimate corresponds only 
to the population and conditions under investigation. It is assumed the population is 
random-mating. Assortative mating (chapter 2) as opposed to random mating, will 
inflate the heritability estimate by increasing the resemblance between spouses and 
therefore increasing the resemblance between family members. For midparent- 
offspring methods (see 3.1.4.1) it will also decrease the variance of the parents and so 
still provide a valid estimate.
It is assumed there is no epistasis, which is no interaction between two or more genes 
acting on the same trait. Also that there is no gene-environment interaction, i.e. the 
environmental factors have no influence on the gene effects. The final assumption is
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that of no dominance. As narrow sense heritability is the phenotypic variance due to 
additive genetic effects, dominance must be assumed to be zero and so the offspring 
trait values should tend to the mean of the parental values.
The involvement of dominance and epistatic effects confound the parental genotype to 
phenotype relationship. The inclusion of these factors makes this relationship more 
difficult to explain, the relationship between parental and offspring phenotype is 
similarly affected. The calculation of narrow sense heritability using only additive 
genetic effects, as opposed to broad sense heritability which includes these dominance 
and epistasis effects, is therefore more useful in this prediction of offspring 
phenotype.
3.1.4. Methods of calculating heritability
3.1.4.1. Within Family Regression
Taking into account a definition involving the degree of resemblance between 
relatives, regression between relatives, either between offspring and parents or 
between siblings can provide heritability estimates (table 3.1).
Table 3.1. Calculation o f heritability estimates (h2) based on regression and correlation of the 
phenotypes o f relatives (adapted from (Falconer, 1996)).
Relatives Regression (b) or 
correlation (t)
Offspring and one parent b=‘/2h2
Offspring and mid-parent b=h^ort=(>/0.5)h'!
H alf sibs t='/4h2
Full sibs t>'Ahz
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For example by plotting the mean phenotypic values of two parents against the 
phenotypic value of their offspring, the heritability is equal to the regression 
coefficient.
3.1.4.2. Variance Components Method
The SOLAR (Sequential Oligogenic Linkage Analysis Routines) (Almasy and 
Blangero, 1998) software package provides a heritability estimate by decomposing the 
variance of the phenotype into that caused by genetic effects and that by residual, 
presumably environmental factors. The genotypic variance can be further partitioned 
into additive and dominant gene effects, and again into the variance due to a major 
effect quantitative trait locus and that of combined smaller effect polygenic 
influences. It is the variance due to the additive effects that is considered for the 
heritability estimate. This involves taking into account all members of the pedigree, 
exploiting all informative relationships as well as those between parents and 
offspring, or between siblings.
3.1.4.3. Markov Chain Monte Carlo (Gibbs sampling) methods
A Markov chain is a sequence of random numbers, in which each following number is 
conditionally independent of the past sequence, given the current number. To 
construct a Markov chain that has the required distribution, sampling occurs from 
probability distributions using specific algorithms. This method is known as Markov 
Chain Monte Carlo method (MCMC). The probability distributions can be joined 
together forming one distribution by means of Gibbs sampling.
As an example, [taken from Sorensen and Gianola (Sorensen and Gianola, 2002)] 
(figure 3.2.), imagine there are three compartments numbered 1, 2 and 3 which are
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interconnected and a mouse is placed into one of the compartments. The sequence of 
the compartments visited makes up the numbers in the Markov chain. The movements 
of the mouse are dependent only on its current position. The probability of the mouse 
moving into either of the other compartments, the transitional probability, can be 
calculated, which is conditional on it actually starting this move in the stated 
compartment. The distribution of the proportion of the number of times spent in each 
compartment is produced. After a large number of movements, or transitions, the 
distribution may stabilise and “converge”, the evidence suggesting that the 
compartment that is visited the most times is the most likely state. For heritability 
estimates, each state or compartment is equivalent to a specific heritability estimate 
based on an assumed gene flow through the pedigree. The heritability estimate that is 
most likely will be revisited and therefore provide the modal value of the distribution 
when it has stabilised. Gibbs sampling samples from all of the fully conditional 
posterior distributions to produce a joint distribution.
Possible states o f system
Transitional probability=p(mouse 
moving from 1 to 2 conditional on 
compartment 1 being the mouse’s 
starting point)
Figure 3.2. Pictorial representation o f Markov Chain.
Two main disadvantages of this method are the time needed to run the analysis and 
the difficulty in knowing when the likely states have been sampled proportionally to 
their likelihood (E. Sobel, 2004 WTAC). Algorithms and transition rules can be set up 
using different software programmes to decrease the time needed for these
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calculations but maintaining the correct sampling guidelines, i.e. proportional to their 
likelihood.
3.1.3. Heritability and Refractive Error
Studies which have investigated the heritability of refractive error vary from twin 
studies to family studies of indigenous populations. The estimates range from -0.03 to
0.98 (table 3.2.). The lowest values suggest little or no genetic influence on the trait 
whereas the higher values suggest a strong association with family history.
The higher values of heritability were calculated in twin studies. These will give an 
upper limit to the heritability estimates but also provide strong evidence of a major 
genetic component.
Table 3.2. Summary o f heritability estimates of refractive error. Results from studies marked with an 
asterisk are taken from (Rose et al., 2002). MSE stands for mean spherical equivalent and ref for total 
refraction= (1392/axial length)-MSE.
Study
_
Method Notes
Alsbirk* 0.14
0.04
0.50
Parent-offspring
Midparent-
offspring
Sib-sib
159 parent-offspring pairs from 
West Greenland
-600 Eskimo people aged 15+
(Angi et al., 1993) 0.11 Twin 19 MZ and 20 DZ twin pairs age 
3-7 years
Ashton* 0.49
0.74
Midparent-
offspring
Sib-sib
Nuclear families of Japanese and 
European descent in Hawaii
(Biino et al., 2005) 0.18
(MSE)
0.50 (ref)
Midparent-
offspring
201 nuclear families, age 4-90 
years
(Hammond et al., 0.84-0.86 Twin 226 MZ and 280 DZ twin pairs
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2001) age 49-79 years
Hu* 0.61 Twin 49 MZ and 37 DZ twin pairs age 
7-19 years
Johnson* -0.03 Parent-offspring Inuit and mixed Inuit-Caucasian 
population in Labrador
Kimura* 0.80 Twin 33 MZ and 16 DZ twin pairs aged 
15-20 years
Lin & Chen* 0.25 Twin 90 MZ and 36 DZ twin pairs aged 
7-23 years
(Lyhne et al., 2001) 0.89-0.94 Twin 53 MZ and 61 DZ twin pairs age 
20-45 years
Nakajina et al* 0.83
0.73
0.16
0.42
Twin
Twin
Parent-offspring
Parent-offspring
39 MZ and 10 DZ Japanese twin 
pairs age 12-17
Sorsby et al* 0.87 Twin 78 MZ and 40 DZ twins age 4-14
0.45 Parent-Offspring 28 UK nuclear families
0.49 Midparent-
offspring
0.72 Sib-sib
Teikari* 0.58 Twin 54 MZ and 55 DZ twin pairs age 
30-31 years
(Wojciechowski et 
al., 2005)
0.61 Sib-sib 759 siblings in 241 families, mean 
age 73.4 years
(Young et al., 1969) 0.10
0.98
Parent-offspring
Sib-sib
197 subjects in 41 Eskimo family 
units
(Young and Leary, 
1972)
0.46 Midparent-
offspring
71 Eskimo families
Despite the fact that heritability studies are difficult to compare due to the estimate 
being population specific, the previous studies suggest that a high degree of refractive 
error is determined by genetic factors, although not discounting effects from 
environmental influences. There is a large range of values of heritability estimates for 
refractive error and these will vary due to study design and sample population but the
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main focus of this study is to regard the trend. As the study populations are different 
the estimates cannot be compared but an overall pattern may be shown.
3.1.4. Ocular Components and Heritability
The eye is made up of a number of components correlated to produce an accurate 
refracting system, see figure 1.2 ., including the vitreous chamber depth, radius of 
corneal curvature, anterior chamber depth and lens thickness. In an emmetropic eye 
all of the ocular components are correlated so producing a focal point coincident with 
the retina. A disruption to this correlation will cause the eye to be ametropic by 
focusing the light in front of or behind the retina (Sorsby et al., 1957).
These ocular biometric measurements can be calculated using standard clinical 
equipment, including the Zeiss IOLMaster (Carl Zeiss Meditec). This instrument 
works using partial coherence interferometry to measure the axial length o f the eye. It 
incorporates a keratometer to enable measurement of the corneal curvature. Anterior 
chamber depth is estimated by measuring the distance between the reflected light 
from the optical sections of the lens and comeal surface using lateral slit illumination 
(Zeiss IOL Master manual website).
Table 3.3. shows heritability estimates calculated for ocular refractive components. 
Values range between 0.55 to 0.88 for comeal curvature and between 0.31 and 0.84 
for axial length suggesting highly heritable traits. Anterior chamber depth has a larger 
and lower range between 0.05, suggesting genetic factors play a very minor role in the 
development of this refractive component in this population, to a higher estimate of 
0 .68.
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Table 3.3. Heritability estimates o f ocular refractive components. Studies marked with ** estimates 
taken from (Goss, Hampton and Wickham, 1988). (f) is female specific estimate and (m) is male 
specific, “optically derived axial length measurements and bis via ultrasound.
Study Method h estimates
Corneal
curvature
Axial length Anterior
chamber
depth
Alsbirk** Parent-offspring 0.64 0.76b 0.56
(Biino et al., Midparent- 0.57 0.31a (f) 0.47 (f)
2005) offspring 0.60a (m) 0.44 (m)
Kimura** Twin 0.55 0.68a 0.05
Nakajima** Parent-offspring 0.82 0.66a 0.72“ 0.30
Twin 0.88 0.68a 0.26
(Sorsby, Parent-offspring 0.75 0.62“ 0.52
Sheridan and 
Leary, 1962; 
Sorsby, Leary 
and Fraser, 
1966)
Twin 0.78 0.84“ 0.68
(Y oung and 
Leary, 1972)
Parent-offspring 0.72 0.44b 0.52
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3.2.1. Recruitment
A questionnaire (PQl(IW), Appendix II) was sent to all o f the family members in the 
large Irish-Welsh pedigree. The questionnaire asked subjects to indicate the name and 
address of their optometrist, the age they began to wear spectacles, any ocular surgery 
or treatment and any systemic medical conditions. Subjects were also asked if they 
were bom prematurely. A copy of the family tree was also sent to each family 
member and they were asked to indicate if there were any other relatives missing 
(Appendix III). Any additional relatives were also sent a questionnaire and were 
included in the analysis if appropriate. Spectacle prescriptions were obtained from the 
subjects’ optometrists, as previously.
The family were then invited to attend either one of two get-togethers in Kilkenny or 
Dublin, Ireland at which ocular biometry was undertaken along with autorefraction 
and DNA sample collection. Due to the lack of interest for the Dublin gathering, only 
the Kilkenny one went ahead.
3.2.2. Heritability Estimates
For each of the methods, the trait under investigation was refractive error of the right 
eye in the least minus meridian. (There was no statistically significant difference 
between the refractive error in the right and left eyes; Spearman’s rank r=0.957, 
p<0.001) (table 3.5.). Least minus meridian is used to ensure the most conservative 
result and therefore maintaining a low type I error rate.
Chapter 3. Heritability
3.2.2.1. Within Family Regression
84
3.2.2.1.1. Midparent-offspring regression
The midparent trait value, i.e. the mean parental refractive error (RE LMM), was 
regressed against the trait value of the offspring. If there was more than one offspring 
within a nuclear family, the mean RE LMM value of the offspring was used. The 
regression coefficient was taken to be equal to the heritability. These calculations 
were performed both non-weighted and weighted for the number o f children in the 
family. In the non-weighted situation, each family group (i.e. each midparent with the 
average of all offspring) provides an equal contribution to the calculation regardless 
of the number of offspring. Weighting provides a method to distribute the contribution 
of each o f the families depending on the number o f offspring; the larger families 
therefore contribute a higher proportion to the calculation.
3.2.2.1.2. Sibling-sibling regression
One sibling’s refractive error was regressed against the other to obtain a regression 
coefficient equal to the heritability. If there are more than two siblings in a family, a 
variety of methods were used; following the approach of (Schmidt et al., 2005):
1. One sibling is chosen at random and the mean of the others is used as equivalent to 
the second sibling’s trait value [sibl v mid sib (not weighted)].
2. As 1. and then weighted using the weighted least squares method [sibl v mid sib 
(weighted)].
3. As 1. with each sibling in turn being chosen as the first sibling [multiple sibl v mid 
sib (not weighted)].
4. As 3. and weighted using the weighted least squares method [multiple sibl v mid 
sib (weighted)].
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5. A random sibling within each family was plotted against all of the other siblings 
separately, each point representing one pair o f siblings [multiple sibl v sib2 (not 
weighted)].
6. As 5. weighted using the weighted least squares method [multiple sibl v sib2 
(weighted)].
Although naturally weighted, cases 3 and 5 are described as non-weighted because the 
weighted least squares method was not applied. Cases 4 and 6 used the weighted least 
squares method to regress the data using the inverse number o f siblings as the 
weighting variable.
The correlation coefficient between the two sets of values is equal to half o f the 
heritability estimate.
3.2.2.2. Variance Components Method
The SOLAR (Sequential Oligogenic Linkage Analysis Routines) variance 
components linkage analysis software package was used to calculate heritability 
estimates by partitioning the phenotypic variance of the trait (refractive error, RE 
LMM) into genotypic and environmental components.
The pedigree structure, phenotypes and any covariates, for example, sex and age, 
were inputted into the programme. Each individual had an identifying number and by 
stating the parental identifiers the whole pedigree structure was constructed, thereby 
benefiting from using all familial relationships. This package also enables any effect 
of covariates on the phenotype to be accounted for.
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The files were altered to use selected family members for further tailored analysis, 
removing females and males consecutively to produce gender specific results.
3.2.2.3. Markov Chain Monte Carlo (Gibbs sampling) methods
This analysis was performed at the Roslin Institute, Edinburgh, by R. Pong-Wong and 
C.S. Haley, using custom-written software.
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3.3.1. Recruitment
Two hundred and thirty family members were contacted and 148 consented to take 
part in the initial stage of the research project. Sixty seven subjects were sent a second 
questionnaire in an attempt to increase the response. Out of these 67, 20 more subjects 
consented to participation. Therefore there was an initial response rate of 64.3%, a 
follow up response rate of 29.9% and a total response rate of 73.0%.
Spectacle prescriptions were obtained for 85 individuals, and 57 subjects stated that 
they did not have an optometrist but also did not wear glasses. We were unable to 
obtain spectacle prescriptions for 16 subjects due to the lack of response from their 
optometrists. Five subjects did not write their optometrists’ details on the form, one 
subject’s optometrist did not have any records for that subject and four subjects did 
not give consent to contact their optometrist.
3.3.2. Trait Characteristics
Sixty six subjects were able to attend the Kilkenny gathering. Successful 
autorefraction results were obtained for 65 subjects. Axial length measurements were 
obtained for 49 right eyes and 42 left eyes. Keratometry measures were obtained for 
56 right eyes and 58 left eyes (table A, Appendix III). DNA samples (mouthwashes) 
were obtained for all family members who attended the party and a further 47 subjects 
provided DNA samples by post. All of the subjects involved in the second stage of the 
project provided written consent (form CO(IW), Appendix II).
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Autorefraction results were available for some subjects for whom a spectacle 
prescription was not available so a regression between spectacle prescriptions (RE 
LMM) and autorefraction results was performed. The resultant regression equation 
was used to convert any autorefraction results to the equivalent spectacle prescription 
where none were available (figure 3.3). This increased the number of subjects 
included in the analysis from 85 to 155.
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Figure 3.3. Regression o f spectacle prescription against autorefraction (n=35 eyes from 35 subjects).
In order to assign a trait value to those subjects who did not have an autorefraction 
result and who also stated they wore no glasses and had never had an eye 
examination, the RE LMM of those people who had had an eye examination and/or an 
autorefraction was examined and the median value of this distribution was found to be 
zero (piano). Therefore those people with no phenotypic information available were 
assigned a refractive error trait value of zero (piano). The trait distribution was non­
normal (p<0.01, Kolmogorov-Smimov normality test), skewed towards myopia and 
leptokurtosed at emmetropia (figure 3.4.).
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Figure 3.4. Distribution o f refractive error, RE LMM (D), in the multigenerational Irish-Welsh 
pedigree (n=155 subjects).
Gender specific refractive error distributions are shown in figure 3.5. Males and 
females share similar distributions in this cohort but there is a slight increase of male 
emmetropes and female moderate myopes.
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Figure 3.5. Female and male trait distributions o f refractive error.
The characteristics of the biometry measurements are shown in table 3.4. and the 
frequency distribution curves are seen in figures 3.6. and 3.7.
Mean corneal curvature RE (D)
Figure 3.6. Frequency distribution o f RE mean corneal curvature (D), in the multigenerational Irish- 
Welsh pedigree, (n=56 subjects).
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RE Axial Length (mm)
Figure 3.7. Frequency distribution o f  RE axial length (mm), in the multigenerational Irish-Welsh 
pedigree (n=49 subjects).
Right and left eye measurements are shown in table 3.5. The high correlation between 
eyes supports the use of only the right eye measurements.
3.3.3. Heritability estimates
Heritability estimates using within family regression methods are shown in table 3.6. 
The heritability estimate using the midparent-offspring regression was 0.12 (p=0.61) 
with the full set of 33 family groups (figure 3.8). Using the correlation calculation 
method a similar, non significant result was produced (r=0.19, p=0.55). Weighting the 
data for number of offspring did not significantly alter the heritability estimates.
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Figure 3.8. Midparent-offspring regression.
Sibling-sibling regression (figure 3.9.) gave heritability estimates of between 0.24 and 
0.43 depending on which method was used (table 3.6). In general the correlation 
results gave higher heritability estimates, those statistically significant values being 
between 0.52 and 0.56.
s ib l Rx (D)
Figure 3.9. Sibling-sibling regression o f refractive error (S ib l v m id sib (no t w eighted)).
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By the variance components method (SOLAR) the heritability estimate was 0.39 
(p=6.92xl0'5) for refractive error. This method was also used to calculate the 
heritabilities of axial length (h =0.30, p=0.13) and mean corneal curvature (h =1.00, 
p=1.84 x 10*4) (table 3.7.). This estimate for mean corneal curvature being highly 
significant and suggesting the variance is wholly due to additive polygenes with little 
influence from the environment. This method was used to investigate if there is a 
gender effect on the heritability. The results show much higher heritability estimates 
for the females compared to the males although sex as a covariate had no statistically 
significant effect on the values.
The MCMC method produced a heritability estimate of 0.68 when using a random 
starting point for the Markov chain and 0.73 when using the mode o f posterior 
densities for refractive error (table 3.8.); again suggesting a high proportion of 
variance is due to genetic factors. This method also included covariates of age and 
sex.
Table 3.4. Characteristics of biometry measurements in the multigenerational Irish-Welsh pedigree.
Biometry Measure Mean Median Range Non-Normally
Distributed?
R.E. L.E. R.E. L.E. R.E. L.E. R.E. L.E.
Autorefraction (D) -0.96
(S.D.=2.73)
-1.03
(S.D.=2.75)
-0.33
(S.E.M.=0.33)
-0.25
(S.E.M.=0.34)
-9.75 to 4.78 -12.25 to 4.47 Yes
(p=0.03)
Yes
(p<0.01)
Axial Length (mm) 24.18 
(S.D =1.11)
24.03
(S.D.=1.15)
23.94
(S.E.M.=0.16)
24.02
(S.E.M.=0.18)
22.38 to 27.82 20.49 to 26.63 Yes
(p<0.01)
No
(P>0.15)
Mean Corneal 
Curvature (D)
43.00 
(S.D =1.38)
43.06
(S.D.=1.31)
42.94
(S.E.M.=0.19)
42.89
(S.E.M.=0.17)
39.27 to 45.86 39.59 to 45.61 No 
(p>0.15)
No
(p>0.15)
Table 3.5. Right and left eye characteristics of traits.
Biometry Measure N RE v LE correlation
R.E. L.E. Pearson Spearman’s rank
Autorefraction (D) 67 67 r=0.65, p<0.001 r=0.80, p<0.001
Axial Length (mm) 49 42 r=0.95, p<0.001 r=0.96, p<0.001
Mean Corneal 
Curvature (D)
56 58 r=0.97, p<0.001 r=0.97, p<0.001
Table 3.6. Heritability estimates for refractive error using within-family regression and correlation methods.
Within families: 
Method
N Regression Correlation
h2 S .E . 95% C.I. P value h2 S.E . 95% C.I. P value
Midparent-offspring 
(not weighted)
22 0.10 0.19 -0.30 to 0.50 0.61 0.24 1.74 -3.17 to 3.65 0.61
Midparent-offspring
(weighted)
22 0.11 0.32 -0.56 to 0.78 0.21 0.26 1.02 -1.74 to 2.26 0.56
Sibl v mid sib 
(not weighted)
30 0.22 0.13 -0.05 to 0.49 0.10 0.60 1.46 -2.26 to 3.46 0.10
Sibl v mid sib 
(weighted)
30 0.27* 0.11 0.04 to 0.50 0.02 0.84* 2.16 -3.39 to 5.07 0.02
Multiple Sibl v mid sib 
(not weighted)
94 0.28* 0.07 0.14 to 0.42 0.00 0.74* 1.44 -2.08 to 3.56 0.00
Multiple Sibl v mid sib 
(weighted)
94 0.30* 0.07 0.14 to 0.42 0.00 0.64* 0.82 -0.97 to 2.25 0.00
Multiple sibl v sib2 
(not weighted)
146 0.29* 0.08 0.14 to 0.46 0.00 0.58* 2.19 -3.83 to 4.99 0.00
Multiple sibl v sib2 
(weighted)
146 0.26* 0.08 0.10 to 0.42 0.00 0.48* 0.85 -2.01 to 2.97 0.00
* significant at p<0.05
Table 3.7a. Heritability estimates for refractive components using SOLAR for all subjects
Ocular Component n All subjects
h2 SE 95% C.I. P
Refractive Error (D) 153 0.39* 0.14 0.12 to 0.66 6.92 x 10'5
Transformed Refractive Error (D) 153 0.39* 0.13 0.14 to 0.65 9.90 x 10'6
Axial Length (mm) 49 0.30 0.33 -0.35 to 0.95 0.13
Mean Corneal Curvature (D) 56 1.00* 0.22 0.57 to 1.43 1.84 x lO4
* significant at p<0.05
Table 3.7b. Heritability estimates for refractive components using SOLAR for male and female subjects separately
Ocular Component Male Female
n h2 SE 95% C.I. P n h2 SE 95% C.I. P . . .
Refractive Error (D) 80 0.37* 0.21 -0.04 to 0.78 0.03 73 0.61* 0.22 0.18 to 1.04 9.00 x 10-4
Transformed Refractive Error (D) 80 0.39* 0.21 -0.02 to 0.80 0.02 73 0.72* 0.21 0.31 to 1.13 6.20 x 1 O'4
Axial Length (mm) 27 0.08 0.32 -0.55 to 0.71 0.40 22 0.73 0.60 -0.45 to 1.91 0.16
Mean Corneal Curvature (D) 29 1.00* 0.00 1.00 to 1.00 3 x 10'3 27 1.00* 0.00 1.00 to 1.00 0.02
Table 3.8, Heritability estimates for refractive error using MCMC methods.
Method N h2 Standard error 95% C.I.
MCMC 89 individuals 0.68 0.17 0.35 to 1.01
MCMC (mode of posterior densities) 89 individuals 0.73 0.17 0.35 to 1.01
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3.4. Discussion
For refractive error a range of heritability estimates were obtained, ranging from 0.12 
and not significantly different from zero, to 0.73 and highly significant, within this 
pedigree. The heritability estimates for the refractive components of the eye show 
only refractive error and mean comeal curvature to be significant. Plotting refractive 
error against mean comeal curvature shows a correlation of -0.35 (Pearson correlation 
coefficient, p=0.009) when considering all of the subjects together (figure 3.10.). 
However the wide spread of the data suggests there may be some interaction between 
the other components of the eye when determining refractive error, therefore the 
possibility of mapping a QTL controlling refractive error based on the control of the 
comeal curvature may not be as likely as the heritability value suggests.
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Figure 3.10. Correlation between refractive error and mean corneal curvature.
Axial length, despite its strong correlation with refractive error has an estimate which 
is statistically insignificant. However, for this measurement the sample size could 
have significantly affected the results (n=49 for axial length and n=153 for refractive
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error); those included individuals may not be as closely related to optimise the 
heritability calculations and allow less assumptions to be made regarding the missing 
data. Animal studies have also suggested that axial length change (specifically 
vitreous chamber depth) is visually driven; changes in the environment producing a 
change in the rate of vitreous chamber elongation, and therefore the trait is less likely 
to be heritable. Corneal curvature, on the other hand, alters little with a change in 
environmental factors and is therefore more likely to be genetically based and so a 
highly heritable trait.
The results produced here have a general trend of having higher heritability estimates 
within the female section of the pedigree for refractive error compared to males and 
the same estimate for mean corneal curvature. Considering sex as a covariate the 
effects are not significant: however there is a slight increase in myopic females and a 
reduction in emmetropic females compared to males and therefore the increased 
heritability may be mostly driven by this difference.
Midparent-offspring, sibling-sibling and variance components methods assume a 
normal distribution of the trait and therefore show some limitations when dealing with 
refractive error but appear to be more appropriate for the investigation of other ocular 
components. Within family regression methods are also not ideal due to only using 
part of the available sample, whereas variance components and MCMC methods 
utilise all possible family members and relationships. They are also able to 
incorporate covariates into the analysis. However, variance components methods have 
a distinct disadvantage in that the analysis is based on a normal distribution and, as 
shown; refractive error does not fit this description. Tests have shown that 
leptokurtosis increases the type I error rate as does skewness in the data (Camp and 
Cox, 2002). Mean corneal curvature and axial length estimates using this method can 
therefore be regarded as accurate but it is more of a suggestive value for refractive 
error.
The estimates measured for the Irish-Welsh family are unique as heritability is a 
measure of the proportion of variation of phenotype due to genetic factors within the
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specified population, therefore other studies using different or isolated populations are 
not comparable, but may be regarded as suggestive of a trend. The trends set by 
heritability studies of alternative populations of ocular refractive components being 
highly heritable are followed by this pedigree when considering refractive error and 
corneal curvature.
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4. Evaluation of Quality and Quantity of DNA 
Extracted from Mouthwashes.
4.1. Introduction
4.1.1. Mouthwashes.
The standard procedure for collecting DNA for genetic and epidemiological studies 
involves obtaining blood samples from individuals. Each millilitre o f blood will 
provide a yield of around 30pg DNA. However, from a 10ml mouthwash, a range of 
yields of up to ~200pg is possible. Studies have also shown that using treated cards 
(Harty et al., 2000) and cytobrush techniques (Garcia-Closas et al., 2001) for sample 
collection also work well and have similar advantages to the mouthwash samples as 
compared to blood but, on average, provide lower yields of human DNA. For the 
DNA collected by treated cards, a significant decline in yield occurred after storage at 
room temperature and -70°C after nine months (Harty et al., 2000).
Advantages of using mouthwashes as a sample collection technique over blood 
include increasing the likelihood of subject participation (by eliminating both the need 
for medical supervision and reducing the risk of infection from hepatitis and HIV) and 
decreasing the inconvenience to the subject. Also, the cost is less and the collection is 
made easier due to the ability to post the samples (Lench et al., 1988).
To obtain maximum DNA yield and integrity samples should be collected before 
tooth brushing; those collected after show a 40% reduction in yield (Feigelson et al., 
2001). They should also be extracted within a week of collection to avoid degradation 
(Harty et al., 2000; Heath et al., 2001). For a genome scan, 300-400 polymerase chain 
reactions are required per subject, 40ng of DNA being required for each. To be certain 
of sufficient DNA, allowing for reactions that may need to be repeated, at least 14pg 
DNA yield is required from the two mouthwashes provided by each individual. As 
genetic analysis of large numbers of individuals by molecular methods is often
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restricted by the availability of DNA (Lench et al., 1988), by using mouthwashes as a 
source, more samples can be requested at little inconvenience to the subject. 
Alternatively, a method of amplifying the DNA can be attempted. This is discussed 
further in section 4.1.2.
4.1.2. Whole Genome Amplification (WGA)
The quantity of high quality genomic DNA is often a major factor governing the 
breadth and potential of a genetic study. Low DNA yields lead to a reduction in the 
amount of genotyping possible, limiting the available information and therefore 
resulting in a loss of statistical power. One solution to this limitation is the application 
of whole genome amplification (WGA). Previous methods of increasing DNA yield 
are PCR based and have been found to provide amplification bias and inadequate 
genome coverage (Dean et al., 2001). Ideally, the WGA method should produce equal 
amplification of the total genome with no amplification error or non specific product 
amplification. Whole genome amplification by multiple displacement amplification 
(MDA) has been shown to fulfil these criteria by providing a highly uniform 
representation across the whole genome with minimal amplification bias (Dean et al., 
2002; Paez et al., 2004). This method works by non specific primers binding to 
regions of complementary DNA within the genome, and then providing strand 
displacement (unwinding of the DNA double helix) and replication o f the template by 
cp29 DNA polymerase. This cp29 DNA polymerase is a highly specific enzyme with 
both strand displacement activity and proofreading capabilities i.e. the ability to check 
the sequence of the new DNA strand and remove any mistakenly added bases. Further 
benefits of this method include potential amplification from as little as 1-10 copies of 
human genomic DNA (gDNA) and no need for adjustment of final concentration due 
to a saturation of the reaction yielding the same amount o f final DNA independent of 
the amount of initial template.
The multiple displacement amplification method (MDA) involves firstly alkaline- 
denaturing the double stranded DNA template. Addition of a neutralising buffer 
reduces the pH again but due to the length and complexity of the newly single
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stranded template, re-annealing does not occur. A hexamer primer comprised of six 
randomly ordered bases binds to the template at regions of complementarity. This 
primer remains intact in spite of the cp29 polymerase’s proofreading (3’ to 5’ 
exonuclease activity) due to the inclusion of two 3’ phosphorothioate bonds. 
Pyrophosphatase is added to the reaction to break down diphosphates released by the 
dNTPs when bases are added to create new DNA strands. An accumulation of 
diphosphates can inhibit the activity of the (p29 DNA polymerase. The MDA reaction 
takes place over 16 hours of incubation.
Using single nucleotide polymorphisms (SNPs) to test these methods for accurate and 
concordant genotyping, a concordance rate of over 99% was found (Barker et al., 
2004; Paez et al., 2004), the latter investigation finding an increase in this 
concordance rate with the addition of a DNA alkaline denaturing step prior to 
amplification. Holbrook and colleagues (Holbrook et al., 2005) found that there was 
100% concordance between genotyped microsatellite markers of pre- and post-WGA 
samples, suggesting accurate replication and therefore making MDA WGA a solution 
to increasing supplies of depleted DNA samples.
Unfortunately, MDA does not provide a solution to recovering already degraded DNA 
samples, the process producing a smaller yield and a slower rate o f MDA reaction in 
these cases (Holbrook et al., 2005). The degraded DNA will not provide a high 
quality template for MDA and other techniques including PCR due to the low 
molecular weight and potential early sequence termination of the specified section. 
Amplification of this template will only produce larger volumes of the shorter and 
degraded sequences in an inefficient reaction and will not restore the quality of the 
original sample.
Dickson and colleagues (Dickson et al., 2005) evaluated the suitability of using WGA 
on samples designed for microsatellite marker genotyping and found only a very 
slight increase in error rate in the MDA samples of approximately 0.6% compared to 
the human genomic DNA samples along with some variation in allele peak heights, 
indicating some amplification bias. Both of these problems could be improved by 
pooling multiple samples. However, there was some inter-marker variability, with
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some microsatellites providing the majority of the genotyping errors within the MDA 
group of samples.
An investigation of genotyping DNA from different tissue samples showed equal and 
complete concordance between blood and buccal cells using both SNPs and short 
tandem repeats (Hosono et al., 2003).
Genomic representation is also a critical issue. Reports have shown that coverage is 
comparable to that of non amplified DNA (Dean et al., 2002; Hosono et al., 2003; 
Paez et al., 2004). The study by Paez and colleagues stated there were several 
chromosomal sections that were not represented. There were also sections of 
chromosome that were consistently underrepresented in the amplified samples even 
though the SNPs were concordant. This could become problematic for some genetic 
analyses techniques. However, the evidence from these studies suggests that, in 
general, this method is an extremely useful solution to the problems o f sample 
depletion for genetic studies.
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4.2. Methods
4.2.1 Sample Collection
Two sterile tubes each containing 15ml sterile 0.9% saline solution were posted to 
each participating subject. The subject poured the solution into his/her mouth and 
swished it around for 20 seconds. The subject was asked to spit the solution back into 
the tube. This was repeated for the second solution and they were asked to post the 
samples back as soon as possible after they had taken them in a pre-paid envelope. 
The subjects were asked to provide the samples first thing in the morning before 
eating, drinking or tooth brushing (see mouthwash instructions -Appendix I).
4.2.2. DNA Extraction from Mouthwashes.
On receiving the samples, they were refrigerated as soon as possible for at least 30 
minutes. The samples were centrifuged at 3500rpm for 5-7 minutes to pellet the 
buccal cells (this was repeated if the pellet was not fully formed) and the supernatant 
was discarded. The pellet was resuspended by adding 380pl proteinase K buffer 
(lOmM tris-HCl, pH8.0, ImM EDTA, 0.5% SDS) and pipetted up and down until 
fully resuspended. The mixture was transferred to a 1.5ml screw top tube and frozen 
at -20°C until ready to process further. The samples were removed from the freezer, 
thawed at 37°C, vortex-mixed and briefly centrifuged. Twenty microlitres of 
proteinase K (lOmg/ml) was added to each tube and incubated at 37°C for two hours 
in a waterbath with continuous shaking (lOOrpm). The samples were removed from 
the waterbath and centrifuged at 14000rpm for three minutes to pellet insoluble 
material and the supernatant was transferred to a 1.5ml “silicon grease” Eppendorf 
tube. These tubes were prepared by adding approximately lOOpl silicon grease (high 
vacuum grease; Dow Coming®, Midland, U.S.A.) to the underside of the hinge of an 
Eppendorf tube, then centrifuging the tube for four seconds at 3000rpm. 
Phenol/chloroform (phenol:chloroform:isoamyl alcohol-25:24:1), 470pl, was added 
and vortexed vigorously for 30 seconds and then the tube was centrifuged at 
14000rpm for two minutes. If debris remained in the supernatant, this layer was
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transferred to a second silicon grease Eppendorf tube and the phenol/chloroform 
extraction was repeated. When no debris remained in the supernatant, it was 
transferred to a sterile 1.5ml screw top vial and 19pl 5M NaCl was added. The 
mixture was vortex-mixed and briefly centrifuged. One millilitre of 100% ethanol was 
added, mixed and left to precipitate at -20°C for 30 minutes or more. The samples 
were removed from the freezer, inverted a few times to mix and then centrifuged at 
14000rpm for 10 minutes. The supernatant was discarded, 1ml o f ice cold 70% 
ethanol was added and the solution was then centrifuged at 14000rpm for two 
minutes. The majority of the supernatant was removed, then a narrow bore pipette tip 
was used to remove the last traces of ethanol. The tube was air dried in an inverted 
position for five minutes. The pellet was resuspended in 51 pi TE (lOmM Tris, ImM 
EDTA) and incubated for 15 minutes at 37°C with periodic gentle vortexing.
4.2.3. Quantification of DNA Yield and Quality by 
Spectrophotometry.
A 1:100 dilution was prepared by adding lp l sample to 99pl TNE (lOmM Tris, 
lOOmM NaCl, ImM EDTA, pH 8.0). The absorption at wavelengths o f 260, 280 and 
320nm was measured (A2 6 0 , A2 8 0  and A3 2 0  values) by spectrophotometry 
(GeneQuant™, GE Healthcare Life Sciences, Amersham, UK) and the concentration 
and yields were calculated using equations 4.1. and 4.2.
[ 1 ] DNA concentration (pg/pl) = A im  x 50 x dilution factor
1000
[2] DNA Yield (pg) = DNA concentration (pg/pl) x volume (pi)
Equations 4.1. and 4.2. DNA Concentration and Yield Calculation.
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Spectrophotometry provides a quantification method of DNA samples. However, this 
value may be inaccurate due to the inability of this method to distinguish between 
human genomic DNA, RNA and DNA from sample contaminants such as bacteria 
and food (Garcia-Closas et al., 2001). Therefore to calculate the actual human 
genomic DNA content a human DNA assay was carried out.
4.2.4.1. SYBR® Green I human genomic DNA assay
DNA samples under test were diluted to a concentration of 6.67ng/pl, according to 
their spectrophotometric absorbence. Six microlitres of this DNA template solution 
was added to 6pl master mix solution to give final concentrations of 1 x Hotstar PCR 
buffer, 0.2mM dNTP mix, 0.3pM primer mix (D1S534, D4S1625 or D7S3506, 
upstream and downstream) and 0.033U/pl Hotstar Taq. The same was repeated for 
human placental genomic DNA standards, purchased from Sigma, o f concentrations 
of 6.67ng/pl, 5ng/pl, 3.33ng/pl and 1.67ng/pl. The PCR was cycled as follows:
15 minutes @ 95 °C 
20 seconds @ 94°C 
30 seconds @ 63 °C r  30 cycles 
45 seconds @ 72°C 
5 minutes @ 72°C
Three microlitres 5x Ficoll EDTA loading dye (15% Ficoll 400, lOmM EDTA, 0.5% 
xylene cyanol FF) was added to each PCR sample and 1 Opl o f this sample was run on 
a 3% agarose gel. The samples were run at 70V for approximately 30 minutes. The 
gel was stained with S YBR® Green I for 20 minutes and then destained for 15 
minutes. A photograph was taken and then analysed using ImageMaster ID Prime 
program (ImageMaster ID Prime, GE Healthcare Life Sciences, Amersham, UK). A 
standard curve was produced from the human DNA standards and calculations for the 
other samples were taken from this curve.
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Final human genomic DNA concentrations were then calculated for the subjects’ 
mouthwashes. Samples containing less than 15pg human gDNA underwent whole 
genome amplification and the human gDNA assay was then repeated until at least 
15pg human gDNA was present.
4.2.5. Whole Genome Amplification
The MDA reaction saturates at a specific yield and this occurs independently of the 
initial template. Therefore one microlitre of DNA from the first sample from each 
subject was added to 4pl TE (lOmM Tris, lrnM EDTA) irrespective o f its initial DNA 
concentration. “Solution A” was prepared by adding 900pl H2 O to 80pl 5M KOH and 
20pl 0.5M EDTA, pH8.0. Five microlitres of a 1:8 dilution of solution A were added 
to each sample, mixed by pipetting and incubated at room temperature for three 
minutes. Ten microlitres of 20mM HC1 were then added. Eighty microlitres of 
mastermix were added giving final concentrations of 1 x MDA buffer (37mM Tris- 
HC1 (pH 7.5), 50mM KC1, lOmM MgCl2,5mM (NH^SCU), ImM dNTPs, 50pM 
WGA random hexamer primer (with 2 phosphorothioate linkages at the 3’ end), 0.1U 
pyrophosphatase and 80U cp29 DNA polymerase. The plate was heat sealed and 
placed in a thermal cycler for 16 hours at 30°C followed by five minutes at 65°C. The 
final yield was quantified by spectrophotometry as previously and then human 
genomic DNA content was calculated by performing the S YBR® green human 
genomic DNA assay. For those subjects with no PCR band on the gel, i.e. a minimal 
human gDNA yield, WGA was repeated.
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4.3. Results.
4.3.1. Spectrophotometry
A total of 113 subjects from the Irish-Welsh family provided mouthwashes. Figures 
4.1 and 4.2 show the distribution of yields of DNA calculated by spectrophotometry 
from all mouthwashes and from all subjects (sum of both mouthwashes for each 
subject) respectively.
Figure 4.1. Yield of DNA from separate mouthwashes from Irish-Welsh family.
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Figure 4.2. Total yield of mouthwashes (sum of two mouthwash samples) from Irish-Welsh family.
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Each mouthwash gives an average yield of 40.56jng, the median value being 29.25(ig 
(SEM=2.80) and the range from 0 to 184.25pg. The total yields from both 
mouthwashes have an average of 78.76pg, a median of 65.25pg (SEM=6.57) and a 
range from 3.43 to 255.25tig.
Other members of the Family Study of Myopia also provided mouthwash samples for 
alternative genetic analyses including an association study (chapter 6) and for future 
linkage analysis studies. Of the families recruited, approximately 243 subjects 
provided mouthwash samples. The distributions are shown in figures 4.3 and 4.4.
Yield from each mouthwash (ug)
Figure 4.3. Yield of DNA from separate mouthwashes from the Family Study o f Myopia subjects.
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Figure 4.4. Total yield of DNA from mouthwashes from the Family Study of Myopia subjects.
Each mouthwash gives an average yield of 66.89pg, the median value being 52.88pg 
(SEM=2.57) and the range from 0 to 399.25fig. The total yields from both mouthwash 
samples have an average of 133.78pg, a median of 117.75pg (SEM=5.91) and a range 
from 1 to 612.75 pg.
4.3.2. SYBR® green I human DNA assay
Figure 4.5. shows an example of the agarose gel image produced for the human 
genomic DNA assay.
Standards 
  A_______ _
f '  r
0 10 20 30 40
Subject samples
Figure 4.5. Agarose gel image. Bands shown are human specific PCR products stained with SYBR® 
green I. The bands’ pixel density is compared to that of the standards to quantify the DNA yield. The 
figures for the standards refer to the amount of human genomic DNA (ng) used as a template.
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Figure 4.6. shows the distribution of total human gDNA yield from the subjects 
calculated by the SYBR^ green I human DNA assay. The average yield is 36.97|ug, 
median of 29.67pg (SEM=3.62) ranging from 0.11 to 157.02pg.
20 -
15-
total hdna (ug)
Figure 4.6. Total yields of human gDNA from SYBR® green I human gDNA assay.
As stated previously, it is necessary to have a total yield of approximately 15pg or 
more human DNA. Thirty one individuals in the Irish-Welsh family had less than this 
value and so underwent whole genome amplification. Out of 31 subjects, only two 
subjects failed to produce a WGA human gDNA yield, 29 subjects amplified to give 
adequate human gDNA yields. Figure 4.7. shows the final human gDNA yields 
including those samples which underwent WGA. These samples have a mean of 
50.67pg, a median of 38.83pg (S.E.M=3.70) and a range from 0 to 157pg. 75% of 
samples had a yield greater than 24.33 pg. The two subjects providing the samples 
which failed to amplify were removed from the genotyping part of the study.
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total hDNA yield (ug)
Figure 4.7. Total human DNA yield for Irish-Welsh family including samples which underwent WGA.
4.3.3. Whole Genome Amplification
See figure 4.8. The samples requiring whole genome amplification were identified 
and the first 16 samples were amplified. Only 6.25% of the samples amplified 
successfully. The next step was to try the alternate mouthwash from those subjects 
whose MDA WGA did not provide a human gDNA yield of over 15pg. The alternate 
mouthwash from these 15 subjects was taken along with both mouthwash samples 
from a further eleven subjects for amplification. From these first two attempts, 20 
samples from 15 subjects amplified to give a human gDNA yield of over 15pg giving 
a sample success rate of 35.1% and a subject success rate of 55.6%. In an attempt to 
increase this success rate the volume of initial template was increased from lpl to 5pl. 
From 29 samples, 51.9% were successfully amplified. The addition of an extra 
phenol-chloroform extraction step further increased the number of samples with an 
amplified human gDNA yield of over 15pg by 10.2% of subjects. Therefore in total, 
the DNA for 28 subjects was amplified using this technique to be used for genotyping 
and only 3% of subjects were excluded due to non-amplification.
DNA samples 
quantified by 
spectrophotometry
Human genomic 
DNA assay
,ndMore than 
15fig hgDNA
No No No NoNo
attempt? attempt?attempt? attempt? attempt?
YesYes Yes Yes Yes Yes
\ f
Exclude 
subject from 
genotyping
Increase initial 
template to 5pl
Use second mouth­
wash sample
Phenol chloroform 
extract samples
Genotype
subject
MDA WGA
Figure 4.8. Flowchart o f the sample preparation pre-genotyping process using a human genome DNA assay and multiple displacement amplification for the whole genome.
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4.3.4. Age and total human DNA yield
Farbrother (Farbrother, 2003) found that age was significantly correlated with 
mouthwash DNA yield. In this sample of subjects aged between 8 to 88, this finding 
was replicated in that total yields were found to be correlated with age (Spearman’s 
rank correlation coefficient rs=0.617, p<0.001) suggesting a trend of older patients 
providing a greater yield of DNA than younger patients. This, however, proved not to 
be the case when looking at the total human gDNA yield for the Irish-Welsh family, 
no significant correlation was found (Spearman’s rank correlation coefficient 
rs=0.082, p=0.431) (figure 4.9).
For the Family Study of Myopia subjects no correlation between age and total yield of 
DNA calculated by spectrophotometry was found (Spearman’s rank correlation 
coefficient rs=0.104, p=0.107) (figure 4.10.).
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Figure 4.9. Age and total human genomic DNA yield for Irish-Welsh family (n=l 13). No statistically 
significant correlation was found between the two variables.
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Figure 4.10. Age and total DNA yield for FSM subjects (n=243). No statistically significant 
correlation was found between the two variables.
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4.4. Discussion
For those DNA samples with an initial adequate yield (i.e. a total yield of more than 
15pg) the total yield of DNA estimated by spectrophotometry and by the human DNA 
assay, showed a statistically significant shift in yield distribution (Mann Whitney, 
p<0.001 for spectrophotometry>human gDNA yield) (figure 4.11.).
35 H I I Spectrophotometry yield 
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Figure 4.11. Yield distributions for spectrophotometry and human gDNA yields.
Mouthwashes appear to be a very useful method of DNA collection, providing up to a 
maximum of 157pg human gDNA, with 95% of subjects providing a total yield of 
28 pg or more. For those samples providing a low value, whole genome amplification 
can be performed increasing the yield to up to 243 pg (mean=70.1 pg, median=50.3pg, 
stdev=62.4, S.E.M.=10.9) from as little as 20ng of initial template.
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Figure 4.12. Mean yield o f those samples undergoing WGA
Several attempts at whole genome amplification were tried (figure 4.8.). If the 
samples failed to amplify, the alternate mouthwash sample was tried. Increasing the 
template added for the WGA process increased numbers of successful reactions by 
45%. If this second mouthwash sample also failed to amplify the DNA was re­
extracted by using a repeat phenol-chloroform extraction protocol and the WGA was 
once again repeated. The extra phenol-chloroform extraction was partly successful in 
increasing the chance of the success of the whole genome amplification, of those re­
extracted, 76% were successful, suggesting the presence of inhibitory factors within 
the initial template, possibly due to protein contamination within the mouthwash prior 
to extraction. Contamination of the mouthwash with non-human DNA, for example 
from food or bacteria, may partly explain the difference between spectrophotometry 
readings and the human DNA assay values, the alien DNA absorbing the light along 
with the human DNA.
Age was found not to affect the human gDNA yield in this sample population. 
Separating the Irish-Welsh mouthwash samples into male and female and comparing 
these yields shows a statistically significant difference between genders such that 
females produce a larger human DNA yield than males (p=0.0075, Mann Whitney) 
(figures 4.13 and 4.14.).
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Figure 4.13. Human DNA yield in females and males
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Figure 4.14. Human DNA yield in females (red outline) and males (black outline)
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Repeating this analysis with the Family Study of Myopia participants showed no 
significant difference between male and female DNA yields, measured by 
spectrophotometry, (p=0.36, Mann Whitney, n=244) see figures 4.15. and 4.16.
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Figure 4.15. DNA yields in males and females measured by spectrophotometry.
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Figure 4.16. Distribution o f DNA yields in males and females measured by spectrophotometry.
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In summary, mouthwashes provide adequate quality DNA for the purposes of genetic 
analyses. The yield obtainable is highly variable between subjects and is affected by 
gender in the Irish-Welsh family, females providing a greater average yield than 
males. However, this is not supported by the other Family Study of Myopia 
participants. The Family Study participants provided a larger yield compared to the 
Irish-Welsh family members, as measured by spectrophotometry (p<0.001, Mann 
Whitney). This may mainly be due to the collection technique. Family Study 
members’ mouthwashes were collected by post and instructions given to the 
participants specify the optimum time for performing the mouthwash to gain the 
highest quantity of DNA is first thing in the morning. The Irish-Welsh family’s 
mouthwashes were collected either as above, but also during a family get together 
(chapters 2 and 3) which occurred towards the evening. It was at this time that the 
majority of mouthwashes were performed and could therefore contribute to an 
explanation of the overall lower yields found in these mouthwashes compared to those 
collected first thing in the morning.
If an inadequate quantity is obtained, whole genome amplification is suitable for 
increasing the yield of human DNA. Using mouthwashes as a source of DNA has the 
potential to ease the methodology of recruiting large numbers o f subjects within short 
periods of time and obtaining DNA samples without the use of trained health 
professionals or requiring the participants to travel. Increasing the sample size will 
increase the power of the study and the ability to regenerate depleting supplies of 
DNA increases the potential of the study, allowing a number o f different loci or 
different analyses to be performed on the same population.
See section 5.3.3.1.2. for an investigation into the quality of WGA samples for 
genotyping.
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5. Linkage Analysis for Myopia in the Multi- 
Generational Irish-Welsh Pedigree.
5.1. Introduction
5.1.1. Linkage Analysis
Linkage is present when alleles at two loci are inherited more often than would have 
been expected by chance, due to the two loci lying close to each other on the same 
chromosome. Linkage analysis is the investigation of the cosegregation between a 
putative disease locus, i.e. the locus controlling the trait phenotype, and a marker 
locus. Specifically, observing the inheritance of the trait with regard to the marker 
genotypes. If a particular marker allele is transmitted along with the phenotype it may 
be that this allele and the disease pre-disposing allele are linked (chapter 1).
There are various different methods of linkage analysis, the appropriate method 
dependent on the assumed mode of inheritance of the trait, the penetrance and the 
disease gene frequency. One exceptionally large pedigree was recruited into the 
Family Study of Myopia cohort (Irish-Welsh pedigree). The large size and the higher 
than average myopia prevalence of this family prompted an investigation separate to 
that of the Family Study of Myopia’s general strategy of examining a large number of 
small families within a combined cohort and so was investigated in isolation. 
Considering the pedigree and phenotype of interest, a variance components approach 
was deemed applicable.
5.1.1.1. Power and SLINK
For a genetic study, it is important to know if the recruited cohort is large enough to 
detect linkage, if it exists. In order to obtain an estimate of the potential power of this 
pedigree, a computer simulation program, SLINK, was used (Ott, 1989; Weeks et al.,
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1990). SLINK simulates a genotype for one pedigree member conditional on the 
phenotype. Each following pedigree member is also assigned a genotype based not 
only on the phenotype but also considering the genotype assigned to the previous 
individual until all members of the pedigree have a genotype. This requires the input 
of pedigree structure information and disease parameters in standard pedigree and 
parameter files. The number of required replicates, a random seed number and the 
proportion of unlinked families (if allowing for heterogeneity) are also required to 
create a third input file. Other information required by SLINK regards the availability 
of phenotype and genotype data. A code is added to the end o f the pedigree file to 
state whether the genotypes are available (i.e. if DNA is obtainable) and whether the 
phenotypic information is available or if it has to be simulated.
5.1.1.2. Variance Components Linkage Analysis
This type of linkage analysis is mostly suited to extended pedigrees and quantitative 
traits. The main benefit over other analysis methods is that no assumptions are made 
regarding the genetic model, i.e. it is a non parametric approach. It is most powerful 
when the trait distribution follows that of multivariate normality; a deviation from this 
distribution increases the type I error rate. However, when the distribution is highly 
leptokurtosed, it is the type I error that is inflated as opposed to the type II error 
(Majumder and Ghosh, 2005), the potential areas of linkage are therefore not 
necessarily excluded. The increase in power of variance components analysis occurs 
because all of the available information is used, including that from relatives who may 
not be affected by the disease or who have a comparatively low trait value. The 
pedigree is also seen as a whole entity and the analysis is not limited to analysing 
separate relative pairs (Almasy and Blangero, 1998; Williams and Blangero, 1999) 
thereby increasing the amount of information extracted from the pedigree.
Most variance component analyses make use of allele-sharing theory (chapter 1). 
Allele sharing methods are based on the theory that, for a quantitative trait, the more 
similar the phenotypes of a sibling pair, the higher the number of alleles shared 
identical by descent (IBD) at that locus.
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5.1.1.2.1. SOLAR
Sequential Oligonucleotide Linkage Analysis Routines (SOLAR) (Almasy and 
Blangero, 1998) is a software package which applies a variance components method 
of analysis to investigate allele sharing within family members and is not restricted to 
relative pairs. As previously described (chapter 3) the variance of the trait under 
investigation can be partitioned into additive genetic effects and environmental 
effects, thereby calculating a heritability estimate for that pedigree. The hypothesis is 
stated that the variance of the trait is due to a major QTL acting on a polygenic 
background. This hypothesis is compared to the null hypothesis when only the 
polygenic background effects are modelled. The difference in the log likelihoods of 
these situations equates to a conventional LOD score (Almasy and Blangero, 1998). 
As the variance components method calculates the likelihood of the data at a certain 
variance estimate, the likelihood value (as well as the variance) must be positive 
values. The LOD score is equivalent to the difference in these values and therefore 
must also be a positive value. This contrasts to conventional LOD score analysis 
where negative values occur where linkage is not present. In variance components 
analysis the exclusion of linkage is indicated if the LOD score is around 0, rather than 
at a LOD score of -2 or below as in conventional linkage analysis.
Following on from this polygenic analysis, identity by descent matrices are calculated 
based on specifying the expected genetic covariances between relatives as a function 
of the IBD relationships at a QTL (Almasy and Blangero, 1998).
The IBD probability matrices are produced in two different ways, the choice of 
method is dependent on the complexity of the pedigree and data:
1. Based on a Curtis and Sham algorithm (Curtis and Sham, 1994) this method 
produces IBD matrices based on the probabilities that two relatives share the 
alleles considering the observed genotypic data.
2. A Monte Carlo method. Uses Monte Carlo algorithms to input marker 
genotypes for those with missing data conditional on the observed data and a 
maximum likelihood estimation method produces the IBD matrices.
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Twopoint and multipoint linkage analyses can then be performed based on these IBD 
calculations. These also provide an estimate of the effect size, specifically the relative 
variance of the trait attributable to the underlying QTL (Williams and Blangero, 1999) 
and the residual variance attributable to other additive genetic effects.
5.1.2. Genotyping
This process involves identifying the genotype at each locus under investigation using 
the polymerase chain reaction with fluorescently labelled primers and differentiating 
between the size of the products and therefore between alleles (chapter 1, section
1.2.1.4.).
5.1.2.4. Genotyping Errors
It is important to identify errors in genotyping as any incorrectly ascribed genotype 
can alter the apparent transmission pattern within a pedigree and therefore affect the 
results obtained from genetic analysis. Errors are likely to decrease the power of both 
linkage and association studies and show an increase in recombination where none 
exists (Badzioch, Thomas and Jarvik, 2003).
5.1.2.4.1. Description and Sources o f  Error
In most genetic studies there will be a low genotype error rate. Generally it is around
0.5 to 1% but can be higher if the DNA template used is of low quantity or quality as 
this reduces the reliability of PCR amplification (Pompanon et al., 2005). Error rates 
are useful to calculate as they can produce a measure of how reliable the genotypes 
are and therefore the data as a whole. It can also identify particular markers or alleles 
which are more prone to errors and therefore the decision of whether the benefits of 
including that specific locus into the analysis outweigh the disadvantages of including 
potentially unreliable genotypes can be made.
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Mendel’s second law states that one allele from each parent is transmitted to an 
offspring. Any inconsistency from this law can be identified as an error in genotyping. 
However, even if a pedigree “Mendelises” well, it could be that there are genotyping 
errors not identified. It follows that by genotyping a highly informative marker, any 
errors will be highlighted easily but those present with a marker with low 
heterozygosity may not be as easy to identify. The only way to eliminate the 
possibility of including undetected errors is to perform further laboratory based work 
with the identified samples. This may include duplicating samples, either using 
replicates or by strategic reamplification at chosen loci that may be more susceptible 
to errors, or by comparing genotypes with other matched tissues. Alternatively the 
errors may be reduced by pre-testing the quality of the DNA (Hoffman and Amos, 
2005). There is also the possibility, in large studies, that a mutation may have 
occurred between generations and that the detected error is not a true error (Pompanon 
et al., 2005).
Errors can be caused by a number of sources (Pompanon et al., 2005):
1. Mutation of the sequence either in the amplified product or in the template 
itself, leading to variations in allele sizes and, in the case o f insertion or 
deletion of one base, difficulty with allele calling.
2. Preferential amplification of one allele, either the shorter allele or that one 
with a lower GC content.
3. Contamination or cross contamination of the sample.
4. Mislabelling of the sample.
5. Addition of an extra base at the end of the new product (section 1.2.1.4.2.).
6. Mislabelling of alleles due to a poor signal. Specifically, microsatellite 
markers can produce stutter bands by slippage of Taq DNA polymerase during 
PCR, especially in highly polymorphic markers (Hoffman and Amos, 2005).
7. Mispriming. The coding of alleles that are not true alleles but amplification 
products of the PCR.
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5.1.2.4.2. PEDCHECK
PEDCHECK (O'Connell and Weeks, 1998) is a software package which identifies 
inconsistencies in the marker data according to Mendelian laws of inheritance. It 
requires the input of the pedigree structure and genotypic data which will then be run 
through a series of checking algorithms as described.
Firstly, the nuclear family algorithm will identify any inconsistencies between parents 
and offspring, known as Level 1 errors. Specifically it will identify situations in that:
1. The alleles of a child and parent are incompatible
2. The alleles of a child are compatible with each parent separately but not with 
both parents together.
3. There are more than the appropriate number alleles in a sibship considering 
the number of homozygous children.
4. For an X-linked locus a male is not coded as homozygous.
5. An individual has only one allele.
The next algorithm is not restricted to nuclear families but also extends the search for 
errors to more complex relationships (Level 2 errors). This genotype-elimination 
algorithm identifies an error and then eliminates the genotype at that marker for each 
member of the family in turn and outputs the possible genotypes the rest of the 
pedigree may have. This is compared to the observed genotypes to identify the 
individual with the error. This can sometimes prove to be difficult as there may be 
more than one individual with a genotyping error or the error comes not from a 
nuclear family but from an adjoining relationship. If this is the case there are two 
further algorithms which can be used (Level 3 and 4 error checking algorithms).
Critical genotypes are those which eliminate inconsistency if  removed from the data, 
and are found using the level three error detection and the critical genotype algorithm. 
The subject with the critical genotype is likely to be the individual with the error, 
however if there is more than one and there is no way to identify the erroneous 
genotype, an odds ratio statistic is used (Level 4 error). This nominates alternative 
genotypes for those subjects with critical genotypes. Likelihoods for the pedigrees are
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calculated using each of the genotypes and a ratio of the highest likelihood to each of 
the others is produced. The best supported genotypes will have a likelihood ratio close 
to 1.
5.1.3. Exclusion loci
A number of systemic diseases are associated with myopia (section 1.1.3.3.). In order 
to restrict the potential genetic basis of the trait under investigation, it is necessary to 
exclude linkage to these disease loci. Specifically, mutations in the gene FBN1, which 
encodes fibrillin, a protein found in the connective tissues, are known to cause 
Marfan’s syndrome (OMIM #154700). Also mutations in the COL2A1 and COL11 Al 
genes, which code for collagen types II and XI, give rise to Stickler’s syndrome type I 
(OMIM #120140) or type II (OMIM #604841) respectively. Including the genotyping 
of markers at these chromosomal loci allows an extra filter to exclude these 
syndromes as a causative factor and is the method used in other myopia studies 
(Young et al., 1998b; Farbrother et al., 2004b). Larger scale studies may require 
alternative methods using SNPs to detect individuals with mutations at these loci. 
Popular high-throughput methods for mutation detection include a method using 
fluorescence resonance energy transfer detection and DNA microarray genotyping 
based method (Shi, 2001).
5.1.4. Candidate Genes
These are genes which are presumed likely to control the disease and are suggested 
due to their position or biological function. Polymorphisms often occur within a gene 
and the probability that they affect the phenotype is often dependent on whether they 
will alter the function of a protein by causing an amino acid sequence change or a 
premature stop to the protein synthesis, these changes being the most likely to cause 
disease associations (Tabor et al., 2002). Amino acid substitutions are the most 
frequent type of mutation, at around 59%. The importance o f that amino acid in
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relation to the function of the protein is the relevant issue when considering the 
clinical outcome (Botstein and Risch, 2003).
5.1.4.1. Myopia candidate genes
Despite the numerous loci identified by linkage to high myopia (see section 1.3.), 
there have not been any causal genes specifically identified.
At the MYP1 locus, cone pigment genes were sequenced and compared to the 
sequences of unaffected individuals, but no mutations were found in affected 
individuals suggesting that colour vision defects were not related to the underlying 
disease (Young et al., 2004a).
MYP2 is the most intensively investigated locus with respect to candidate gene 
sequencing. Nine positional candidate genes were identified for this locus, including 
two structural genes and six transcription factors. However, none of the 
polymorphisms found in the MYP2-linked pedigrees were found to segregate with the 
disease (Scavello et al., 2005; Zhou and Young, 2005). One of these candidate genes, 
TGIF-p, a transforming growth factor related protein, was excluded as a candidate 
gene (Scavello et al., 2004) despite being previously found to be associated with a 
susceptibility to high myopia in a Hong Kong Chinese population (Lam et al., 2003). 
These differences may be due to the differences in ethnic background, as suggested by 
Scavello and colleagues as the wild type DNA sequences of the two cohorts were not 
concordant (Scavello et al., 2004).
The MYP3 locus incorporates a number of possible candidate genes. The first to be 
identified was phenylalanine hydroxylase (PAH) which is involved with metabolism. 
This was used as a marker in linkage analysis and resulted in a high LOD score 
although its physiological role makes it an unlikely candidate gene for myopia 
(Young et al., 1998a). The small leucine-rich proteoglycans (SLRPs): decorin, 
lumican and fibromodulin genes also reside within this locus and are expressed in 
ocular tissues. They have a structural function in that they interact with collagen
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fibrils. Lumican and fibromodulin were both excluded by sequencing affected 
individuals: no sequence mutations appeared to segregate with the disease (Paluru et 
al., 2004).
The locus on chromosome 7, MYP4, does not contain any strong potential candidate 
genes based on their function alone (Naiglin et al., 2002). However, MYP5 contains 
four genes which have been evaluated, two of which are involved in connective tissue 
disorders (COL1 Al and chondroadherin) and two which have been found to be 
involved in eye development (TBX2 and TBX3). Again, none of the polymorphisms 
found segregated with the high myopia (Paluru et al., 2003; Young et al., 2004b).
The region around PAX6 was found to be linked to myopia (MYP7) but no 
association was found with a selection of haplotype-tagging single nucleotide 
polymorphisms (tSNPs) across the region (Hammond et al., 2004). Tagging-SNPs are 
highly informative polymorphisms selected from a group along a region of 
chromosome in which there is elevated linkage disequilibrium (Weale et al., 2003). 
Due to this high level of linkage disequilibrium, where SNPs on the same 
chromosome are inherited together more often than by chance, typing all of the SNPs 
will not increase the information compared to genotyping only those selected (tSNPs). 
By genotyping only the tSNPs within this region, the effect is that o f typing a 
haplotype. Rare recombination events will enable further discrimination between non 
causal and causal SNPs once an association is found. PAX6 (MIM #607108) lies 
within the linked region on chromosome 11 and is known to be involved in 
oculogenesis. Due to the known functionality of the gene and the high linkage signal, 
this is potentially a strong candidate gene within this region. It is possible that the 
causal variant may simply have been missed by the tSNPs used, or it could be that the 
causal variants lie outside of the PAX6 gene itself (Hammond et al., 2004).
In summary, many positional candidate genes have been excluded but no causative 
genes have yet been found.
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5.2. M ethods
5.2.1. Power calculations and SLINK
SLINK requires the trait to be dichotomised and is also unable to handle large 
extended pedigrees. Thus, only a small section of the family could be used for the 
power calculation to produce an estimate of the minimum power o f the total pedigree.
A sub section of 41 family members from Irish-Welsh pedigree was used for this 
power calculation (figure 5.2.). Subjects were assigned as affected if  the refractive 
error was -5.00D or more in the least minus meridian o f the right eye, unaffected if 
less and unknown if  no phenotypic data was available, as used for the analysis 
detecting MYP5. Using a threshold of-6.00D  would further decrease the power of 
this simulation as the number of affected individuals in the available pedigree section 
would be decreased. Dominant inheritance model parameters used were: disease gene 
frequency of 0.0133, 100% penetrance, no phenocopies and eight alleles all occurring 
with equal frequency at a co-dominant marker. Mutation rate was 0, with no sex 
difference. This model was used by Young and colleagues for the detection of MYP2, 
3, and 5 (Young et al., 1998a; Young et al., 1998b; Paluru et al., 2003). No 
heterogeneity was allowed for. Power was calculated by simulation with 250 
replicates.
This was repeated using the parameters set out for a linkage analysis study for 
common myopia (Stambolian et al., 2004). Affectation status was classified as a mean 
spherical equivalent (spherical component of refractive error plus half of the 
cylindrical component) of-l.OOD and over as affected with an age based adjustment 
for individuals under 20 years old (figure 5.5). Twelve different models were used 
using penetrances of 0.584, 0.8 and 0.9. Phenocopy rates of 0, 0.05, 0.1 and 0.15 were 
also used. Gene frequencies and mode of inheritance were the same as described 
above.
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5.2.2. Genotyping
Primers were designed and optimised to their PCR parameters by performing PCR as 
described below and running the products on an agarose gel with a size standard 
(figure 5.1.) on a selection of unrelated samples known to amplify well. Those with 
weak product bands or double bands were re-optimised or re-designed.
S PI P2 P3 P4 P5 P6 P7 P8 P9 P10 P ll P12 P13 P14
Figure 5.1. Example o f a gel for testing primers prior to genotyping. Pn shows each separate primer 
pair and S is the size standard. Primer P10 will be re-optimised due to a shown double band, P5 and P6 
will also be re-optimised due to weak product bands.
Forty nanograms of DNA were added to 8pl master mix solution to give final 
concentrations of 1 x PCR buffer (Promega), 200pM dNTPs, 1.5mM MgCfy lpM 
fluorescently labelled upstream primer, 1 pM downstream primer and 0.3 units Taq 
DNA polymerase in each well. PCR was set for programs as shown in table 5.1. and 
cycling was performed in a MJ Research DNA Engine DYAD. Primers used are 
shown in table 5.2. Forward primers were fluorescently labelled with FAM, HEX or 
NED as indicated.
Table 5.1. PCR programmes where n is the number o f cycles.
NAME OF PROGRAM PARAMETERS
58TD/I 1. 94°C for 3 mins
2. 94°C for 20 secs
3. 62°C for 30 secs, reduce by 1°C per cycle
4. 72°C for 45 secs
5. Repeat from step 2 a further two times
6. 94°C for 20 secs
7. 58°C for 30 secs
8. 72°C for 45 secs
9. Repeat from step 6, n~ 1 times
10. 72°C for 10 mins
62TD n 1. 94°C for 3 mins
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2. 94°C for 20 secs
3. 66°C for 30 secs, reduce by 1°C
4. 72°C for 45 secs
5. Repeat from step 2 a further two times
6. 94°C for 20 secs
7. 62°C for 30 secs
8. 72°C for 45 secs
9. Repeat from step 6, n- 1 times
10. 72°C for 10 mins
64TD/I 1. 94°C for 3 mins
2. 94°C for 20 secs
3. 68°C for 30 secs, reduce by 1°C
4. 72°C for 45 secs
5. Repeat from step 2 a further two times
6. 94°C for 20 secs
7. 64°C for 30 secs
8. 72°C for 45 secs
9. Repeat from step 6, n- 1 times
10. 72°C for 10 mins
60 n 1. 94°C for 3 mins
2. 94°C for 20 secs
3. 60°C for 30 secs
4. 72°C for 45 secs
5. Repeat from step 2, n- 1 times
6. 72°C for 10 mins
5.2.2.1. Preparation for genotyping analysis
PCR products were pooled into their respective “gel sets” (see table 5.2.). Three 
microlitres of this diluted sample was added to 0.5jnl size standard (Genescan 500 
ROX; Applied Biosystems) and 8pl HiDi formamide reagent (Applied Biosystems). 
The samples were loaded into the ABI Prism® 310 Genetic Analyzer and run on 
program D. Genotyper software (ABI Prism®) was used to call the alleles.
Table 5.2. Marker, primer and PCR product descriptions.
Region Marker
Name
Position
(CM)
No.
Alleles
Heterozygosity
(Mar)
Forward Sequence Reverse Sequence Range Gel
Set
PCR
program
MYP1 162.62 11 0.85 GCCTT CT CAAAGT CAAC AGGT A GTTT CTT GGAATT CAGAAT GGCT GCTAT 156-176 8 58TD30
169.72 10 0.90 GAT GACACT CGGACTGCTCTT GTTT CTT CCT CACAAAGCTTT GGGATT 320-346 6 58TD30
173.40 4 0.78 GCAAATT GAT GGGG AACTT GTTT CTT CCAGGACT ACTT AAAACT GT CCT GT 340-346 3 58TD30
177.25 6 0.80 CCACT CC AAATT GTT GGGTAT GTTT CTT GGGAAAGCACAAGTTT CAGAA 162-172 4 58TD30
181.08 8 0.88 GCTT CAT GG AGCT AAAGGG AA GTTT CTT CCAAGGTGGGAGGAT CACTT 190-206 4 58TD30
184.34 5 0.82 GGCTGCCCTTTTGTTCAA GTTT CTT CT GGCAAGGACGC AT AC AT 322-332 4 58TD30
184.34 5 0.89 CGCCTT GCT AGAG AGAC AT GT A GTTT CTTCCT GAAGATGACTCACT CACTT 246-262 4 58TD30
MYP2 0 8 0.82 GCACT CT CT AAAT CTT GCCTT GGAACT GGT ACT CT GAAAGAGA 157-173 10 58TD30
2.84 7 0.76 CCAGT AT GAT GGT GAAATCCT CCTT AGTT CCTCTCT ACAGAAGCA 283-295 11 58TD30
6.94 9 0.75 GTTTGCT GAGGGT C AGCAT GCCT CAGCCTT CCAAAGT 189-211 15 64TD32
8.30 10 0.79 GGAAACATGTTCACCAAATCA CT AT GT CACCAT CTGGCT GT 260-284 12 58TD30
11.21 6 0.69 GTTT CTTT GCTGCCCT ACCAGACC AA AGCCACAACGACCAGCCTTT 120-130 10 58TD30
18.70 10 0.84 GCAAACCTAT CCT GAAGTT CA CAGAT GAACCTGGAAT GGT 102-131 11 58TD30
24.08 7 0.59 GTTT CTT CCCACCCTTAT GACTT CATTTAACC CGCCACACACTCTCACACAC 201-217 10 60TD32
31.17 6 0.63 CCAGACTTT GT GCC ATTT CT CCT GAAT CT CTT GT GGTTT GT 276-286 15 58TD28
38.92 3 0.66 GCATCTATGCAGTGCCAAAT GTTT CTT CACCAGGAT GCCAGCC 103-107 10 58TD30
MYP3 83.19 7 0.77 CCAGCCT GG AAT GAT AT GT A GAAT GT CAATGGACCAGAT G 205-219 11 58TD30
86.40 8 0.80 CCACT AAGAT GCAGCT CAGT A GCTAGTGTTGAATGGCTTCC 292-316 13 58TD30
89.42 8 0.59 CCAGATTTT GACCACTT CT CT CGCAAACAT GGAGAG AAC 132-146 13 58TD30
94.49 6 0.56 CGT GGAT GAT GC AATAGT CAGT A GTTT CTTCCT CAACT ACCTCCCTTT CACTT 172-184 13 58TD30
100.92 6 0.68 C AG ATCTGCTCCTG G AAT C AA GTTT CTT GCAGGAAAGCT GGTT AGG AG AT 297-307 16 58TD30
105.18 7 0.64 GAAACT ATT GGGCT GCT GA AGT CGT AATT GGG AAC AAAA 325-343 10 58TD30
107.86 6 0.75 AGCT GAGAT CAT GCC ACT G TT GGT GAGCCCT GAAGAA 134-152 15 6034
111.87 13 0.91 CCT CT GTT GCAACT AT CTT GAA GCTTTGCAGCACCATGTA 192-216 12 58TD30
116.66 5 0.78 CAGGG AT CT C AC AAT CT G AAA CTGAGCCTTGGAGGGTATG 193-201 16 58TD30
123.77 6 0.73 GGTGGTT CTGGGT CAG AT GGTTT CCT AATTT C AAGT CAA 183-197 13 58TD28
MYP4 168.98 7 0.79 GCTT CAAAGAGCT GCT CAA GTTT CTT CCGATT ACT AT AGT C AAGCGAA 246-260 5 58TD30
173.03 5 0.76 GCAAGT AAG AGGGT AAGG AGGTT GTTT CTT CCTT ACT GGAGAACAT GCAAGAA 310-318 3 58TD30
178.41 13 0.81 CCT GAT AGGC AGTT GGGTT GTTT CTT CACT CCT AGGCATTT ACT GACA 146-192 9 58TD30
180.24 14 0.82 GCAGCT AT CT AAGC ACGCTT GTTT CTT GGAGACT GAGGCAGGAGAAT 306-352 2 58TD30
181.97 5 0.71 CCTTCT CT GGGAGT CT CT GTT GTTT CTT CCT GAT GAGCTGCG AT CTT 210-222 7 58TD25
Table 5.2 contd.
MYP5
PAX6
MYP6
D17S1868
D17S1795
D17S956
D17S1290
D17S942
H 7 S 2 0 5 9
D17S1831
D17S1817
D11S2368
D11S1308
D11S4114
D11S992
D11S904
D11S4152
D11S4154
L/ I I b l  /  0  I
D11S4200 
D11S4203 
D11S4083 
D11S1330 
D11S905 
D11S1993 
D11S1361 
D22S310 
D22S1167 
D22S1144
D22S1176
D22S424 
D22S683 
D22S1173
64.16 7 0.73 GAGG AT GT CGAGGCAGA GCTTGAGCCTAGGAGTCAA 127-139 14 58TD30
68.44 7 0.71 CCAT G AGGTT GAT GGGA GAGCAGGCAGTCTGCAA 219-231 14 58TD28
73.62 6 0.63 CCT GAAGGCTT GGAGCTT GGAGTAATGAAGGAGGGAAAG 231-243 12 58TD30
80.38 13 0.81 GAC ATGGT GAAT GTTTT CCT AG CCAGTTCTCAATGCTTCTTAGT 279-318 10 58TD30
82.00 11 0.84 CT GT GCCCT CT AAT CTTT AGGA GTT GAGGCTT CAGTT AGCCA 152-192 11 58TD30
85.94 4 0.66 GTGACATGGTATCATGAGTACCT GGT AAAGAGCT GAT GCCAA 275-281 16 58TD30
93.27 4 0.60 GCAGT G ATTTT C AC ATT GCTT CT GT AT CT GAACCAACT GTAT C ACA 209-229 13 58TD28
97.60 9 0.81 GGAAGCT CT GACTT CGGTT CT GTTT CTT CT CAGCCT CCCAAAGT GCT 327-349 12 58TD30
103.53 9 0.77 GGGT GAT G AAAGCAAT CT G AA GTTT CTT GGTT GGCAGT GAGCCAAA 168-192 12 58TD30
22.56 9 0.79 CCCCAACTATGATGCCTCCTT GTTT CTTG GT GC AAG AAT GTCTGTCTGTCTA 277-313 1 58TD32
24.73 3 0.54 GGCAG AAGT GGTTT CAG ACAGT A GTTT CTT GGAGGAGAGT AGGAAAC AGGAAA 197-201 6 58TD30
26.98 10 0.77 GCAGACCCAGAGAGATGACAT GTTT CTT GGAGCT GAGCT GTGT CAT ATCTT 279-307 9 58TD35
30.88 7 0.60 CCT GT CT CAT AGGGT AGTT GT GAGA GTTTCTT CCACAGAT GCCAAAGACAT AGAT 305-319 2 58TD32
33.57 8 0.82 GGCT GCTT GAAT CT GAATCCT A GTTT CTTGGCT CACACT AT G AC AAGC AAT 264-282 2 58TD30
35.21 13 0.89 CCCTCCAGAATACTCTTCTATCCTT GTTTCTTGGCACCAACATTCAGACCTT 113-145 1 58TD30
37.62 8 0.79 CCCTAACCT CCAT GTT GCTT GTTTCTT GGCTTT CT CAGAGCACTT CAA 140-157 16 58TD30
40.12 14 0.87 GCAGCCTTTAGTTTTGCCTA GTTT CTT GGCT GGAAT CAGCT CACTT 268-306 3 58TD32
42.55 10 0.74 CCCTCT G AGT CT AAT GCT ACT CTTT GTTT CTT GCCTT GCT GTT CT GT CT CTTT 232-256 6 58TD30
45.94 11 0.76 GCAGCAGGCT GAACACATT GTTT CTT CCAGGATGCT GGAAT AGAGAA 156-207 5 58TD30
47.06 14 0.86 GGACATT CT GC AGGG ACT CTT GTTT CTTGGTT CCTT AGACT C AGATT GGGAT 206-234 2 58TD30
49.73 3 0.23 GCTTT ACAGCC AGAT GCTGTA GTTTCTTGGATACGGACCACTATGTAGGTA 246-250 7 58TD30
51.95 9 0.72 CCTCACACACACCT CT GT CT ATT GTTT CTT GGTTT CAAAGACCTGGACAA 120-140 9 58TD30
54.09 8 0.77 GGGAT AAT GAT AACACCCTT C A GTTT CTTGCTCTGGTCCTATAGCT GCTTA 225-249 16 58TD30
56.76 5 0.50 GC AT AT CCT GAGT GGT GGAAA GTTT CTT GCTT CCCT CT GCT GGACAA 212-227 17 58TD30
23.37 9 0.64 CCCGAAAGG AGT CT CAGTTT GTTT CTT GT CT GT CT GTTT CCAGAGTTT 184-198 10 58TD30
24.74 5 0.74 GGGCTT CAACAAC ATT CTTA GTTT CTT CCT AT AGTTT AGT CCCAGCT GCTT 213-225 9 58TD28
27.48 9 0.76 CCAACT GTTGCGTT G AAGTT GTTT CTT CCACAAAC ACAC ACAT GCTT 139-159 3 58TD30
28.57 8 0.76 CCACCAGTCCT ACT CCT CTTTT GTTT CTT CTGCCTGCCTGCCTATCT AT 261-317 14 58TD30
29.66 10 0.67 GCTT CCT GGAAGT CCT GAAA GTTT CTT GCC AAAAGT AGAT CT GT GCC AT 128-152 4 58TD30
31.30 0.82 CCAGT CT CTT AGG ACAAGC AA GTTT CTT GGGAAAT GCAGGACACATT 257-281 10 58TD30
32.39 9 0.79 GCT CTCCAGCT CT CAGACTTT GTTT CTT GGAAGGG AT CCTAGTT AT C ACCT A 270-334 5 58TD30
33.76 5 0.55 GGAAT GAGT GT CAGT CACT GGAA GTTTCTTGGGACCAGCAAGCACAAA 93-109 2 58TD30
36.22 13 0.90 GGAT AGAGCGAGACT CT GT CT CAA GTTT CTT GGT GG AAAT GCCT CAT GT AG AA 197-233 3 58TD30
37.82 3 0.46 GGT GTCCAACTT CAT CC AGATT GTTT CTT GCCAACAAGT GGAT GAAGAAA 158-162 10 58TD30
Table 5.2 contd.
38.62 13 0.90 GCT GCTTGCTT CCTT CT GAA GTTT CTT CCAGCAT CAT CAT CT ACC ACTT 182-206 1 58TD30
41.42 6 0.61 GGGAGGT GAAAGT GGGAA GTTT CTT CCGTT AT CT CT AGCT AGT GGGTT 277-287 6 58TD35
42.81 5 0.64 CT CT GTAGGT GGCCT GGTT GTTT CTT CCAGTT CCT CT CCACCCTAT A 360-378 9 58TD30
45.82 7 0.64 CCACT GT CT GT CCAT CCGTT GTTT CTT GGAT GAACAG AAT CAGGAT GAA 165-187 14 58TD30
47.31 8 0.85 GCACTT C AGCCT CGT CAA GTTT CTT GGT CCCCT AGT CCT ACAT CAA 369-385 8 58TD30
48.19 9 0.78 CCACT GCACCT GACCCT AGAT GTTT CTT GCCT CAGGG AAT CT AT GACT CAT 172-188 16 58TD32
50.09 5 0.42 GGGAT ACTT CGCTT GT GAGGT A GTTT CTT GGCACGAGAAGC ACTT GAA 235-251 1 58TD28
MYOC 5 GCACAGT GCAGGTT CT CAA GTTT CTT CCGAGCT CCAG AG AGGTTT A 369-377 2 58TD30
5 CCAACC AT C AGGTAATT CCTT GTTT CTT CCT CAAAACCAGGC AC AA 116-125 7 58TD32
FBN1 47.85 6 0.74 TGGT AGT AC CCCT GGAT ACCT G AAT CTTT GT GGAT AT GGCT CT GCT 195-212 14 58TD32
45.62 11 0.80 GGTTGTTTGTATATCTTCTCTCTTTC GCCACCTTGATAGTATGTTAGCA 84-112 12 58TD30
COL2A1 62.54 5 0.75 GT AG AGGT CTT AC AACT CCTTGGT GTTT CTTGCT GAGAACT AAAT C AAG AACT CA 125-137 13 58TD30
64.96 7 0.78 CTCTTAGNCCCACTCTGTAG AAAT AT AT GT G ACCT AAAT GGCAT 241-255 11 58TD30
COL11A1 136.34 9 0.72 GCAGATGACCTTCCGTTCAA GTTT CTTCCCTGGTGTACTGTT CAG AGT ACT 292-310 4 58TD28
136.88 6 0.74 GAAT GTCCCTTT C ATT GCTA CCACTTTGATCTAAAGTGCCT 278-288 13 58TD32
Chr2 232.36 8 0.87 GCTT AGCTT CT AGT GCT GCTTTT GTTT CTT CCACT GAGGCTT GAGG ATT A 109-125 17 58TD30
233.62 11 0.81 GCAATACAGCGAAACCCCAT GTTT CTT GCT GGAAAAG ACAAGG AAACAA 159-191 7 58TD30
235.07 19 0.92 GGCAAAGGCACAACTGCTTA GTTT CTT CCATCCAGGTT GCT GT GAAT 262-302 8 58TD32
236.70 13 0.90 GCT GT CAT CAGAATCCAGTCTT GTTT CTT GCTT CT GGT CAT CT CAT GGGT A 370-402 17 58TD30
238.33 10 0.79 G AC CTGCTAGGATGT C ATT AG ATTT GTTT CTT GCT GCTT ACAGAAGGAAAGGAT 247-273 18 58TD30
240.79 10 0.79 GGTCTGTTACATTGGTTCTCATT GTTT CTT GGCTTTT GGTT AAGCACAGAA 200-222 18 58TD30
242.17 18 0.90 CCT CAGT CT CTT GGAAT GCTT GTTT CTTCGAGT CCAGAACAGT GGAAA 257-313 7 58TD30
243.01 5 0.69 CAGGAACTGGGAGACAAGATAGAT GTTT CTT CCT CAT CAT AAC ACT CAT CCCAA 150-162 2 58TD28
245.44 8 0.81 CCAGCCTGGTAAGCTTTTTCTA GTTT CTT GGCACTT GGACTT CTT ATT GTT 192-221 17 58TD28
247.85 6 0.75 CACAAGGTACCACGACACAAGTA GTTT CTT CCTTGCAT CTTT ACCAAC ACTT 123-144 18 58TD30
249.22 5 0.66 CGTT ACT ACAGT GCT AGG ACT GAA GTTT CTT GGGAACTT GT GATTCCAT GAA 149-157 18 58TD25
Key
I Colour Fluorescent Dye
HEX
FAM
NED
Red= Presumed SNP in ampiimer
Orange=not able to optimise
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5.2.3. Checking for Mendelian errors
Prior to the linkage analysis, the data was analysed with the PEDCHECK program to 
identify any Mendelian errors. Any errors found were rechecked for allele mis- 
specification and if still found to be erroneous they were repeated or removed from 
the analysis for that marker.
5.2.4. Linkage analysis: SOLAR
SOLAR analysis was carried out using data regarding the pedigree structure along 
with age, sex and phenotypic data of all of the family members. Marker genotypes 
were inputted along with genotypic map information of the markers within the loci 
under investigation. Input files were created from this information and a LINUX 
workstation was used to carry out the analysis.
Due to the non-normality of the phenotype, a transformation was considered desirable 
to alter the frequency distribution to that as close as possible to normality. Standard 
transformations (e.g. log, square-root, Box-Cox) were not effective in removing non­
normality. Therefore an alternative approach was adopted using normalised deviates 
as used by several studies for a non-normally distributed phenotype (Fox et al., 2004; 
Yalcin et al., 2004). Specifically, the transformation involved simulating a normal 
distribution of trait values with the mean of 0 and a standard deviation of 3. The 
original and simulated values were arranged by rank. An equivalent quantitative trait 
phenotype (q2) was then assigned to each subject dependent on their ranked position. 
Analysis was performed with both the original and the transformed phenotypes (ql 
and q2, respectively).
The analysis was performed with different allele frequency settings. Equal allele 
frequencies were calculated and used in the initial analysis. Next, allele frequencies 
calculated using maximum likelihood were performed by SOLAR. Due to 
computational constraints, this process was extremely lengthy when there was 
genotypic data missing and for highly polymorphic markers (>5 days per marker in
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some cases). Therefore an alternative method was used; the allele frequencies were 
calculated from all of the married-in individuals and pseudo-founders of the pedigree. 
The founders consisted of individuals as close in pedigree structure to the actual 
founders as possible. Married-in relatives were used to provide a representation of the 
population’s allele frequencies and reduce bias due to the fact that the related 
individuals may inherit the alleles IBD and so the population is comparatively 
enriched with the alleles of its founders.
SOLAR is unable to analyse X chromosomal data using the same method as for the 
autosomal chromosome data. Unfortunately this alternative method could not handle 
the pedigree in full. To overcome this problem, the pedigree was divided into several 
smaller families and the IBD files were produced using the Curtis and Sham 
algorithm. A twopoint analysis was then completed.
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5.3. Results
5.3.1. Pedigree and phenotype statistics
The trait distributions of ql and q2 (the non-transformed and transformed values of 
refractive error, respectively) are shown in figure 5.2. As is expected for refractive 
error, the distribution of ql is leptokurtotic at emmetropia (k=3.85) and skewed 
towards myopia (s=-0.25) (non-normal, Kolmogorov-Smimov, p<0.01). The 
transformation by rank, q2, shows a normal distribution (k=-0.41, s=0, normal, 
Kolmogorov-Smimov, p>0.15).
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Figure 5.2. Frequency distribution of traits ql and q2. Ql represents the refractive error in the least 
minus meridian of the right eye. Q2 represents the rank transformed ql data.
Considering the original data, q l, 37.8% of phenotyped individuals were myopic 
(<-0.50D) and 3.2% were highly myopic (<-6.00D). Emmetropes (>-0.50D and
i
<+0.50D) made up 46.8% of the pedigree and the remaining 15.4% were hyperopic 
(>+0.50D).
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Married in individuals are highlighted in red in table A of the appendix. The trait 
values of whom appear to be skewed more towards hyperopia (yi=l .64) but remains 
leptokurtosed at emmetropia (figure 5.3.).
Figure 5.3. Frequency distribution of married-in individuals (n=24).
5.3.2. Power
SLINK’s simulations produced an average LOD score of 5.53 (standard 
deviation=1.42); 95.2% of the replicates having a LOD score of over 3. These 
calculations used the reduced pedigree with individuals with a refractive error of 
-5.00D classified as affected (figure 5.4.). Dominant inheritance model parameters 
were used as: disease gene frequency of 0.0133, 100% penetrance, no phenocopies 
and eight alleles all occurring with equal frequency at a co-dominant marker. 
Mutation rate was 0, with no sex difference. These results suggest a high power to 
detect linkage from this reduced pedigree using the dichotomised trait. For the 
complete pedigree, there would be an expectation of increased power further with the 
increased size of the pedigree and the extra information of the quantitative 
phenotypes.
The simulations using the models described by Stambolian and colleagues produced 
LOD scores ranging from 0.99 to 3.48 (table 5.3.) for this pedigree (figure 5.4.). This
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pedigree is less powerful for linkage when using common myopia as a phenotype, but 
would still potentially detect a linkage signal if the disease penetrance was 0.9 and the 
phenocopy rate 0 and be suggestive of linkage with penetrance of over 0.8 with 
phenocopy rates under 0.05.
Table 5.3. SLINK LOD score production using models described by Stambolian and colleagues 
(Stambolian et al., 2004).
PHENOCOPY RATE
PENETRANCE 0 0.05 0.1 0.15
0.9 3.48 2.96 2.49 2.16
0.8 2.76 2.29 1.90 1.62
0.584 1.83 1.55 1.13 0.99
These models use a disease gene frequency of only 0.0133. If, for example, a 
penetrance of 0.9 and a phenocopy rate of 0 were used, and assuming Hardy- 
Weinberg equilibrium, this would suggest a common myopia prevalence of only 
2.4%, whereas it is known to be approximately 25% (chapter 1). These results are, 
therefore, only an approximate guide to the power of this study.
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Figure 5.4. Reduced pedigree for power calculation. Filled symbols denote subjects with myopia of more than -5.00D in the least minus meridian of their right eye and those 
with a question mark have an unknown phenotype. Those individuals coded with a 0 have no available genotypic information and an unknown phenotype. Those individuals 
coded with a 2 have genotypic and phenotypic information available. Individuals with a diagonal line through the symbol are deceased.
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Figure 5.5. Reduced pedigree for power calculation (Stambolian model). Filled symbols denote subjects with myopia of more than -1.00D mean spherical equivalent and 
those with a question mark have an unknown phenotype. Those individuals coded with a 0 have no available genotypic information and an unknown phenotype. Those 
individuals coded with a 2 have genotypic and phenotypic information available. Individuals with a diagonal line through the symbol are deceased.
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5.3.3. Genotyping
5.3.3.1. Genotyping procedures
From an initial microsatellite check performed by running subjects’ PCR products on 
the sequencer, 60.0% of reactions needed no optimisation and produced clean signals 
and therefore accurate genotyping information. Other markers needed only minor 
changes to the PCR protocol: either more (10.6%) or less (11.8%) PCR cycles. Due to 
the failure to produce a clean signal from the fluorescently labelled PCR product, 
12.9% of microsatellite markers were redesigned (final primer sequences are shown in 
table 5.2.). Only 4.7% had to be excluded due to presumed single nucleotide 
polymorphisms occurring within the amplimer and therefore potentially complicating 
the allele coding. After redesigning and reoptimising the previously unsuccessful 
markers, a further 4.7% of markers (approximately 36% of those redesigned) were 
excluded due to continued failure to obtain a PCR product of the expected length and 
therefore a clear signal for genotyping.
5.3.3.1.1. Genotyping success rates: subjects
Subject success rate for producing genotypes at all markers are shown in figure 5.6. 
where success rate is calculated by dividing the number of genotypes produced by the 
number of reactions carried out. Following the initial assessment o f DNA quality 
(chapter 4), the expectation was of a high rate of success for all subjects. In reality, 
79.5% of subjects could be genotyped for at least 75% of all markers.
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Figure 5.6. Success rates of subjects where success rate is equal to the number o f genotypes produced 
divided by the number of reactions carried out.
5.3.3.1.2. Genotyping success rates: WGA samples
Of those 96 subjects genotyped, 29 underwent whole genome amplification by way of 
multiple displacement amplification (MDA, chapter 4). Figure 5.7. shows the 
comparison of the percentage of genotypes produced by those subjects who 
underwent whole genome amplification and those who’s original DNA sample 
extracted from the mouthwash was high enough in human DNA content to be used as 
a suitable and plentiful DNA template. The distributions show a difference in success 
of genotyping (two sample t-test, pO.OOOl), the mean percentage of WGA subjects 
being 53.22% (standard deviation= 16.32) and that of the non-WGA individuals as 
73.57% (standard deviation=9.17). Generally the WGA samples produced a lower 
percentage of genotypes, although there is some overlap.
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Figure 5.7. Comparing the genotype success rate produced by subjects using DNA from the original 
mouthwash (black outline) and those using WGA DNA (red outline).
5.3.3.1.3. Genotyping success rates: loci
Figure 5.8. shows the genotyping success rates of the individual marker loci. The best 
performances were for the FBN1 and MYOC loci, the worst for the collagen COL2A1 
and COL11A1 loci.
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Figure 5.8. Success rates o f groups o f markers at the candidate loci investigated.
5.3.3.2. PED C H E C K
When examining the genotypes for Mendelian inconsistencies, each locus was 
investigated individually. MYP1 was found to have 11 errors, six of which were due 
to a male subject being scored as a heterozygote. This subject was subsequently 
removed from the analysis. One of the errors appeared to be due to preferential allele 
amplification and on re-examination of the genotyping data; this was corrected by re­
assigning the genotype. Three errors appeared at the same marker and on re­
examination of the genotyping traces identical results to the original analysis were 
found. This marker was therefore eliminated. A final error also showed no difference 
on reanalysis of the traces and therefore the immediate family group was removed for 
this marker.
MYP2 showed no Mendelian errors. One Mendelian inconsistency was found at each 
of the MYP3, MYP6, PAX6 and MYOC loci, which were corrected by removing the
6
Chapter 5. Linkage Analysis for Myopia in the Multi-Generational Irish-Welsh Pedigree
specific nuclear families involved. The chromosome 2 locus contained two errors 
which were dealt with in the same manner. MYP4 and MYP5 Mendelised well.
5.3.4. Allele frequencies
The calculated allele frequencies are shown in tables 5.4a-l.
Table 5.4a-l. Allele frequencies calculated from founders and married in individuals.
Locus Allele DXS8106 
Freq Size
DXS8028 
Freq Size
DXS998 
Freq Size
DXS8069 
Freq Size
DXS8087 
Freq Size
DXS1073 
Freq Size
MYP 1 0.044 156 0.387 320 0.179 340 0.022 162 0.345 322 0.066 246
1 2 0.087 158 0.044 322 0.598 342 0.023 764 0.022 326 0.419 245
(mle) 3 0.337 160 0.022 324 0.201 344 0.483 766 0.461 323 0.428 250
4 0.087 162 0.044 326 0.022 346 0.227 168 0.151 330 0.022 260
5 0.022 164 0.066 330 0.224 170 0.022 332 0.066 262
6 0.137 166 0.022 334 0.022 772
7 0.022 168 0.067 335
8 0.111 170 0.131 342
9 0.022 172 0.066 344
10 0.109 174 0.153 346
11 0.022 176
Locus Allele D18S59 
Freq Size
D18S476 
Freq Size
D18S481 
Freq S7ze
D18S63 
Freq Size
D18S1132 
Freq Size
D18S452 
Freq Size
D18S1163 
Freq Size
D18S464 
Freq Size
D18S1158 
Freq Size
MYP2 1 0.250 757 0.071 253 0.033 759 0.276 260 0.148 720 0.019 702 0.207 207 0.053 276 0.542 103
2 0.054 159 0.107 255 0.317 797 0.017 262 0.111 722 0.056 111 0.034 203 0.053 275 0.188 705
3 0.018 767 0.214 237 0.100 793 0.052 264 0.019 724 0.241 777 0.603 205 0.070 250 0.271 707
4 0.107 763 0.054 259 0.083 795 0.069 272 0.463 726 0.093 779 0.017 207 0.632 232
5 0.286 767 0.429 297 0.083 797 0.052 274 0.222 723 0.037 727 0.017 277 0.140 234
6 0.054 769 0.054 293 0.233 201 0.259 276 0.037 730 0.259 723 0.086 273 0.052 236
7 0.178 777 0.071 295 0.033 203 0.138 275 0.111 725 0.034 277
8 0.053 773 0.084 209 0.069 230 0.074 727
9 0.034 277 0.017 252 0.019 729
10 0.051 254 0.093 737
Locus Allele D12S80 
Freq Size
D12S326 
Freq Size
D12S64 
Freq Size
D12S316 
Freq Size
D12S348 
Freq Size
D12S332 
Freq Size
D12S1607 
Freq Size
D12S78 
Freq Size
D12S1605 
Freq Size
D12S354 
Freq .Size
MYP3 1 0.093 205 0.234 292 0.059 732 0.500 772 0.074 297 0.047 325 0.186 734 0.328 792 0.273 793 0.290 733
2 0.167 207 0.106 304 0.029 734 0.053 774 0.148 299 0.047 333 0.102 744 0.069 794 0.055 795 0.226 757
3 0.037 277 0.064 306 0.029 736 0.053 776 0.296 307 0.581 335 0.271 746 0.052 796 0.309 797 0.032 759
4 0.204 273 0.255 305 0.029 735 0.263 775 0.019 303 0.163 337 0.051 743 0.017 795 0.127 799 0.323 793
5 0.407 275 0.085 370 0.441 740 0.105 750 0.370 305 0.023 339 0.322 750 0.069 200 0.218 207 0.097 795
6
7
8
9
10 
11 
12 
13
0.056 277 
0.036 279
0.064 372 
0.149 374 
0.043 376
0.294 742 
0.089 744 
0.030 746
0.026 734 0.093 307 0.023 34/ 
0.116 343
0.068 752 0.017 202 
0.052 204 
0.121 206 
0.121 205 
0.069 270 
0.034 272 
0.017 274 
0.034 276
0.018 203 0.032 797
Table 5.4. continued
Locus Allele D7S798 
Freq Size
D7S2546 
Freq Size
D7S2423 
Freq Size
MYP4 1 0.050 246 0.083 310 0.071 210
2 0.017 248 0.188 312 0.429 214
3 0.083 250 0.125 314 0.089 216
4 0.217 252 0.354 316 0.375 275
5 0.083 256 0.250 318 0.036 222
6 0.117 258
7 0.433 260
Locus Allele D17S1868 
Freq Size
D17S1795 
Freq Size
D17S956 
Freq Size
D17S1290 
Freq Size
D17S942 
Freq Size
D17S2059 
Freq Size
D17S1831 
Freq Size
D17S1817 
Freq Size
MYP5 1 0.021 127 0.053 219 0.286 231 0.043 152 0.216 275 0.083 209 0.022 327 0.058 168
2 0.064 129 0.035 221 0.268 233 0.064 156 0.039 277 0.361 221 0.133 331 0.250 170
3 0.043 131 0.175 223 0.393 235 0.043 160 0.196 279 0.417 225 0.022 333 0.327 180
4 0.106 133 0.158 225 0.018 237 0.043 164 0.549 281 0.139 229 0.044 335 0.058 182
5 0.660 135 0.035 227 0.018 239 0.021 168 0.200 337 0.019 184
6 0.064 137 0.491 229 0.017 243 0.043 172 0.022 339 0.135 186
7 0.042 139 0.053 231 0.128 176 0.133 345 0.058 188
8 0.340 180 0.022 347 0.077 190
9 0.084 184 0.400 349 0.018 192
10 0.148 188
11 0.043 192
Locus Allele D22S310 
Freq Size
D22S1167 
Freq Size
D22S1144 
Freq Size
D22S1176 
Freq Size
D22S424 
Freq Size
D22S683 
Freq Size
D22S1173 
Freq Size
D22S283 
Freq Size
D22S426 
Freq Size
D22S1045 
Freq Size
D22S44S 
Freq Size
D22S1157 
Freq Size
D22S1179 
Freq Size
D22S1168 
Freq Size
MYP6 1 0.038 184 0.413 213 0.038 139 0.018 128 0.255 93 0.073 197 0.661 158 0.018 182 0.085 277 0.176 360 0.026 165 0.188 369 0.154 172 0.093 235
2 0.269 186 0.138 215 0.019 141 0.127 132 0.018 101 0.145 203 0.264 160 0.053 184 0.191 279 0.039 369 0.158 167 0.063 371 0.019 174 0.703 237
3 0.077 188 0.069 221 0.058 147 0.073 134 0.691 103 0.164 205 0.075 162 0.088 186 0.149 281 0.334 372 0.053 171 0.219 375 0.115 176 0.019 243
4 0.115 190 0.328 223 0.443 149 0.073 136 0.036 105 0.164 207 0.070 188 0.426 283 0.412 375 0.158 175 0.031 377 0.058 178 0.148 245
5 0.115 192 0.052 225 0.288 151 0.382 138 0.091 209 0.105 190 0.128 285 0.039 378 0.474 179 0.313 379 0.269 180 0.037 251
6 0.077 194 0.058 153 0.255 140 0.073 211 0.088 192 0.021 287 0.105 183 0.094 381 0.077 182
7 0.173 196 0.077 155 0.018 142 0.036 213 0.070 194 0.026 187 0.031 383 0.231 184
8 0.115 198 0.019 157 0.018 144 0.073 217 0.070 196 0.063 385 0.058 186
9 0.019 200 0.018 150 0.018 221 0.070 198 0.019 188
10 0.018 152 0.036 223 0.193 200
11 0.091 227 0.105 202
12 0.018 229 0.053 204
13 0.018 233 0.017 206
Table 5.4 continued
Locus Allele D11S2368 
Freq Size
D11S1308 
Freq Size
D11S4114 
Freq Size
D11S992 
Freq Size
D11S904 
Freq Size
D11S41S2 
Freq Size
D11S4154 
Freq Size
DUS4200 
Freq Size
D11S4203 
Freq Size
D11S4083 
Freq Size
D11S1330 
Freq Size
D11S905 
Freq Size
D11S1993 
Freq Size
D11S1361 
Freq Size
PAX6 1 0.020 277 0.341 197 0.239 279 0.021 305 0.132 264 0.018 113 0.167 140 0.153 232 0.281 156 0.085 206 0.891 246 0.018 120 0.407 225 0.735 212
2 0.040 285 0.585 199 0.022 281 0.043 307 0.132 266 0.091 115 0.167 142 0.051 234 0.386 166 0.220 208 0.036 248 0.105 122 0.017 228 0.122 214
3 0.240 289 0.074 201 0.043 287 0.511 309 0.132 270 0.073 119 0.056 144 0.102 238 0.018 187 0.017 210 0.073 250 0.298 124 0.068 231 0.020 216
4 0.140 293 0.022 295 0.064 311 0.057 272 0.055 121 0.185 146 0.424 240 0.105 189 0.102 212 0.018 128 0.102 237 0.082 225
5 0.140 297 0.043 297 0.021 313 0.038 274 0.145 123 0.093 149 0.051 242 0.053 191 0.119 214 0.035 132 0.220 240 0.041 227
6 0.300 301 0.217 299 0.149 315 0.208 278 0.091 125 0.222 151 0.034 244 0.018 193 0.017 216 0.035 134 0.119 243
7 0.060 305 0.239 301 0.191 319 0.283 280 0.018 127 0.093 153 0.034 246 0.018 195 0.068 218 0.175 136 0.034 246
8 0.020 309 0.065 303 0.019 282 0.036 132 0.019 155 0.034 248 0.053 197 0.119 220 0.211 138 0.034 249
9 0.040 313 0.110 305 0.109 134 0.102 250 0.018 199 0.136 222 0.105 140
10 0.161 136 0.017 252 0.035 201 0.051 224
11 0.161 138 0.018 207 0.017 226
12 0.018 143 0.017 228
13 0.018 145 0.034 230
Locus Allele D2S2297 
Freq Size
D2S2317 
Freq Size
D2S172 
Freq Size
D2S2193 
Freq Size
D2S2344 
Freq Size
D2S206 
Freq Size
D2S2205 
Freq Size
D2S336 
Freq Size
D2S2973 
Freq Size
D2S2202 
Freq Size
Chr2 1 0.087 109 0.017 159 0.021 262 0.147 370 0.173 247 0.026 200 0.041 150 0.123 192 0.173 123 0.019 149
2 0.043 113 0.053 161 0.021 266 0.029 380 0.058 249 0.154 202 0.061 156 0.053 205 0.017 127 0.245 151
3 0.130 115 0.088 163 0.128 268 0.029 382 0.038 251 0.077 204 0.531 158 0.193 211 0.259 131 0.245 153
4 0.065 117 0.088 165 0.021 270 0.147 384 0.193 253 0.077 206 0.347 160 0.158 213 0.034 136 0.434 155
5 0.348 119 0.053 167 0.085 272 0.029 386 0.038 255 0.256 208 0.020 162 0.070 215 0.414 140 0.057 157
6 0.022 121 0.228 177 0.106 274 0.206 388 0.366 257 0.308 210 0.298 217 0.103 144
7 0.283 123 0.211 179 0.043 276 0.059 390 0.038 259 0.026 212 0.070 219
8 0.022 125 0.017 185 0.021 278 0.088 392 0.019 265 0.026 214 0.035 221
9 0.193 187 0.085 280 0.059 394 0.058 269 0.050 222
10 0.035 189 0.064 282 0.088 396 0.019 273
11 0.017 191 0.064 284 0.029 398
12 0.043 286 0.029 400
13 0.064 288 0.059 402
14 0.021 290
15 0.043 292
16 0.085 294
17 0.043 298
18 0.021 300
19 0.021 302
Table 5.4. continued
Locus Allele MYOC1 
Freq Size
MYOC2 
Freq Size
MYOC 1 0.019 370 0.053 116
2 0.426 372 0.263 118
3 0.296 374 0.070 120
4 0.148 375 0.596 122
5 0.111 376 0.018 124
Locus Allele D12S1701 (mle) 
Freq Freq rale Size
D12S361 (mle) 
Freq Freq mle Size
COL2A1 1 0.056 (0.054) 125 0.241 (0.242) 241
2 0.444 (0.464) 131 0.037 (0.035) 245
3 0.250 (0.259) 133 0.167 (0.159) 247
4 0.167 (0.151) 135 0.018 (0.017) 249
5 0.083 (0.072) 137 0.426 (0.442) 251
6 0.093 (0.087) 253
7 0.018 (0.018) 255Locus Allele D15S1003 
Freq Size
D15S992 
Freq Size
FBN1 1 0.148 195 0.018 84
2 0.426 197 0.178 94
3 0.333 199 0.089 96
4 0.037 201 0.018 98
5 0.019 203 0.018 100
6 0.037 212 0.036 102
7 0.054 104
8 0.374 106
9 0.054 108
10 0.054 110
11 0.107 112
Locus Allele D1S2626 
Freq Size
D1S2888 
Freq Size
COL11A1 1 0.036 292 0.040 278
2 0.018 294 0.200 280
3 0.182 296 0.200 282
4 0.218 298 0.400 284
5 0.345 300 0.040 286
6 0.073 302 0.080 288
7 0.073 304 0.040 290
8 0.055 306
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5.3.5. Linkage analysis: SOLAR
The linkage analysis results are shown in table 5.5. for twopoint analysis. Figures 5.9i. 
a-c and 5.9iia-g. show multipoint analysis for exclusion candidate gene regions and 
potential linkage regions respectively.
5.3.5.1. Syndromic Loci
The COL2A1 locus showed a suggestion of linkage with a maximum twopoint LOD 
score of 0.768 at D12S1701 using trait q2 and maximum likelihood estimate (MLE) 
allele frequencies. This was supported by a twopoint LOD score o f 0.585 using the 
same analysis criteria but with trait ql. The other analyses showed lower LOD scores 
(0 to 0.298) therefore suggesting absence of linkage to this region.
The COL11A1 locus showed no linkage, the highest twopoint LOD score being 0.030 
therefore it is possible to exclude linkage to this locus.
The FBN1 locus, again, showed little evidence of linkage with a maximum LOD 
score occurring when analysing the trait ql with equal allele frequencies and 
obtaining a twopoint LOD score of 0.193.
5.3.5.2. Non syndromic loci
The MYP1 locus had its highest twopoint LOD score consistently at marker 
DXS1073, ranging from 0.260 to a maximum of 0.880 dependent on the criteria used. 
The maximum was calculated using ql as the trait and equal allele frequencies.
Chromosome 18’s locus, MYP2, had the highest LOD score o f 0.088 when analysing 
trait q2 with equal allele frequencies and a multipoint analysis (figure 5.9iia). The 
scores for the other markers within this region varied only slightly from 0.
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LOD scores at the MYP3 locus showed little variation from 0 using trait ql as the 
phenotype. However, when using q2, the LOD scores increased. The multipoint LOD 
scores reached a peak of 1.370 when using equal frequencies; between markers 
D12S1605 and D12S354 (figure 5.9iib). Lower peaks occurred at markers D12S348 
and D12S1607 (0.850 and 0.915 respectively) this pattern being followed by the 
analysis using the founder allele frequencies, but having lower LOD scores of 
approximately 0.3. Twopoint analysis gives a maximum LOD score of 0.459 at 
D12S354 and 0.417 at D12S348 with equal allele frequencies but only 0.048 at 
D12S354 for founder frequencies increasing to a maximum of 0.534 at D12S348.
MYP4, on chromosome 7 showed no evidence for linkage, the maximum LOD score 
being a multipoint score of 0.309 using q2 and equal frequencies (figure 5.9iic.), the 
twopoint LOD scores maximizing at 0.049.
MYP5 had a maximum twopoint LOD score of 0.806 at D17S1831 (q l, founder 
frequencies). The ql twopoint analysis with equal allele frequencies also showed a 
peak at this marker and the multipoint analysis was at its maximum LOD score 
between this marker and D17S1817 (figure 5.9iid). Trait q2 showed a similar trend.
The analysis of the MYP6 region on chromosome 22 showed a 5cM region with 
multipoint LOD scores over 1 with trait q2 and equal allele frequencies (figure 5.9iie). 
The majority of the higher LOD scores occurred around markers D22S1173 and 
D22S1176 for the twopoint analysis and D22S1173 and D22S683 for the multipoint.
Chromosome 11 contains the candidate gene PAX6. Twopoint analysis produced a 
maximum peak of 0.598 at marker D11S1993 with trait q2 and equal allele 
frequencies. There were also consistently relatively high LOD scores at markers 
D11S904 and D11S4152. This was supported by the multipoint analysis showing 
peaks around these two markers, the maximum score of 0.796 for q2 with equal allele 
frequencies (figure 5.9iif.).
The chromosome 2 locus had a maximum twopoint LOD score of 0.831 at marker 
D2S2344, which was consistently higher than the adjacent markers, with q2 and
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founder allele frequencies. Multipoint analysis showed a peak at the edge of the 
region around marker D2S2202, with a LOD score of only 0.686 (figure 5.9iig).
The criteria of trait ql with equal allele frequencies are those for which the MYOC 
locus had its highest LOD score, of 0.034 at the MYOC2 marker; therefore exclusion 
of linkage from this region of chromosome 1 is appropriate.
In summary the higher LOD scores occurred with the trait q2 and using equal allele 
frequencies. Generally the next highest scores were found using the same trait but 
with allele frequencies calculated from pedigree founders and married-in subjects. 
Allele frequencies did not seem to have such an influential effect on trait q l .
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Table 5.5. Summary o f SOLAR twopoint analysis
COL2a1 Equal frequencies, q1
Model  LOD L o g l i k e  H2r H2ql
D12S361  
D12S17 01
0 . 0 0 2 8
0 . 2 5 3 0
- 1 8 1 . 5 5 9  
- 1 8 0 . 9 8 3
0 . 3 5 7 6 5 7  
0 . 0 0 0 0 0 0
0 . 0 2 8 1 8 7  
0 . 3 8 0 8 5 1
COL2a1 MLE frequencies, q1
Model LOD L o g l i k e H2r H2ql
D12S361  
D12S17 01
0 . 0 1 1 7
0 . 5 8 4 9
- 1 7 8 . 9 6 6  
- 1 7 7 . 6 4 6
0 . 3 5 3 8 5 6  
0 . 0 0 0 0 0 0
0 . 0 6 6 6 0 2  
0 . 4 2 4 6 5 2
COL2a1 Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
D12S361
D12S1701
0 . 0 0 0 0  
0 . 2 9 8 2
- 2 3 1 . 5 3 6  
- 2 3 0 . 8 4 9
0 . 3 9 4 8 3 0  
0 . 0 0 0 0 0 0
0 . 0 0 0 0 0 0  
0 . 4 0 6 6 7 0
COL2a1 MLE frequencies, q2
Model LOD L o g l i k e H2r H2ql
D12S361
D12S1701
0 . 0 0 0
0 . 7 6 8
- 2 3 1 . 5 3 6
- 2 2 9 . 7 6 7
0 . 3 9 5  
0 .  000
0 .  00 
0 . 4 2
C O L 1 1 a 1 Equal frequencies, q1
Model  LOD L o g l i k e H2r H2ql
D1S2626
D1S2888
0 . 0 0 0 0
0 . 0 0 0 0
- 1 8 1 . 5 6 5
- 1 8 1 . 5 6 5
0 . 3 8 6 9 9 6  
0 . 3 8 6 9 9 6
0 . 0 0 0 0 0 0
0 . 0 0 0 0 0 0
C O L 1 1 a l  MLE frequencies, q1
Model LOD L o g l i k e H2r H2ql
D1S2626
D1S2888
0 . 0 0 0 0
0 . 0 2 9 6
- 1 7 8 . 9 9 3  
- 1 7 8 . 9 2 5
0 .  4 2 0 8 1 6  
0 . 2 1 6 4 1 5
0 . 0 0 0 0 0 0
0 . 2 0 9 4 3 7
CO L 11 a1  Equal frequencies, q2
Model  LOD L o g l i k e H2r H2ql
D1S2626
D1S2888
0 . 0 0 0 0
0 . 0 0 0 0
- 2 3 1 . 5 3 6  
- 2 3 1 . 5 3 6
0 . 3 9 4 8 3 0  
0 . 3 9 4 8 3 0
0.000000 
0.000000
C O L I I a l  MLE frequencies, q2
Model LOD L o g l i k e H2r H2ql
D1S2626
D1S2888
0.0000
0 . 0 0 6 5
- 2 3 1 . 5 3 6  
- 2 3 1 . 5 2 1
0 . 3 9 4 8 3 0
0 . 3 1 9 7 4 7
0.000000
0 . 0 7 4 5 4 3
Equal frequencies, q1
Model LOD L o g l i k e H2r H2ql
D15S992 0 . 0 0 5 4  - 1 8 1 . 5 5 3  0 . 3 6 3 1 0 6  0 . 0 3 0 5 6 2
D15S1003  0 . 1 9 3 1  - 1 8 1 . 1 2 1  0 . 1 9 6 3 1 3  0 . 1 6 1 0 6 3
Chapter 5, Linkage Analysis for Myopia in the Multi-Generational Irish-Welsh Pedigree
Table 5.5. continued
MLE frequencies, q1
Model LOD L o g l i k e H2r H2ql
D15S992
D15S1003
0 . 0 9 6 5  
0 . 0 2 8 8
- 1 8 1 . 3 4 3  
- 1 8 1 . 4 9 9
0 . 2 7 9 5 4 6
0 . 3 0 7 6 4 7
0 . 1 3 6 7 3 2
0 . 0 7 6 1 4 8
Founder frequencies, q1
Model LOD L o g l i k e H2r H2ql
D15S992
D15S1003
0 . 1 1 2 0  
0 . 0 2 3 2
- 1 8 1 . 3 0 8
- 1 8 1 . 5 1 2
0 . 2 6 6 4 7 9
0 . 3 1 1 6 3 7
0 . 1 5 2 0 4 7  
0 . 0 7 2 1 3 3
Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
D15S992
D15S1003
0 . 0 0 0 0  
0 . 1 2 8 9
- 2 3 1 . 5 3 6  
- 2 3 1 . 2 3 9
0 . 3 9 4 8 3 0
0 . 2 2 4 5 3 2
0 . 0 0 0 0 0 0  
0 . 1 4 7 9 8 4
MLE frequencies, q2
Model LOD L o g l i k e H2r H2ql
D15S992
D15S1003
0 . 0 0 0 5  
0 . 0 1 6 9
- 2 3 1 . 5 3 5  
- 2 3 1 . 4  97
0 . 3 8 5 8 2 7
0 . 3 3 6 6 5 9
0 . 0 1 0 7 8 4  
0 . 0 5 6 4 4 7
Founder frequencies, q2
Model LOD L o g l i k e H2r H2ql
D15S992
D15S1003
0 . 0 0 4 6
0 . 0 0 9 8
- 2 3 1 . 5 2 5
- 2 3 1 . 5 1 3
0 . 3 6 5 2 1 1
0 . 3 4 5 4 4 5
0 . 0 3 5 0 4 5  
0 . 0 4 7 4 0 1
MYOC Equal frequencies, q1
Model LOD L o g l i k e H2r H2ql
m y o c l
myoc2
0 . 0 0 0 0
0 . 0 3 3 6
- 1 8 1 . 5 6 5
- 1 8 1 . 4 8 8
0 . 3 8 6 9 9 6  
0 . 3 1 1 5 5 4
0 . 0 0 0 0 0 0
0 . 0 6 4 7 5 4
MYOC MLE frequencies, q1
Model LOD L o g l i k e H2r H2ql
m y o c l
myoc2
0 . 0 0 0 0
0 . 0 1 5 8
- 1 8 1 . 5 6 5
- 1 8 1 . 5 2 9
0 . 3 8 6 9 9 6
0 . 3 3 5 9 0 8
0 . 0 0 0 0 0 0
0 . 0 4 5 4 7 4
MYOC Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
m y o c l
myoc2
0 . 0 0 0 0
0 . 0 0 0 8
- 2 3 1 . 5 3 6
- 2 3 1 . 5 3 4
0 . 3 9 4 8 3 0  
0 . 3 8 0 3 0 6
0 . 0 0 0 0 0 0
0 . 0 1 3 1 9 9
MYOC MLE frequencies, q2
Model LOD L o g l i k e H2r H2ql
m y o c l  0 . 0 0 0 0  - 2 3 1 . 5 3 6  0 . 3 9 4 8 3 0  0 . 0 0 0 0 0 0
myoc2 0 . 0 0 0 0  - 2 3 1 . 5 3 6  0 . 3 9 4 8 3 0  0 . 0 0 0 0 0 0
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Table 5.5. continued
MYP2 Founder frequencies,
Model
q i
LOD L o g l i k e H2r H2ql
D18S59 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S63 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S452 0 . 0 1 2 0 - 1 8 1 . 5 3 8 0 . 3 2 6 5 1 3 0 . 0 5 3 2 3 4
D18S464 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S476 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S481 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S1132 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S1158 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D1 8 S 1 163 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
MYP2 Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
D18S59 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S63 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S452 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S464 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S47 6 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S481 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S1132 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S1158 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S1163 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
MYP2 Founder frequencies, q2
Model LOD L o g l i k e H2r H2ql
D18S59 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S63 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S452 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S464 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S47 6 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S481 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S1132 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D18S1158 0 . 0 1 5 0 - 2 3 1 . 5 0 1 0 . 3 1 3 5 8 2 0 . 0 7 5 1 6 0
D1 8 S 1 163 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
MYP3 Equal frequencies, q1
Model LOD L o g l i k e H2r H2ql
D12S64 0 . 0 0 9 8 - 1 8 1 . 5 4 3 0 . 3 0 4 1 1 2 0 . 0 9 7 1 0 0
D12S7 8 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D12S80 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D12S316 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D12S326 0 . 1 7 0 6 - 1 8 1 . 1 7 3 0 . 1 8 9 0 3 8 0 . 2 4 6 9 7 2
D12S332 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D12S348 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D12S354 0 . 2 4 0 5 - 1 8 1 . 0 1 2 0 . 0 0 0 0 0 0 0 . 4 2 4 5 9 0
D12S1605 0 . 0 0 6 5 - 1 8 1 . 5 5 0 0 . 3 3 4 2 9 7 0 . 0 4 7 4 9 0
D12S1607 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
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Table 5.5. continued
M Y P  I Equal frequencies, q1
Model LOD L o g l i k e H2r H2ql
DXS998 0 . 1 4 1 7 - 1 2 9 . 6 0 4 0 . 1 4 7 0 5 3 0 . 1 1 8 7 2 8
DXS1073 0 . 8 8 0 3 - 1 2 7 . 9 0 4 0 . 0 0 0 0 0 0 0 . 3 1 2 2 4 0
DXS8028 0 . 1 2 2 4 - 1 2 9 . 6 4 9 0 . 1 6 8 9 5 4 0 . 1 0 1 0 2 1
DXS8069 0 . 2 2 3 8 - 1 2 9 . 4 1 5 0 . 1 2 8 8 1 0 0 . 1 2 7 1 5 2
DXS8087 0 . 5 3 9 8 - 1 2 8 . 6 8 8 0 . 0 0 0 0 0 0 0 . 2 6 1 7 3 8
DXS8106 0 . 2 4 0 7 - 1 2 9 . 3 7 6 0 . 1 3 1 6 4 1 0 . 1 2 7 7 1 1
I Y P1 Founder frequencies, q1
Model  LOD L o g l i k e H2r H2ql
DXS998 0 . 0 8 3 1 - 1 2 9 . 7 3 9 0 . 1 7 3 1 2 0 0 . 0 9 2 9 5 9
DXS1073 0 . 7 4 5 7 - 1 2 8 . 2 1 4 0 . 0 0 0 0 0 0 0 . 3 0 6 0 3 8
DXS8028 0 . 1 1 8 2 - 1 2 9 . 6 5 8 0 . 1 7 3 0 6 9 0 . 0 9 8 6 7 1
DXS8069 0 . 2 1 1 9 - 1 2 9 . 4 4 3 0 . 1 3 4 8 6 9 0 . 1 2 2 2 7 3
DXS8087 0 . 4 4 0 2 - 1 2 8 . 9 1 7 0 . 0 0 0 0 0 0 0 . 2 6 7 4 7 3
DXS8106 0 . 2 3 5 1 - 1 2 9 . 3 8 9 0 . 1 3 7 8 6 6 0 . 1 2 8 1 1 2
1V1YP1 Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
DXS998 0 . 0 0 0 6 - 1 6 7 . 8 7 4 0 . 2 5 3 1 1 4 0 . 0 0 8 7 7 5
DXS1073 0 . 4 0 2 1 - 1 6 6 . 9 5 0 0 . 0 4 8 1 9 7 0 . 2 5 2 0 9 3
DXS8028 0 . 0 1 2 1 - 1 6 7 . 8 4 8 0 . 2 3 1 6 9 3 0 . 0 3 4 5 4 4
DXS8069 0 . 0 6 9 3 - 1 6 7 . 7 1 6 0 . 1 7 9 3 6 6 0 . 0 8 2 0 5 8
DXS8087 0 . 1 3 4 1 - 1 6 7 . 5 6 7 0 . 1 1 2 1 1 7 0 . 1 5 0 8 7 6
DXS8106 0 . 1 0 9 5 - 1 6 7 . 6 2 4 0 . 1 7 7 6 6 6 0 . 0 8 9 6 4 8
MY P I  Founder frequencies, q2
Model  LOD L o g l i k e H2r H2ql
DXS998 0 . 0 0 0 0 - 1 6 7 . 8 7 6 0 . 2 6 1 3 6 6 0 . 0 0 0 0 0 0
DXS1073 0 . 2 5 9 8 - 1 6 7 . 2 7 7 0 . 0 8 7 6 9 3 0 . 2 0 7 1 6 9
DXS8028 0 . 0 0 9 6 - 1 6 7 . 8 5 3 0 . 2 3 5 5 1 1 0 . 0 3 0 8 5 1
DXS8069 0 . 0 5 9 0 - 1 6 7 . 7 4 0 0 . 1 8 7 9 5 0 0 . 0 7 4 9 3 6
DXS8087 0 . 0 5 4 0 - 1 6 7 . 7 5 1 0 . 1 6 3 4 5 2 0 . 1 0 2 8 9 1
DXS8106 0 . 1 0 4 3 - 1 6 7 . 6 3 6 0 . 1 8 1 2 4 0 0 . 0 9 0 3 4 5
MYP2 Equal frequencies, q1
Model LOD L o g l i k e H2r H2ql
D18S59 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S63 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S452 0 . 0 0 0 7 - 1 8 1 . 5 6 4 0 . 3 7 6 2 0 9 0 . 0 0 9 3 0 0
D18S464 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S476 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S481 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 .  3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S1132 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S1158 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D18S1163 0 . 0 0 0 9 - 1 8 1 . 5 6 3 0 . 3 7 5 7 2 0 0 . 0 1 0 2 0 9
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Table 5.5. continued
MYP3 Founder frequencies, q1
Model  LOD L o g l i k e H2r H2ql
D12S64 0 . 2 1 9 2 - 1 8 1 . 0 6 1 0 . 0 0 0 0 0 0 0 . 4 4 8 2 1 0
D12S78 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D12S80 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 00 0 0 0 0
D12S316 0 . 2 0 8 1 - 1 8 1 . 0 8 6 0 . 0 0 0 0 0 0 0 . 3 8 3 0 6 1
D12S326 0 . 1 5 4 4 - 1 8 1 . 2 1 0 0 . 2 1 2 7 6 1 0 . 2 1 4 4 7 5
D12S332 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D12S348 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D12S354 0 . 1 0 3 4 - 1 8 1 . 3 2 7 0 . 0 0 0 0 0 0 0 . 4 0 2 3 2 8
D1 2 S 1 605 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D12S1607 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
MYP3 Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
D12S64 0 . 0 5 4 1 - 2 3 1 . 4 1 1 0 . 2 3 2 2 5 0 0 . 1 8 5 5 4 0
D12S7 8 0 . 0 0 9 7 - 2 3 1 . 5 1 4 0 . 3 4 6 5 7 6 0 . 0 5 1 1 9 1
D12S80 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D12S316 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D12S326 0 . 2 4 7 4 - 2 3 0 . 9 6 6 0 . 0 5 8 8 0 9 0 . 3 9 3 9 8 9
D12S332 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D12S348 0 . 4 1 6 7 - 2 3 0 . 5 7 6 0 . 0 0 0 0 0 0 0 . 3 9 5 9 3 5
D12S354 0 . 4 5 9 4 - 2 3 0 . 4 7 8 0 . 0 0 0 0 0 0 0 . 4 3 5 7 1 7
D1 2 S 1 605 0 . 1 8 7 1 - 2 3 1 . 1 0 5 0 . 1 5 2 4 2 2 0 . 2 3 6 4 7 1
D12S1607 0 . 1 5 5 9 - 2 3 1 . 1 7 7 0 . 1 9 6 3 9 0 0 . 1 9 4 8 1 5
MYP3 Founder frequencies, q2
Model  LOD L o g l i k e H2r H2ql
D12S64 0 . 1 4 0 5 - 2 3 1 . 2 1 2 0 . 0 1 2 1 9 4 0 . 4 2 0 9 6 3
D12S78 0 . 0 1 5 8 - 2 3 1 . 5 0 0 0 . 3 3 3 2 8 4 0 . 0 6 5 5 5 3
D12S80 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D12S316 0 . 3 1 0 2 - 2 3 0 . 8 2 2 0 . 0 0 0 0 0 0 0 . 4 1 9 8 2 0
D12S326 0 . 2 3 7 3 - 2 3 0 . 9 9 0 0 .  0 8 4 7 4 9 0 . 3 5 7 7 0 5
D12S332 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D12S348 0 . 5 3 4 0 - 2 3 0 . 3 0 6 0 . 0 0 0 0 0 0 0 . 4 0 6 8 0 3
D12S354 0 . 0 4 8 1 - 2 3 1 . 4 2 5 0 . 0 3 3 8 7 5 0 . 3 6 6 0 7 5
D 1 2 S 1 605 0 . 1 1 7 5 - 2 3 1 . 2 6 5 0 . 2 1 3 6 5 2 0 . 1 8 2 0 5 0
D12S1607 0 . 0 9 8 4 - 2 3 1 . 3 0 9 0 . 2 4 3 2 4 0 0 . 1 5 1 6 7 6
MYP4 Equal frequencies, q1
Model LOD L o g l i k e H2r H2ql
D7S798 0 . 0 3 7 7 - 1 8 1 . 4 7 9 0 . 2 9 4 7 0 6 0 . 0 7 2 1 3 3
D7S2423 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D7S2546 0 . 0 3 1 6 - 1 8 1 . 4 9 3 0 . 3 0 8 7 0 3 0 . 0 6 4 9 7 9
MYP4 Founder frequencies, q1
Model  LOD L o g l i k e H2r H2ql
D7S7 98 0 . 0 4 8 5 - 1 8 1 . 4 5 4 0 . 2 7 2 1 5 2 0 . 0 9 0 2 9 1
D7S2423 0 . 0 1 8 8 - 1 8 1 . 5 2 2 0 . 2 8 4 3 7 4 0 .  0 9 5 1 4 9
D7S2546 0 . 0 2 7 1 - 1 8 1 . 5 0 3 0 . 3 1 3 1 1 6 0 . 0 5 9 9 9 7
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Table 5.5. continued
MYP4 Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
D7S798 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D7S2423 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D7S2546 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
MYP4 Founder frequencies, q2
Model  LOD L o g l i k e H2r H2ql
D7S7 98 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D7S2423 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D7S2546 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
MYP5 Equal frequencies, q1
Model LOD L o g l i k e H2r H2ql
D17S942 0 . 0 0 9 7 - 1 8 1 . 5 4 3 0 . 3 4 9 3 7 4 0 . 0 4 0 7 9 9
D17S956 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D17S1290 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D17S17 95 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D17S1817 0 . 1 4 7 3 - 1 8 1 . 2 2 6 0 . 1 6 1 9 0 1 0 . 2 2 7 4 7 3
D17S1831 0 . 4 8 3 9 - 1 8 0 . 4 5 1 0 . 0 0 0 0 0 0 0 . 3 9 4 7 3 9
D17S18 68 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D17S205 9 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
MYP5 Founder frequencies, q1
Model  LOD L o g l i k e H2r H2ql
D17S942 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D17S956 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D17S1290 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D17S1795 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D17S1817 0 . 1 7 8 1 - 1 8 1 . 1 5 5 0 . 1 1 5 7 1 3 0 . 2 7 0 8 4 6
D17S1831 0 . 8 0 5 5 - 1 7 9 . 7 1 1 0 . 0 0 0 0 0 0 0 . 4 0 7 3 3 8
D17S1868 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D17S2059 0 . 1 9 6 5 - 1 8 1 . 1 1 3 0 . 0 0 0 0 0 0 0 . 3 9 3 8 6 7
MYP5 Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
D17S942 0 . 0 0 0 0 - 2 3 1 . 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D17S956 0 . 0 0 0 0 - 2 3 1 . 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D17S12 90 0 . 0 0 5 7 - 2 3 1 . 5 2 3 0 . 3 3 7 4 6 5 0 . 0 5 6 4 8 3
D17S17 95 0 . 1 1 5 8 - 2 3 1 . 2 6 9 0 . 1 5 4 3 9 2 0 . 2 2 3 3 9 8
D17S1817 0 . 3 9 6 6 - 2 3 0 . 6 2 3 0 . 0 3 9 5 2 3 0 . 3 6 3 3 2 3
D17S1831 0 . 2 2 9 0 - 2 3 1 . 0 0 9 0 . 0 8 3 2 7 7 0 . 3 1 3 1 3 0
D17S1868 0 . 0 0 0 0 - 2 3 1 . 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D17S2059 0 . 0 0 0 0 - 2 3 1 . 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
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Table 5.5. continued
MYP5 Founder frequencies, q2
Model  LOD L o g l i k e H2r H2ql
D17S942 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D17S956 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D17S1290 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D17S17 95 0 . 0 8 0 3 - 2 3 1 . 3 5 1 0 . 1 9 7 3 6 5 0 . 1 8 3 2 9 8
D17S1817 0 . 3 8 4 3 - 2 3 0 . 6 5 1 0 . 0 0 8 0 7 7 0 . 4 0 2 1 8 3
D17S1831 0 . 2 4 4 6 - 2 3 0 . 9 7 3 0 . 0 4 9 4 8 6 0 . 3 3 7 0 6 8
D17S1868 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D17S2059 0 . 1 2 4 9 - 2 3 1 . 2 4 8 0 . 0 0 0 0 0 0 0 . 3 8 3 4 9 1
MYP6 Equal frequencies, q1
Model LOD L o g l i k e H2r H2ql
D22S283 0 . 0 2 4 9 - 1 8 1 . 5 0 8 0 . 3 1 3 0 7 5 0 . 0 6 5 9 1 3
D22S310 0 . 5 4 3 2 - 1 8 0 . 3 1 5 0 . 1 1 6 8 0 5 0 . 2 2 6 3 6 7
D22S424 0 . 0 6 6 1 - 1 8 1 .  413 0 . 1 9 8 0 2 7 0 . 1 6 3 4 2 6
D22S426 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D22S445 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D22S683 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 4 8 8 9 0 . 0 0 1 6 2 0
D22S1045 0 . 5 7 0 0 - 1 8 0 . 2 5 3 0 . 0 0 0 0 0 0 0 . 3 5 3 0 2 6
D22S1144 0 . 2 4 7 5 - 1 8 0 . 9 9 6 0 . 2 1 7 1 6 4 0 . 1 6 2 5 0 2
D22S1157 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D22S1167 0 . 3 8 1 3 - 1 8 0 . 6 8 7 0 . 0 2 2 6 1 5 0 . 3 0 9 4 3 9
D22S1168 0 . 0 8 8 1 - 1 8 1 . 3 6 3 0 . 2 9 2 0 9 6 0 . 0 9 1 4 0 7
D22S1173 0 . 7 1 7 5 - 1 7 9 . 9 1 3 0 . 0 0 0 0 0 0 0 . 3 5 5 5 5 2
D22S117 6 0 . 2 4 5 5 - 1 8 1 . 0 0 0 0 . 1 6 9 5 0 2 0 . 2 2 9 0 4 0
D22S117 9 0 . 0 0 1 1 - 1 8 1 . 5 6 3 0 . 3 7 0 3 3 7 0 . 0 1 6 7 6 2
MYP6 Founder frequencies, q1
Model  LOD L o g l i k e H2r H2ql
D22S283 0 . 0 4 0 8 - 1 8 1 . 4 7 2 0 . 2 9 9 2 3 6 0 . 0 7 8 3 4 7
D22S310 0 . 4 8 6 1 - 1 8 0 . 4 4 6 0 . 1 1 9 4 7 6 0 . 2 2 6 8 8 9
D22S424 0 . 1 2 2 4 - 1 8 1 . 2 8 4 0 . 1 5 5 8 8 3 0 . 1 9 8 9 6 7
D22S426 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D22S445 0 . 0 2 8 9 - 1 8 1 . 4 9 9 0 . 2 8 8 1 6 8 0 . 0 9 9 3 2 5
D22S683 0 . 0 0 1 2 - 1 8 1 . 5 6 3 0 . 3 6 6 4 9 6 0 . 0 1 5 3 5 9
D22S104 5 0 . 5 6 4 0 - 1 8 0 . 2 6 7 0 . 0 0 0 0 0 0 0 . 3 5 7 9 3 5
D22S1144 0 . 0 6 3 4 - 1 8 1 . 4 2 0 0 . 2 9 0 6 5 4 0 . 1 0 0 3 1 4
D22S1157 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D22S1167 0 . 3 3 3 7 - 1 8 0 . 7 9 7 0 . 0 4 0 1 1 6 0 . 3 0 1 2 6 7
D22S1168 0 . 0 3 2 3 - 1 8 1 . 4 9 1 0 . 3 1 3 8 4 7 0 . 0 7 5 8 3 8
D22S1173 0 . 7 8 2 8 - 1 7 9 . 7 6 3 0 . 0 0 0 0 0 0 0 . 3 6 7 1 3 7
D22S117 6 0 . 4 5 1 8 - 1 8 0 . 5 2 5 0 . 0 9 6 2 6 1 0 . 3 0 8 3 8 6
D22S1 1 7 9 0 . 0 4 6 6 - 1 8 1 . 4 5 8 0 . 2 7 4 9 4 9 0 . 1 1 6 9 4 1
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Table 5.5. continued
MYP6 Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
D22S283 0 . 2 9 2 1 - 2 3 0 . 8 6 3 0 . 1 2 6 5 2 6 0 . 2 4 3 0 6 2
D22S310 0 . 9 6 4 0 - 2 2 9 . 3 1 6 0 . 0 0 0 0 0 0 0 . 3 7 8 5 6 7
D22S424 0 . 3 7 6 1 - 2 3 0 . 6 7 0 0 . 0 0 0 0 0 0 0 . 3 5 6 8 3 1
D22S426 0 . 1 5 0 9 - 2 3 1 . 1 8 8 0 . 1 9 6 4 1 5 0 . 2 0 6 5 2 9
D22S4 4 5 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D22S683 0 . 3 1 0 9 - 2 3 0 . 8 2 0 0 . 0 5 1 9 4 4 0 . 2 9 5 3 7 8
D22S1045 0 . 5 4 8 1 - 2 3 0 . 2 7 4 0 . 0 0 0 0 0 0 0 . 3 6 4 5 4 1
D22S1144 0 . 2 4 6 1 - 2 3 0 . 9 6 9 0 . 1 7 2 5 7 3 0 . 2 0 5 3 7 1
D22S1157 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D22S1167 0 . 5 0 9 6 - 2 3 0 . 3 6 3 0 . 0 0 0 0 0 0 0 . 3 4 8 3 3 8
D2 2 S 1 1 68 0 . 0 8 5 9 - 2 3 1 . 3 3 8 0 . 2 7 6 2 8 1 0 . 1 1 6 2 7 2
D2 2 S 1 17 3 1 . 0 1 1 3 - 2 2 9 . 2 0 7 0 . 0 0 0 0 0 0 0 . 3 9 5 7 9 9
D22S1176 1 . 0 7 7 9 - 2 2 9 . 0 5 4 0 . 0 0 0 0 0 0 0 . 4 4 3 5 9 9
D22S1179 0 . 0 2 8 5 - 2 3 1 . 4 7 0 0 . 3 2 0 9 5 5 0 . 0 7 5 6 4 4
MYP6 Founder frequencies, q2
Model LOD L o g l i k e H2r H2ql
D22S283 0 . 2 6 6 2 - 2 3 0 . 9 2 3 0 . 1 5 4 0 5 4 0 . 2 2 0 5 3 7
D22S310 0 . 9 0 5 6 - 2 2 9 . 4 5 1 0 . 0 0 0 0 0 0 0 . 3 8 3 2 7 4
D22S424 0 . 3 6 1 3 - 2 3 0 . 7 0 4 0 . 0 0 0 0 0 0 0 . 3 6 1 6 9 2
D22S426 0 . 1 1 0 5 - 2 3 1 . 2 8 2 0 . 2 1 9 1 4 7 0 . 1 8 4 1 1 6
D22S445 0 . 0 2 7 4 - 2 3 1 . 4 7 3 0 . 2 8 8 9 0 7 0 . 1 0 6 5 4 7
D22S683 0 . 2 8 4 4 - 2 3 0 . 8 8 1 0 . 0 8 7 1 4 7 0 . 2 5 8 4 0 5
D22S1045 0 . 3 5 7 1 - 2 3 0 . 7 1 4 0 . 0 0 0 0 0 0 0 . 3 6 3 7 2 8
D22S1144 0 . 0 2 6 2 - 2 3 1 . 4 7 5 0 . 3 1 9 4 4 4 0 . 0 7 4 8 5 5
D22S1157 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D 2 2 S 1 1 67 0 . 3 6 1 6 - 2 3 0 . 7 0 3 0 . 0 0 0 0 0 0 0 . 3 4 8 4 7 7
D22S1168 0 . 1 0 3 8 - 2 3 1 . 2 9 7 0 . 2 2 3 0 8 9 0 . 1 7 6 1 0 2
D22S1173 0 . 9 8 2 1 - 2 2 9 . 2 7 4 0 . 0 0 0 0 0 0 0 . 4 0 8 0 0 3
D22S1176 1 . 1 8 7 1 - 2 2 8 . 8 0 3 0 . 0 0 0 0 0 0 0 . 4 4 8 9 0 1
D22S1179 0 . 0 5 8 2 - 2 3 1 . 4 0 2 0 . 2 8 8 1 6 0 0 . 1 1 4 3 5 9
Equal frequencies, q1
Model LOD L o g l i k e H2r H2ql
D11S904 0 . 5 6 1 6 - 1 8 0 . 2 7 2 0 . 1 5 4 6 5 1 0 . 2 6 6 6 9 7
D11S905 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D11S992 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D11S1308 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D11S1330 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D11S1361 0 . 3 3 8 6 - 1 8 0 . 7 8 6 0 . 0 3 8 3 0 2 0 . 3 1 1 8 2 4
D11S1993 0 . 3 4 1 8 - 1 8 0 . 7 7 8 0 . 1 6 7 8 9 0 0 . 2 2 6 7 3 4
D11S2368 0 . 0 3 9 4 - 1 8 1 . 4 7 5 0 . 3 1 1 5 5 5 0 . 0 8 0 3 8 6
D11S4083 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D1 1 S4 114 0 . 0 2 3 6 - 1 8 1 . 5 1 1 0 . 3 1 4 4 2 8 0 . 0 5 7 3 1 9
D1 1 S4 152 0 . 3 6 2 6 - 1 8 0 . 7 3 1 0 . 1 4 2 7 0 0 0 . 2 1 7 7 5 8
D1 1 S4 154 0 . 0 2 6 2 - 1 8 1 . 5 0 5 0 . 3 2 1 3 5 6 0 . 0 6 6 6 4 2
D11S4200 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D11S4203 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
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Table 5.5. continued
Founder frequencies, q1
Model LOD L o g l i k e H2r H2ql
D11S904 0 . 4 1 0 2 - 1 8 0 . 6 2 1 0 . 1 8 2 2 0 0 0 . 2 3 2 6 1 4
D11S905 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D11S992 0 . 0 0 6 2 - 1 8 1 . 5 5 1 0 . 3 2 1 5 2 8 0 . 0 6 6 9 3 1
D11S1308 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D11S1330 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D11S1361 0 . 0 0 4 3 - 1 8 1 . 5 5 6 0 . 3 4 9 2 3 4 0 . 0 3 5 0 9 1
D11S1993 0 . 3 3 7 0 - 1 8 0 . 7 9 0 0 . 1 7 0 7 3 9 0 . 2 3 0 6 0 5
D11S2368 0 . 0 1 5 8 - 1 8 1 . 5 2 9 0 . 3 3 9 8 6 8 0 . 0 5 0 4 8 6
D11S4083 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D11S4114 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D1 1 S 4 152 0 . 5 5 9 0 - 1 8 0 . 2 7 8 0 . 0 8 1 6 1 4 0 . 2 7 0 7 7 3
D11S4154 0 . 0 7 1 4 - 1 8 1 . 4 0 1 0 . 2 8 8 4 9 6 0 . 1 0 3 7 1 0
D11S4200 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D11S4203 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
D11S904 0 . 3 7 9 4 - 2 3 0 . 6 6 2 0 . 2 1 1 2 2 5 0 . 2 1 7 2 1 5
D11S905 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D11S992 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D11S1308 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D11S1330 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D11S1361 0 . 1 6 1 1 - 2 3 1 . 1 6 5 0 . 1 6 7 2 4 0 0 . 2 0 3 7 6 0
D11S1993 0 . 5 9 7 7 - 2 3 0 . 1 6 0 0 . 0 0 0 0 0 0 0 . 4 2 8 5 2 9
D11S2368 0 . 0 0 4 7 - 2 3 1 . 5 2 5 0 . 3 6 9 2 3 8 0 . 0 2 9 4 2 0
D11S4083 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D1 1 S4 114 0 . 0 5 8 2 - 2 3 1 . 4 0 2 0 . 2 7 5 8 4 3 0 . 0 9 9 0 9 7
D1 1 S 4 152 0 . 3 0 7 8 - 2 3 0 . 8 2 7 0 . 1 6 2 8 4 8 0 . 2 0 8 7 1 1
D11S4154 0 . 0 2 3 1 - 2 3 1 . 4 8 3 0 . 3 1 9 8 4 7 0 . 0 7 6 1 9 4
D11S4200 0 . 0 5 8 4 - 2 3 1 . 4 0 1 0 . 2 9 4 5 6 6 0 . 1 0 8 6 8 6
D11S4203 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
Founder frequencies, q2
Model LOD L o g l i k e H2r H2ql
D11S904 0 . 1 7 9 3 - 2 3 1 . 1 2 3 0 . 2 6 5 6 3 3 0 . 1 4 9 2 6 4
D11S905 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D11S992 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D11S1308 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D11S1330 0 . 0 0 4 5 - 2 3 1 . 5 2 5 0 . 3 1 8 2 1 9 0 .  0 7 8 4 5 9
D11S1361 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D11S1993 0 . 4 0 9 1 - 2 3 0 . 5 9 4 0 . 0 5 7 1 8 4 0 . 3 6 8 6 9 2
D11S2368 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D11S4083 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D11S4114 0 . 0 2 7 0 - 2 3 1 . 4 7 4 0 . 3 0 4 6 4 4 0 . 0 7 4 1 2 0
D1 1 S4 152 0 . 4 9 5 6 - 2 3 0 . 3 9 5 0 . 0 9 2 7 1 5 0 . 2 7 0 8 4 0
D11S4154 0 . 0 3 4 8 - 2 3 1 . 4 5 6 0 . 3 1 0 1 3 1 0 . 0 8 7 1 8 1
D11S4200 0 . 0 0 7 8 - 2 3 1 . 5 1 8 0 . 3 6 6 5 5 9 0 . 0 3 1 8 0 3
D11S4203 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
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Table 5.5. continued
CHR2 Equal frequencies, q1
Model LOD L o g l i k e H2r H2ql
D2S172 0 . 0 6 2 4 - 1 8 1 . 4 2 2 0 . 3 1 5 9 2 1 0 . 0 7 3 8 1 4
D2S206 0 . 0 7 4 7 - 1 8 1 . 3 9 3 0 . 1 1 3 9 3 7 0 . 2 2 3 6 8 3
D2S336 0 . 0 5 1 2 - 1 8 1 . 4 4 8 0 . 2 8 1 2 8 1 0 . 0 9 5 9 7 2
D2S2193 0 . 3 4 5 2 - 1 8 0 . 7 7 1 0 . 0 0 0 0 0 0 0 . 3 5 1 7 6 1
D2S2202 0 . 1 7 5 1 - 1 8 1 . 1 6 2 0 . 0 7 8 5 1 2 0 . 2 6 1 4 1 9
D2S2205 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D2S2297 0 . 1 1 8 8 - 1 8 1 . 2 9 2 0 . 2 7 2 0 5 9 0 . 1 3 4 9 0 4
D2S2317 0 . 0 3 4 2 - 1 8 1 . 4 8 7 0 . 3 0 8 7 7 6 0 . 0 6 9 7 5 5
D2S2344 0 . 3 6 4 7 - 1 8 0 . 7 2 6 0 . 0 8 1 0 1 7 0 . 2 9 3 0 3 5
D2S2973 0 . 0 0 0 4 - 1 8 1 . 5 6 5 0 . 3 7 7 4 0 1 0 . 0 0 7 6 3 2
CHR2 Founder frequencies, q1
Model  LOD L o g l i k e H2r H2ql
D2S172 0 . 0 8 0 8 - 1 8 1 . 3 7 9 0 . 2 9 8 7 2 0 0 . 0 8 9 3 3 8
D2S206 0 . 0 5 8 0 - 1 8 1 . 4 3 2 0 . 1 6 4 4 5 4 0 . 1 8 6 8 4 2
D2S336 0 . 0 7 3 8 - 1 8 1 . 3 9 6 0 . 2 4 1 9 6 1 0 . 1 2 7 7 3 8
D2S2193 0 . 0 2 4 1 - 1 8 1 . 5 1 0 0 . 0 0 0 0 0 0 0 . 3 3 7 8 2 2
D2S2202 0 . 1 1 3 3 - 1 8 1 . 3 0 5 0 . 1 0 5 0 5 0 0 . 2 5 1 5 0 9
D2S2205 0 . 0 0 0 0 - 1 8 1 . 5 6 5 0 . 3 8 6 9 9 6 0 . 0 0 0 0 0 0
D2S2297 0 . 2 2 4 4 - 1 8 1 . 0 4 9 0 . 2 2 1 2 6 8 0 . 1 8 9 7 9 6
D2S2317 0 . 0 4 0 3 - 1 8 1 . 4 7 3 0 . 3 0 1 8 6 9 0 . 0 7 7 8 1 7
D2S2344 0 . 7 3 1 9 - 1 7 9 . 8 8 0 0 . 0 0 0 0 0 0 0 . 3 8 0 8 4 7
D2S2973 0 . 0 0 2 2 - 1 8 1 . 5 6 0 0 . 3 5 3 7 0 8 0 . 0 2 8 2 0 4
CHR2 Equal frequencies, q2
Model LOD L o g l i k e H2r H2ql
D2S172 0 . 0 0 6 3 - 2 3 1 . 5 2 1 0 . 3 6 2 2 5 9 0 . 0 3 0 4 9 1
D2S206 0 . 2 0 1 4 - 2 3 1 . 0 7 2 0 . 0 0 0 0 0 0 0 . 3 3 6 8 3 0
D2S336 0 . 0 0 1 7 - 2 3 1 . 5 3 2 0 . 3 7 1 4 5 6 0 . 0 2 0 6 5 8
D2S2193 0 . 1 9 3 7 - 2 3 1 . 0 9 0 0 . 0 0 0 0 0 0 0 . 3 4 3 9 4 0
D2S2202 0 . 0 9 0 5 - 2 3 1 . 3 2 8 0 . 2 1 5 5 3 8 0 . 1 6 4 1 8 9
D2S2205 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D2S2297 0 . 0 6 5 1 - 2 3 1 . 3 8 6 0 . 2 6 5 9 6 2 0 . 1 4 1 1 4 2
D2S2317 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D2S2344 0 . 7 0 0 6 - 2 2 9 . 9 2 3 0 . 0 0 0 0 0 0 0 . 4 0 3 2 2 5
D2S2973 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
CHR2 Founder frequencies, q2
Model  LOD L o g l i k e H2r H2ql
D2S172 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 3 0 2 2 0 . 0 0 1 6 6 1
D2S206 0 . 1 7 2 9 - 2 3 1 . 1 3 8 0 . 0 0 0 0 0 0 0 . 3 3 6 8 0 6
D2S336 0 . 0 0 7 0 - 2 3 1 . 5 2 0 0 . 3 3 5 5 6 6 0 . 0 5 0 6 3 1
D2S2193 0 . 0 3 3 1 - 2 3 1 . 4 6 0 0 . 1 5 4 7 6 5 0 . 2 1 0 7 5 4
D2S2202 0 . 0 3 2 5 - 2 3 1 . 4 6 1 0 . 2 7 2 0 9 8 0 . 1 1 8 5 2 0
D2S2205 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
D2S2297 0 . 0 8 9 3 - 2 3 1 . 3 3 0 0 . 2 5 8 2 1 1 0 . 1 5 0 0 2 1
D2S2317 0 . 0 0 0 3 - 2 3 1 . 5 3 5 0 . 3 8 3 6 8 7 0 . 0 0 9 6 9 1
D2S2344 0 . 8 3 1 0 - 2 2 9 . 6 2 2 0 . 0 0 0 0 0 0 0 . 4 0 5 9 6 3
D2S2973 0 . 0 0 0 0 - 2 3 1 . 5 3 6 0 . 3 9 4 8 3 0 0 . 0 0 0 0 0 0
2.0
1.5-
£o
1. 0 -
0.5-
0.0
0.0 0.5 1.0 1.5 2.0
— • —  q l equal freq 
— ■ — q l founderfreq 
—  q2 equal freq 
—A  -  q2 founder freq
COL2A1
Location (cM)
C 2.0
1.5-
£o
1.0-
0.5-
0.0-L —
0.0 0.5 1.0 1.5
— • —  q l equal freq 
— ■ -  q l founderfreq 
q2 equal freq 
—A - q2 founder freq
FBN1
Location (cM)
2.0
1.5-
£
1.0 -
0.5-
0.0
0.0 0.5 1.0 1.5 2.0
— • —  q l equal freq 
— ■— q l founderfreq 
— q2 equal freq 
—A - q2 founder freq
COL11A1
Location (cM)
Figure 5.9i. SOLAR Multipoint scores for syndromic loci.
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Figure 5.9ii. SOLAR Multipoint results for non syndromic loci.
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5.4. Discussion
5.4.1. Genotyping
DNA from mouthwashes is generally of a lower quality than from tissues such as blood. 
Contamination of the sample (with, for example, non-human DNA) could account for a 
lower than 100% success rate of genotyping. Fluorescently labelled primers have a 
comparatively short shelf life. This could, therefore, also have reduced the success rates 
of markers held in storage for long periods of time such as COL2A1 and COL 11A 1 and 
some of the MYP2, MYP3 and MYP5 primers.
Those subjects whose DNA was whole genome amplified had, on average, a lower 
percentage of genotypes which were produced out of the number of reactions performed 
compared to those using the original DNA. WGA-amplified DNA has been shown to 
have high genotype concordance rates with non-amplified DNA and also complete 
genome coverage (chapter 4). However, in this study, a decrease in number of genotypes 
produced suggests a problem with the quality of DNA produced or possible inhibitory 
elements for PCR. This may be due to the initial quality of the DNA template, the 
amplified product containing contaminants or highly degraded low molecular weight 
elements which may inhibit the efficiency of the PCR.
From this finding it is possible to say that ideally original human DNA template should 
be used for genotyping studies where possible. However, if the DNA sample is depleted, 
it is possible to achieve genotyping results but it may have a lower success rate.
5.4.2. Married-in individuals
Including married-in individuals to the analysis brings up a number of issues. It is vital to 
include them to allow the maximum informativeness of the meioses and therefore the
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gene flow pattern is able to be determined with more accuracy. However, the inclusion of 
myopic married-in individuals potentially increases the heterogeneity of the disease 
decreasing the power of the linkage analysis to detect linkage. The trait distribution of 
this group of individuals appears to show less bias towards myopia, having a prevalence 
of only 16.7% and includes no high myopes therefore the effect should be minimal.
5.4.3. Linkage Analysis
5.4.3.1. Syndromic loci
The pedigree showed some slight evidence of linkage to markers at the COL2A1 locus 
(Stickler syndrome). However, the highest LOD score is only approximately 0.8 and 
therefore not statistically significant.
COL11A1 and FBN1 loci could be excluded since the LOD scores at these loci were 
invariably close to zero.
5.4.3.2. Non syndromic loci
The most likely regions to be linked with myopia are MYP3 and MYP6 with LOD scores 
of over 1 and therefore suggestive of linkage but, again, not statistically significant. The 
twopoint analysis peaks of the linkage signal of MYP3 occur within the same 14cM 
region as was found for previous studies including that of a UK population cohort 
(Farbrother et al., 2004b) for the analysis using trait ql and also q2 with founder allele 
frequencies. However, the highest LOD score occurred for the q2 trait with equal allele 
frequencies, which gave a peak outside this region.
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MYP6 linkage analysis peaks also occurred within the same region as found by 
Stambolian and colleagues investigating linkage analysis with low myopia (Stambolian et 
al., 2004). The highest twopoint LOD scores (1.19) occurred only approximately 6cM 
away from the peak found in the former study. The same region also encompasses the 
higher multipoint LOD scores (highest multipoint LOD score of 1.13 with q2 and equal 
allele frequencies). The heritability at these regions suggest between 18 to 45% of the 
variance is due to that specific QTL.
Considering the high power produced by the SLINK simulations, a higher LOD score 
would be expected if linkage to a major QTL was present. Therefore, in this pedigree, 
these loci are unlikely to contain this major QTL.
5.4.3.3. Allele frequencies and trait description
The effect of the change in allele frequencies is important to note. The choice of using 
allele frequencies calculated from founders and married-in individuals or equal 
frequencies appears to vary the outcome of the analysis, particularly with trait q2, the 
transformed refractive error. The trait under investigation is also important in that ql 
represents the real phenotype whereas q2 is a simulated trait based on the combination of 
a normally distributed phenotype and the original data, providing the software with the 
basis it needs for an accurate analysis. It is, therefore, difficult to favour one trait over the 
other, one being an accurate representation of the phenotype but potentially providing an 
inflated type I error rate, the other reducing the error rate but not showing an accurate 
representation, particularly around emmetropia.
5.4.4. Summary
The large size of the family in this study should provide an extremely powerful situation 
in which to detect linkage. Multiple testing and replication allow a decrease in the LOD
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score threshold suggested for a significant linkage signal. This is because linkage is less 
likely to be detected at a point that has already been named as a region of linkage. 
Considering this and the results of this study, the LOD scores produced are too low to be 
certain of linkage especially for a pedigree with high power. Also, considering the results 
obtained vary with the trait and the allele frequencies used, these results do not provide 
evidence to support the previous myopia linkage analysis studies. Instead this study 
supports the theory that myopia is a highly heterogenous trait, these loci not being linked 
in this pedigree.
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6. Association Analysis of Myocilin with High Myopia 
6.1. Introduction
Linkage analysis investigates the co-segregation of two loci, generally with one being the 
disease locus and the other a marker locus. Association provides a different strategy: the 
investigation of over-representation or under-representation of a specific marker allele in 
diseased individuals compared to a control population (Baur and Knapp, 1997). 
Association and linkage analysis can be extremely valuable when used together to 
identify potential candidate genes. Once a chromosomal locus linked to a disease has 
been identified, association can be used to investigate the probability of a causal action of 
candidate genes within this region. However, the two strategies can also be used 
separately, association analysis providing greater power to detect genetic contributions to 
complex diseases (Cardon and Bell, 2001) particularly for those markers which are not 
very polymorphic, i.e. have fewer alleles therefore making it more difficult to identify 
from which heterozygous parent the allele is inherited from.
There are a number of methods used to investigate association, including case-control 
studies and family based association tests. Case-control studies compare the allele 
frequencies at a locus in a group of affected individuals compared to those of a control 
population. An increase in frequency of a specific allele within the case population 
suggests association with the disease. If a positive result is found, this association could 
have arisen due to a number of reasons. Firstly, the allele itself could directly affect the 
phenotype expressed. Secondly, the allele could be inherited along with a causative allele 
nearby on the chromosome (i.e. in linkage disequilibrium) or thirdly, that it is just a 
chance finding or an artefact of the test (Cardon and Palmer, 2003). Case-control methods 
are advantageous because they are widely used and understood, easy to recruit for and 
large sample sizes are easily collected. They are also beneficial if the disease studied has 
a late onset i.e. no parental or family phenotypic/genotypic information is required.
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However there are limitations to this type of study. Inconsistency is the primary 
limitation and causes a major problem in the replication of association studies. This can 
be due to population stratification, which exists when there are differences in allele 
frequencies and disease prevalence due to diversity in background populations.
Population stratification leads to false associations. This has been shown to be the main 
cause of non-replication and false positive association (Cardon and Palmer, 2003). One 
solution to avoiding population stratification is the difficult task of more careful matching 
of cases and controls.
An alternative method is to use family based analyses. These use an internal control, 
therefore avoiding population stratification entirely. One such method is called the 
transmission disequilibrium test (TDT) (Spielman et al., 1993). Family groups in the form 
of trios, an affected proband and their two parents, are collected. The equivalent “cases” 
are those alleles transmitted to the affected offspring from heterozygous parents and the 
“controls” are those alleles not passed on. No association exists when a specific allele is 
passed on 50% of the time whereas a value significantly different to 50% will indicate 
association.
6.1.1. Transmission Disequilibrium Test
The standard TDT uses only dichotomous traits and considers only heterozygous parents. 
Contingency tables can be produced by scoring the transmissions between parents and the 
affected offspring. For example, in figure 6.1, allele 2 is not transmitted to the offspring 
by the father in favour of the alternative allele, allele 1. The mother transmits allele 4 and 
allele 3 is not transmitted. These transmissions are fully informative. If a parent is 
homozygous, they are uninformative and so cannot contribute to the analysis. The test 
statistic compares the number of times the allele is transmitted from a heterozygous 
parent to an affected offspring to the number of times the alternative allele is transmitted. 
The test is designed for a marker with only two alleles. To extend its use to polymorphic
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markers, the alternative alleles to that which is under investigation are grouped together. 
For example in figure 6.1. they are collectively labelled as “not 2”.
Marker Allele not
transmitted
2 3 4 2 Not 2
T ransmitted 2 a b
w allele Not 2 c(+l ) d (+ l )
I 4
Figure 6.1. Example of scoring for TDT contingency tables.
The test statistic used in this case follows a x2 distribution and is shown in equation 6.1.
T = 0 tc f
(b+c)
Equation 6.1. Test statistic for TDT.
6.1.2. TDTEX
The TDT can be performed by the TDTEX program of the S. A.G.E. [2004] Statistical 
Analysis of Genetic Epidemiology, Release 5.1.0. This programme uses contingency 
tables as above, but investigates each allele simultaneously i.e. not grouping together 
alleles, and therefore producing a larger contingency table. The test statistics available 
include using two different null hypotheses as follows:
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1. McNemar statistic: The distribution of alleles transmitted is not different to the 
distribution of those alleles not transmitted.
2. Marginal homogeneity: The number of alleles or genotypes transmitted is equal to 
the number not transmitted.
These hypotheses may be tested using allelic or genotypic transmission, the latter being 
preferential as there is no independence between allelic transmissions by one parent. 
However, the sample size would have to be much larger to avoid statistical problems 
caused by sparseness in the table.
The TDTEX programme will test these null hypotheses, but does not indicate which 
specific allele is causing the null hypothesis to be rejected. Therefore further tests can be 
carried out as described by Curtis (David Curtis website) and as implemented in ETDT 
software (Sham and Curtis, 1995). The number of times a specific allele is transmitted is 
compared to the number of times it is not transmitted and the test statistic is calculated as 
shown below, and is approximately equal to a x2 distribution.
X2 = (n-Y2(np))2 + ((np—nt)~>4(np))2 
y2( np) y2( np)
Equation 6.2. Curtis’ method o f testing for association for polymorphic markers. Where nt is the number of 
times that a specific allele was transmitted and np is the number of times that allele could potentially have 
been transmitted.
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6.1.3. Family Based Association Test
To increase the amount of information used for the TDT, an extension to this test can be 
used, the Family Based Association Test (FBAT) (Laird et al., 2000). FBAT is 
advantageous because:
1. Quantitative traits can be analysed as well as dichotomous traits.
2. There is the potential to include covariates.
3. It is robust to missing parental genotypic data.
4. It is capable of dealing with multiple and non-normally distributed traits and
5. It is able to include unaffected offspring if available.
This test is an extension of the TDT which compares the genotype distribution observed 
in the cases to its expected distribution under the null hypothesis of no linkage and no 
association, taking into account the effect of the probands’ phenotypes. The null 
distribution is based on the information provided by parental genotypes thereby avoiding 
population stratification biases (Van Steen and Laird, 2005). FBAT divides the test 
population into individual families, or in this case, trios, to evaluate their individual 
contribution to the test statistic. The number of informative families for each allele is 
calculated and so indicates the statistical relevance based on this value of informativeness 
for that particular test. If more than one locus is used, haplotypes can be built and their 
association evaluated. A Z statistic is calculated, producing a negative value if the 
transmission of alleles is decreased and a positive value if there is over transmission of 
that allele to the affected offspring. The test can also be performed based on genotypes as 
opposed to alleles.
The distribution of the test’s score statistic, S, under the null hypothesis, is calculated 
based on the distribution of the affected offspring’s genotype, conditional on the trait, and 
on the parental genotype. The actual observed genotype distribution is then compared to 
the null, the deviation providing the test statistic. Therefore if the distribution of the
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affected offsprings’ genotypes differs significantly from the null, association between that 
marker and the trait exists.
6.1.4. Power and sample size
The power of the test increases with sample size, but also depends on a number of other 
factors including the disease parameters and modes of inheritance. A software package 
within FBAT, called PBAT, provides tools for the design and analysis of association 
studies and can be used to calculate the power of the family based association test. By 
inputting the pedigree structure and ascertainment strategy along with genetic model 
parameters such as gene frequencies and disease prevalence, the power of the study can 
be calculated by simulation or approximate methods.
Haines and Pericak-Vance (Haines and Pericak-Vance, 1998) estimated the number of 
trios required to gain a power of 0.8 and a type 1 error rate of 0.05. For an autosomal 
dominant model with a disease allele frequency of 0.01, penetrance of 0.8 and disease 
prevalence of 0.0159, 194 trios would be required if the relative risk was 2.9, this sample 
size requirement increases with decreasing relative risk. For a recessive model where 
disease allele frequency is 0.20, penetrance is 0.5 and disease prevalence is 0.02, 86 trios 
are required for a study of equal power and type 1 error rate as above with a relative risk 
of 2.9. These figures demonstrate that the mode of inheritance and the disease allele 
frequency have a marked effect on the power of family based association tests, and 
provide a guide to the number of trios required for such studies.
6.1.5. Hardy-Weinberg Equilibrium
For association studies, the sample must be in Hardy Weinberg equilibrium. That is, the 
genotype frequencies are not changed between generations. In theory, genotype 
frequencies may be changed by evolutionary forces such as mutation, genetic drift or
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migration into or out of a population (Haines and Pericak-Vance, 1998). However, the 
low rate of mutation suggests only a small role in evolution. Genetic drift occurs when 
allele frequencies change by chance due to factors such as mating patterns in small 
populations. Migration occurs when populations with a specific gene pool then breed 
outside their gene pool, introducing new alleles or altering current allele frequencies.
The Hardy-Weinberg theory has important applications including the ability to determine 
whether the trait has a strong genetic basis and also helps to determine carrier frequencies 
of diseases, disease prevalence and gross estimates of penetrance (Haines and Pericak- 
Vance, 1998).
To test whether the alleles within a population are in Hardy-Weinberg equilibrium, the 
following theory is applied. For a bi-allelic marker, with alleles A and a with frequencies 
of p and q respectively, where p+q=l, HW theory predicts that genotypic frequencies of 
AA, Aa and aa are p 2, 2pq and q respectively. If the alleles are in Hardy-Weinberg 
equilibrium it follows that:
p2+2pq+q2= l
Equation 6.3. Hardy Weinberg equilibrium.
For polymorphic markers, either one allele is tested against a pooled collection of the 
other alleles or each allele is tested separately using equation 6.4., this can be extended to 
include n alleles.
For example, if a marker has alleles P,Q and R with allele frequencies of p, q and r 
respectively, genotype frequencies are as follows: PP =p2
P Q=2pq 
PR=2pr
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QQ=C
QR=2qr 
R R ^
And it follows, according to HW theory that
p 2+2pq+2pr+q2+2qr+S=l 
Equation 6.4. Extension of Hardy-Weinberg theory for polymorphic markers.
The observed frequencies are compared to the expected frequencies which follow a x2 
distribution. A deviation from Hardy Weinberg equilibrium suggests that the genetic 
basis of the trait is not correctly specified, that there is non random mating or that there is 
preferential selection for individuals with a specific genotype within the samples (Sham, 
1998).
6.1.6. Association and Myopia
There have been many studies nominating candidate genes and investigating the possible 
associations with myopia (chapter 1). Only a few have returned significant results, hence 
no actual causative genes have yet been found. Most studies have taken candidate genes 
from within linked loci which have biological functions likely to be related to myopia e.g. 
structural functions and investigated the possible associations. For example, LIPIN2, 
within the MYP2 locus was investigated but no significant association was found (Zhou 
and Young, 2005). MYP3 region candidate genes such as lumican and fibromodulin also 
showed no association within a linked population (Paluru et al., 2004) although decorin 
and DSPG were also excluded as candidate genes for MYP3, a SNP in lumican suggested
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possible association in a Taiwanese population (Wang et al., 2006). Replication of 
association studies appears to be less easy to accomplish than expected, possibly due to 
differences in ethnic backgrounds but also in study designs. The myocilin studies 
described below appear to have achieved replication with significant association which 
therefore strengthens the evidence for nominating this as a candidate gene for 
investigation.
6.1.7. Myocilin
Myocilin is a recently discovered protein, encoded by the MYOC gene (also known as 
GLC1 A). The MYOC gene consists of three exons, upstream of which is the promoter 
region, which regulates its expression (Fingert et al., 2002). Myocilin is expressed most 
strongly in the trabecular meshwork of the eye (hence its alternative name of TIGR- 
trabecular meshwork-induced glucocorticoid protein) as well as in the sclera, iris, cornea, 
lens, ciliary body, retina and optic nerve. It is also expressed in other organs in the human 
body such as the heart, stomach and skeletal muscle. Mutations in MYOC have been 
identified as the cause of hereditary juvenile-onset open-angle glaucoma, there being 43 
reported mutations in the gene in patients with open angle glaucoma. Myocilin mutations 
are also found in 3-4% of primary open angle glaucoma patients. Most of these mutations 
occur in exon three and are believed to be disease causing. However there are also 
polymorphisms that exist in the rest of the gene but they may not be disease causing 
(Fingert et al., 2002).
The exact mechanism by which mutations in the myocilin gene cause glaucoma has not 
yet been determined. Studies in the mouse suggest a number of theories:
(1) a loss of function of this protein. However, this is unlikely because 
haploinsuffient mice do not express a glaucomatous phenotype (Ricard and Tamm,
2005).
(2) an effect on the aqueous outflow facility of the eye, due to the retention of 
mutated myocilin by the rough endoplasmic reticulum. The break down of the process of
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protein trafficking may, in turn, cause dysfunction of the trabecular meshwork and 
therefore affect outflow. (Direct outflow obstruction was argued against by alternative 
mouse studies which found a lack of myocilin induction when IOP was high, supported 
by the finding that over-expression of myocilin does not cause a rise in IOP (Ricard and 
Tamm, 2005)).
(3) a muscle-related ciliary body mechanism. This is due to the high 
expression of myocilin within muscle and the action of pilocarpine to reduce IOP (OMIM 
#601652).
The high homology (83%) between mice and humans for this gene (Fingert et al., 1998) 
suggests further studies with the mouse models are likely to provide important 
information regarding myocilin function and the mechanisms underlying glaucoma 
causation in humans (Ricard and Tamm, 2005).
Myocilin also has a connection to myopia. Specifically myopia is a clinical risk factor for 
glaucoma; myopes having an approximate threefold greater risk of developing glaucoma 
but no causal effect has yet been established (Saw et al., 2005). A previous study showed 
association between myopia and MYOC in a Singapore Chinese population of 97 
unrelated high myopes (Wu et al., 1999). Attempts to replicate this finding with a Hong 
Kong Chinese population using a similarly designed case-control study (using 70 
unrelated cases) (Leung et al., 2000), failed, but a positive result was found in 2004 by 
Tang and colleagues using a family based association test and a population of 157 
Chinese nuclear families. Association was noted with a microsatellite polymorphism in 
the MYOC promoter region. The shortest allele (consisting of 13 dinucleotide repeats) 
showed increased transmission to high myopes, whereas the longest allele (15 
dinucleotide repeats) showed decreased transmission, providing a possible protective 
effect (Tang et al., 2004).
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6.2. M ethods
6.2.1. Association analysis
Trios, consisting of a highly myopic proband and two parents, were recruited as described 
in Chapter 2 (Trio pedigrees, appendix III). Spectacle prescription details and DNA 
samples were collected for all subjects. The subjects were genotyped for two markers, 
MYOC1 and MYOC2; using the protocol described in chapter 5. MYOC1 is a 
microsatellite within the promoter region and MYOC2 is in the 3’ untranslated region 
(table 5.2.). The parental alleles were then tested for Hardy Weinberg equilibrium (the 
offspring were recruited based on their phenotype and so will not provide a fair sample 
representation for the population and Hardy-Weinberg equilibrium would not be 
expected). The allele frequencies of the parental sample were determined and, by using 
equation 6.4., the expected genotypic frequencies were compared to those observed.
For the standard TDT, each allele’s transmissions were scored using contingency tables 
as described above. TDTEX was then used to test the null hypothesis. An FBAT analysis 
was carried out considering high myopia as a dichotomous trait; those subjects with a 
refractive error of -6.00D in the least minus meridian of their least myopic eye were 
classed as affected (Young et al., 1998b). The FBAT analysis was then repeated 
analysing the trait quantitatively. Association was tested using alleles, genotypes and 
haplotypes.
Finally, a case-control analysis was performed by dividing the parental cohort into cases 
(those individuals with -6.00D or more myopia in the least minus meridian of both eyes) 
and controls and calculating the allele frequencies and also the genotype frequencies. The 
groups were compared using %2 test.
To identify which alleles matched those associated with myopia in previous studies, the 
microsatellite PCR products were sequenced and number of repeats counted, as discussed 
below.
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6.2.2. Sample preparation for DNA Sequencing
Five replicate polymerase chain reactions (PCR, chapter 1) with the appropriate 
unlabelled primers were carried out. The replicate samples were then pooled and 
Qiaquick spin column (QIAGEN) purified to remove primers. The sample was eluted in a 
volume of 180pl 2mM Tris-HCl, pH8 and then 2pl of 20pg/pl glycogen and 20pl of 3M 
sodium acetate were added. The samples were then vortex-mixed and briefly centrifuged. 
A volume of 200pl of phenol/chloroform (phenol :chloroform: isoamyl alcohol-25:24:l) 
was added and the sample was vortexed vigorously for 30 seconds. The tube was then 
centrifuged at 14000rpm for 2 minutes. When the supernatant was clear it was transferred 
to a fresh tube and 400pl of ethanol was added, vortex-mixed and left to precipitate at 
-20°C for 20 minutes. The samples were centrifuged at 14 OOOrpm for 10 minutes, the 
supernatant was then discarded and 400pi of ice-cold 70% ethanol was added. The 
mixture was centrifuged at 14 OOOrpm for 2 minutes and the supernatant was discarded. 
The pellet was air dried in an inverted position for 5 minutes and then resuspended in 
20pl of PCR water. The template was quantified by spectrophotometry (chapter 4) and 
diluted to a concentration of 25ng/pl. The sequencing section of the Biosciences 
department of Cardiff University were then sent lOpl of 25ng/pl template DNA and 5pM 
forward primer and the sequencing was performed on an ABI 3700 sequencer.
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6.3. Results
See chapter 2 and trio pedigrees (Appendix III) for a full description of the subjects 
involved.
6.3.1. Association Analysis
6.3.1.1 Transmission Disequilibrium Test
Contingency tables were constructed by scoring the transmissions for one allele versus all 
other alleles. A summary of the results is shown in tables 6.1. and 6.2.
Table 6.1. TDT results for MYOC1.
MYOC1 Allele t P value
1 2.27 0.32
2 3.45 0.17
3 4.27 0.12
4 3.63 0.16
5 0.33 0.85
Table 6.2. TDT results for MYOC2.
MYOC2 Allele t P value
1 0.11 0.95
2 0.01 0.99
3 0.00 1.00
4 0.21 0.90
5 0.20 0.91
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No statistically significant association is present between myopia as a dichotomous trait 
and MYOC1 and MYOC2 when analysing with a simple TDT and scoring transmissions 
with one allele versus all other alleles.
6 .3.1.2. TD TE X
Contingency tables were constructed by scoring transmissions for each allele separately 
and simultaneously for MYOC1 (table 6.3.) and MYOC2 (table 6.4.).
Table 6.3. TDTEX contingency table for MYOC1 alleles.
Allele not transmitted
-a
5W)6 ct
Im
H
1 2 3 4 5
1 1 1 0 1 0
2 3 41 17 21 2
3 4 20 6 10 0
4 1 14 2 11 0
5 0 1 0 0 0
Table 6.4. TDTEX contingency table for MYOC2 alleles.
O
Allele not transmitted
1 2 3 4 5
1 0 0 0 5 0
2 1 18 4 23 0
3 0 4 2 3 0
4 5 23 3 55 3
5 0 2 0 0 0
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Table 6.5. shows the summary of TDTEX results and significance levels of each null 
hypothesis tested for both alleles and genotypes.
Table 6.5. Summary of TDTEX results
Data Number of 
informative 
pedigrees
McNemar test Continuity 
corrected 
McNemar test
Marginal
homogeneity
test
MYOC1
alleles
78.79% 0.045* 0.191 0.019*
MYOC1
genotypes
78.79% 0.537 1.000 0.089
MYOC2
alleles
76.77% 0.540 0.945 0.986
MYOC2
genotypes
75.76% 0.613 0.996 0.779
* significant at p<0.05
TDTEX results show that there is a statistically significant lack of symmetry between 
transmitted and non transmitted alleles for MYOC1. The null hypothesis could not be 
rejected for MYOC2.
The analysis was repeated with genotypes but found no statistically significant difference 
from the null hypothesis for either MYOC1 or MYOC2.
This TDTEX analysis shows there is a difference in the distributions of the allele 
transmissions but does not pinpoint the specific allele involved. Therefore using the 
method suggested by Curtis as described above, the results shown in table 6.6. were 
calculated.
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Table 6.6. Results determining specifically which allele has increased or decreased transmission for 
MYOC1.
Allele t P Transmission
1 3.60 0.06 -
2 0.62 0.43 -
3 4.16 0.04* Increased
4 4.59 0.03* Decreased
5 0.33 0.57 -
* significant at p<0.05. Allowing for multiple testing p<0.01, no results are significant.
6.3.1.3. Family Based Association Test
The Z statistic shows the transmission state; a positive number means an increase in 
transmission, a negative value is equivalent to a decrease in transmission.
Table 6.7. FBAT results for MYOC1, allelic mode
Allele Allele
frequency
No. of 
families
Z statistic
Dichotomous Quantitative
(reversed sign)
1 0.04 9 -1.67 -1.73
2 0.52 65 0.85 0.86
3 0.19 52 1.81 1.96* (p=o.o5)
4 0.24 45 -2.18* (p =o.03) -2.25* (P=o.o2)
5 0.02 3 -0.58 -0.78
*significant at p<0.05
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Table 6.8. FBAT results for MYOC2, allelic mode
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Allele Allele
frequency
No. of 
families
Z statistic
Dichotomous Quantitative
(reversed sign)
1 0.04 10 -0.30 -0.50
2 0.30 59 0.00 0.24
3 0.04 15 0.00 -0.12
4 0.61 62 0.23 0.06
5 0.02 5 -0.45 -0.23
*significant at p<0.05
FBAT results show no significant association of myopia with MYOC2. However, for 
MYOC1, there is a significant decrease in transmission of allele 4 when analysing the 
trait as both a dichotomous and a quantitative trait. Quantitative analysis also shows 
increased transmission of allele 3, but this is only just significant and does not occur with 
the dichotomous analysis.
Table 6.9. FBAT results for MYOC1, genotype mode.
MYOC1
Genotype
Genotype
frequency
No. of 
families
Z statistic
Dichotomous Quantitative 
(reversed sign)
1/1 0 0 - -
1/2 0.04 9 -0.85 -0.53
2/2 0.28 49 1.29 1.37
1/3 0.03 2 -0.82 -0.80
2/3 0.18 46 0.94 1.16
3/3 0.04 9 1.13 1.04
1/4 0.01 2 -1.13 -1.14
2/4 0.23 44 -2.00* (p=o.o5) -2.20* (p=o.o3)
3/4 0.08 28 0.73 0.98
4/4 0.07 11 -0.85 -0.75
1/5 0 0 - -
2/5 0.03 3 0 -0.23
3/5 0 1 -0.58 -0.58
4/5 0 1 -0.58 -0.58
5/5 0 0 - -
* significant at p<0.05
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Table 6.10. FBAT results for MYOC2, genotype mode.
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Genotype Genotype
frequency
No. of 
families
Z statistic
Dichotomous Quantitative
(reversed sign)
1/1 0 1 -0.58 -0.58
1/2 0 4 1.16 0.75
2/2 0.10 20 0.61 1.03
1/3 0 1 -0.58 -0.58
2/3 0.06 4 0.54 0.55
3/3 0 2 0.38 0.39
1/4 0.07 9 -0.35 -0.52
2/4 0.32 57 -1.01 -1.27
3/4 0.02 14 -0.14 -0.30
4/4 0.39 51 0.73 0.88
1/5 0 1 -0.58 -0.58
2/5 0.02 1 -0.58 -0.58
3/5 0 1 -1.00 -1.00
4/5 0.02 4 0.54 0.95
5/5 0 0 - -
Using the FBAT analysis and genotypes as opposed to alleles, there was a statistically 
significant decrease in transmission of the genotype 2/4 for MYOC1 as for a dichotomous 
trait and a quantitative trait at significance values of p=0.05 and p=0.03 respectively, but 
no statistically significant result for MYOC2 genotypes (tables 6.9 and 6.10.).
FBAT also allows analysis of the haplotypes at the MYOC1 and MYOC2 loci using the 
Haplotype Family Based Association Test (HBAT). These results are shown in table 
6 . 11.
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Table 6.11. HBAT results showing only those haplotypes with more than 10 informative families.
Haplotype Haplotype No. of Z statistic
MY1 MY2
frequency families Dichotomous Quantitative
(reversed sign)
2 4 0.30 61.0 1.89 1.88
2 2 0.23 48.5 -0.99 -0.87
4 4 0.16 38.0 -2.08* (p-0.04) -2.07* (p=o.04)
3 4 0.12 29.5 0.55 0.60
3 2 0.07 23.5 2.24* (P =o.o3) 2.18* (p=o.o3)
2 3 0.04 11.0 -0.30 -0.43
4 1 0.03 10.0 -0.30 -0.50
* significant at p<0.05
Only the results for the haplotypes with more than 10 informative families are shown in 
table 6.11. The results suggest a decrease in transmission of the haplotype 4 4 (allele 4 of 
MYOC1 marker and allele 4 of MYOC2 marker) to affected offspring and also an 
increase in transmission of haplotype 3 2 (allele 3 of MYOC 1 and allele 2 of MYOC2).
6.3.2. PBAT power calculations
PBAT power calculations suggested this study has low power, of 17.7% by simulation. 
However, the method assumes a number of the model parameters which may not be 
accurate and therefore it can only be used as a guide. Alternatively, considering the trio 
phenotypes (Trio pedigrees, Appendix III), the disease gene frequency and disease 
prevalence, a situation similar to that proposed by Haines and Pericak-Vance (Haines and 
Pericak-Vance, 1998) for a recessive model is possible, suggesting approximately 86 trios 
consist a powerful enough cohort to detect a locus with a relative risk of disease of 2.9.
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6.3.3. Case-control study
191
Although these cases and controls are not matched, it was interesting to carry out a 
comparison of allele and genotype frequencies between those parental trio members who 
are high myopes and those who are not. Allele frequencies were as shown in tables 6.12 
and 6.15 for MYOC1 and MYOC2 respectively and represented by graphs in figures 6.2. 
and 6.3. Genotype frequencies are shown in tables 6.13. and 6.16. Case-control results are 
shown in table 6.14 for MYOC1 and table 6.17 for MYOC2.
Table 6.12. MYOC1 allele frequencies in cases and controls.
MYOC1 Alleles Allele frequency for cases Allele frequency for 
controls
1 0 0.044
2 0.578 0.568
3 0.189 0.189
4 0.222 0.196
5 0.011 0.007
50-
20 -
10 -
51 2 3 4
□  cases 
Q  controls
Alele
Figure 6.2. MYOC1 allele frequencies in cases (black outline) and controls (red outline).
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Table 6.13. MYOC1 case-control genotype frequencies
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MYOC1 genotypes Genotype frequency for 
cases
Genotype frequency for 
controls
1/1 0 0.007
1/2 0 0.027
1/3 0 0.034
1/4 0 0.014
1/5 0 0
2/2 0.378 0.331
2/3 0.222 0.209
2/4 0.156 0.223
2/5 0.022 0.014
3/3 0 0.041
3/4 0.156 0.047
3/5 0 0
4/4 0.067 0.054
4/5 0 0
5/5 0 0
Table 6.14. MYOC1 case-control study results.
MYOC1
Alleles
X2 of alleles X of genotypes
1 [Yates’] 2.85 (p=0.09) 4.24 (p=0.12)
2 0.03 (p=0.87) 0.74 (p=0.69)
3 0.00 (p=0.95) 3.65 (p=0.16)
4 0.30 (p=0.59) 0.27 (p=0.87)
5 [Yates’] 0.08 (p=0.78) [Yates’] 0.00 (p=0.96)
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Table 6.15. MYOC2 allele frequencies for cases and controls.
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MYOC2 Alleles Allele frequency for cases Allele frequency for 
controls
1 0.043 0.021
2 0.404 0.271
3 0.064 0.048
4 0.479 0.644
5 0.011 0.014
70-
60-
50-
c
41Oi .
£
40-
30-
20 -
10 -
21 3 4 5
Alele
Figure 6.3. MYOC2 allele frequencies in cases (black outline) and controls (red outline).
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Table 6.16. Case and control genotype frequencies for MYOC2
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MYOC2 genotypes Genotype frequency for 
cases
Genotype frequency for 
controls
1/1 0 0
1/2 0.021 0
1/3 0 0
1/4 0.064 0.047
1/5 0 0
2/2 0.170 0.100
2/3 0.106 0.033
2/4 0.340 0.280
2/5 0 0.013
3/3 0 0.013
3/4 0.021 0.033
3/5 0 0
4/4 0.255 0.440
4/5 0.021 0.013
5/5 0 0
Table 6.17. MYOC2 case-control study results.
MYOC2
Alleles
X2 for alleles X2 for genotypes
1 [Yates’] 0.19 (p=0.44) [Yates’] 0.38 (p=0.54)
2 5.78 (p=0.02)* 5.83 (p=0.05)*
3 0.37 (p=0.54) 2.23 (p=0.33)
4 7.88 (p=0.01)* 6.98 (p=0.03)*
5 [Yates’] 0.04 (p=0.85) [Yates’] 0.10 (p=0.75)
* significant at p<0.05
There was no statistically significant difference between cases and controls when 
considering the alleles or genotypes separately for MYOC1 (%2=4.36, p=0.36 and 
X2=l 1.97, p=0.22 respectively). For MYOC2 no statistically significant difference was 
found between cases and controls when considering both allele frequencies and 
genotypes (x2=8.43, p=0.08 and %2= 13.55, p=0.14 respectively) although by observation, 
there is a higher frequency of allele 2 and a lower frequency of allele 4 in cases with an
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opposite increase and decrease in controls. Considering one allele separately and 
grouping all other alleles together, therefore reducing the number of degrees of freedom, 
produces x2 values as shown in tables 6.14 and 6.17 for MYOC1 and MYOC2 
respectively. This shows no statistically significant difference between cases and 
controls for alleles and genotypes of MYOC 1. However, an increase of allele 2 and a 
decrease of allele 4 are shown to be statistically significant for MYOC2.
6.3.4. Hardy-Weinberg Equilibrium
Alleles at both the MYOC1 and MYOC2 loci were in HWE. However it should be noted 
that this study would have low power to detect deviations from HWE.
6.3.5. Sequencing results
Figures 6.4., 6.5. and 6.6. show the sequencing traces produced for alleles 2, 3 and 4 
respectively. Allele 2 consists of 13 dinucleotide repeats, allele 3 has 14 repeats and allele 
4 has 15 repeats.
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Figure 6.4. Sequence trace for MY0C1, allele 2(13 dinucleotide repeats).
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Figure 6.5. Sequence trace for MYOC1, allele 3 (14 dinucleotide repeats).
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Figure 6.6. Sequence trace for MYOC1, allele 4 (15 dinucleotide repeats).
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6.4. Discussion
The results suggest the possibility of increased transmission of allele 3(14 repeats) 
and, more strongly, decreased transmission of allele 4(15 dinucleotide repeats) of 
marker MYOC1 (in the promoter region of myocilin) to affected offspring. However, 
in view of the multiple testing carried out, the significance o f the findings must be 
viewed with extreme caution. Power calculations suggest a larger cohort is required to 
verify these results.
Sequencing shows allele 2 corresponds to the “short allele” described in the Hong 
Kong association study and allele 4 to the “long allele”. Therefore this association 
study provides confirmatory evidence of the decreased transmission o f allele 4. In this 
study there was suggestive evidence that allele 3 has increased transmission as 
opposed to allele 2.
Although no significant allelic transmission was found for MYOC2 (in the MYOC 3’ 
untranslated region), an association was found with the decreased transmission of 
haplotype 4 4 (allele 4 o f MYOC 1 marker and allele 4 of MYOC2 marker) to affected 
offspring and also an increase in transmission of haplotype 3 2 (allele 3 o f MYOC 1 
and allele 2 of MYOC2). These results support those shown from FBAT, where, if  the 
MYOC2 alleles show no significant transmission to affected offspring, the haplotype 
test will be governed mainly by MYOC1 alleles and therefore show the increased 
transmission of allele 3 and decrease of allele 4. It is possible that allele 4 of MYOC2 
is in linkage disequilibrium with allele 4 of MYOC 1, being not-transmitted together 
more often than expected by chance, this haplotype occurring more frequently within 
this population than any other with allele 4 of MYOC 1. This may also be the case for 
the haplotype 3 2, allele 2 of MYOC2 being inherited more often than expected by 
chance with allele 3 of MYOC 1.
Case-control study results showed no significant results for MYOC1 but allele 2 in 
MYOC2 showed an increase in prevalence in the case subjects and there was a 
decrease in the frequency of allele 4. These results are consistent with those found in 
the HBAT analysis further supporting the idea that these two alleles may be in linkage
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disequilibrium with alleles 3 and 4 of MYOC 1. Further tests would need to be carried 
out with a larger cohort that is more randomly sampled to confirm these findings, the 
parents being recruited because of their relationship with high myopes and to 
investigate further the distribution and possible association of the MYOC1 alleles.
Using the trait as a quantitative variable appears to give a slightly higher significance 
level and therefore produces a more powerful FBAT test.
Although each analysis is slightly different in its approach and test statistic, there is 
concordance of results such that there is a weak over-transmission o f allele 3 of 
MYOC1 and under-transmission of allele 4, this decreased transmission being 
supported by the genotype analysis. The results provide evidence that myocilin may 
have a weak contribution to high myopia susceptibility in the UK population. 
However, as this is the first time that myocilin polymorphisms have been investigated 
in non East Asian subjects further replication studies are required before a causative 
role can be investigated.
Using this same method alternative genes could be investigated. Generally genetic 
association studies may make use of previous positive linkage results to identify 
candidate genes and attempt to detect association within these linkage regions. 
Alternatively as discussed here, an attempt to replicate association may be made in an 
alternate population. Considering this, a possible next gene to investigate would be 
Hepatocyte Growth Factor which has recently been found to be associated with 
myopia in a Han Chinese population (Han et al., 2006). Association was investigated 
using a family based association method and tag-SNPs and significant association was 
found with the polymorphism HGF5-5b on chromosome 7q21.1. A similar 
experimental design may be employed to attempt replication of association with this 
UK population of trios.
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7. Final Discussion
7.1. Overview
As discussed in the preceding chapters, there is extremely strong evidence suggesting 
myopia is, in some way, genetically controlled. This is provided by linkage analysis 
and heritability studies. There is also a strong environmental component, more so in 
lower degrees of myopia. Farbrother et al (Farbrother et al., 2004a) found a difference 
in the relative risk to siblings in groups of high myopes and mild to moderate myopes. 
Relative risk to siblings is calculated as the risk of being myopic if a sibling is a high 
myope divided by the population prevalence of high myopia (chapter 1). For high 
myopes a value of >*=5.8 was calculated, but for low and moderate myopes a value of 
approximately >*=1.8 was found, suggesting an important role of genetic factors for 
high myopia compared to lower myopia and supporting the hypothesis that there may 
be more than one aetiologically distinct type of myopia. It is particularly difficult to 
allow for environmental variables such as near work due to the uncontrollable 
experimental design. The restrictions of working with human subjects include the 
requirement of the information collected to be observational (Rosenfield and 
Gilmartin, 1998).
To increase the power to detect potential linkage most genetic studies use populations 
or pedigrees enriched with extreme phenotypes, in this case, high myopia. This is also 
relevant in that high myopia is visually more debilitating; the chances o f visual 
impairment being significantly higher due to optical qualities o f refractive correction 
or related ocular pathologies such as retinal degeneration or detachment. The genetic 
basis for high myopia may then provide further information for the treatment of the 
condition which may also be applied to lower degrees of myopia.
Refractive error as a whole is highly heritable. However, there are many components 
which together make up the optical system and therefore determine the refractive 
error. Using the ocular component data, it may be possible to identify quantitative
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trait loci for separate components of this system which may then have a major effect 
on the overall refractive error. The Irish-Welsh pedigree investigated showed high 
heritability of refractive error and corneal curvature. Despite the fact that axial length 
is highly correlated with refractive error and that previous studies have suggested that 
this is the determining component, a statistically insignificant heritability value for 
axial length was calculated for this pedigree. This could be due to a visual feedback 
mechanism, the growth of the axial length being controlled by the attempted 
maintenance of a clear retinal image which may contribute to the final refractive error.
By genotyping areas of chromosomes from buccal cell DNA and using variance 
components linkage analysis, the hypothesis of myopia as a strongly heterogenous 
disease was supported by the failure to replicate linkage to those loci previously found 
to be linked to high myopia for this large pedigree. Power studies showed a 
potentially high likelihood of detecting linkage if it was present and so the suggestion 
of linkage, having a LOD score over 1, was not convincing for this pedigree.
A battery of association tests showed the suggestion of weak association of the 
MYOC gene and high myopia. Initially a statistically significant difference in the 
transmission compared to the non-transmission of MYOC 1 alleles was found. Further 
investigation of this showed an increase in the transmission of allele 3 o f MYOC 1, the 
microsatellite marker located in the 5’ UTR of the MYOC gene, and a decrease of 
allele 4 of the same marker. However, the adjustment for multiple testing decreased 
the power and the results were no longer statistically significant. This trend of 
transmission o f these alleles was supported by FBAT quantitative analysis but due to 
the inconsistency of the results, they should be taken as a suggestion and an extension 
of the analysis by way of increasing the sample size is necessary to establish an 
association of this gene with myopia.
This study has also supported the methodology behind the use o f mouthwashes and 
buccal cells as a source of DNA for genetic studies. The quality of the DNA is 
sufficient to produce genotypic information and if the samples are depleted the use of
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whole genome amplification methods can be applied but with some detrimental effect 
to the quality of the genotyping.
Detecting the possible genes in which causal polymorphisms exist will increase the 
understanding of the aetiology of the disease and therefore provide further clues as to 
the potential treatments to slow the progression of myopia and reduce the possible 
deterioration of vision by refractive or pharmaceutical methods.
7.2. Future work
Considering the potential power to detect linkage of the Irish-Welsh pedigree, a 
genome scan would provide invaluable information for the discovery o f myopia 
susceptibility loci. Exclusion of the loci found to be previously linked to myopia 
suggests the disease to be highly heterogenous and therefore any potentially 
identifiable loci may be novel.
This genome scan could be performed either by using SNPs or microsatellite markers 
and genotyping the pedigree members across the whole genome. This can be done 
using the same method as performed here using SNPs spaced less than lcM  along the 
chromosomes or microsatellites markers spaced lOcM apart. Genotyping is performed 
and the analysis repeated using the genotypes at each chromosomal locus for all of the 
chromosomes. This can be done by hand or via a service provided by a number of 
companies in USA.
Possible linkage peaks may lead to further investigation of specific candidate genes. 
Currently no candidate genes for myopia have been identified but structural 
component genes seem to be the main suspects. Association studies are the key to 
these findings once the linkage peaks have been identified. Although no statistically 
significant results with these populations tested have been produced, MYOC seems to
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have some association, if only weak, to myopia and therefore requires further 
investigation. An increase in study population is needed and exclusion criteria more 
carefully applied, potentially with the exclusion o f any bilineal families.
If association is found and candidate genes are identified, the next stage is to prove 
biological meaningfulness by way of a functional assay. This can be done most 
effectively using in vivo and in vitro laboratory based methods. For example; by 
cloning the gene under investigation and altering its sequence to mimic the mutation, 
allows its effects to be examined in transgenic mouse models o f the disease. Also in 
vitro cell culture experiments allow one to compare the protein activity of the altered 
gene to that of the gene with the original sequence, to observe the functional effects.
The continued recruitment of Family Study of Myopia pedigrees is an essential 
requirement for this investigation into myopia development. This cohort now 
comprises a large number of families with varying pedigree structures and also 
includes affected individuals with no other family members. To date there are a total 
of 150 families, 94 of which include two highly myopic siblings. These 150 families 
are made up of 1451 individuals and include 104 trios. There are also an additional 
108 highly myopic individuals acting as “affected random probands”. This cohort has 
the potential to contribute to many kinds of genetic analyses including wide spread 
heritability studies, linkage analysis, case-control and family based association 
studies. The size and increased prevalence of high myopia compared to the general 
population make it a powerful and near homogenous population for ongoing study.
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Appendix I
«Title» «Forenames» «Sumame»
«Addressl»
« Locality »
«Town»
«County»
« PostCode »
Date
Dear «Title» «Sumame»
The Family Study of Myopia research project
Conlons Opticians is pleased to be helping researchers at Cardiff University in their work 
towards finding a cure for high myopia (high degree of short sightedness). Their research 
project, The Family Study of Myopia, is open to all high myopes and their families across 
the U.K. The aim of the research is to prevent the progression of high myopia by 
discovering the genes that cause it. The study is being funded by two Eye Research 
charities.
Further details about the research project are enclosed, along with a questionnaire and 
consent form to fill in if you are interested in participating. Importantly, if  you would like 
to take part, you would not need to travel, all of the information can be obtained by post.
If you would like to discuss the research further, you can contact one o f the researchers 
involved at the address below.
Yours sincerely
John W. Welsby
John Welsby
M.D. Conlons Opticians
On behalf of: Rosalind Creer
The Family Study of Myopia research group 
Tel. (029) 2087 5063 
email: myopia@cardiff.ac.uk
S c h o o l  o f  O p t o m e t r y  a n d  Vision S c i e n c e s  
Head of School Professor Tim Wess
Ysgol Optometreg a Gwyddorau Golygol
Pennaeth Yr Ysgol Yr Athro Tim Wess
CARDIFF
UNIVERSITY
PRIFYSGOL
C a e RDY[§>
Cardiff University 
Redwood Building
King Edward VII Avenue 
Cathays Park
«Title» «First name» «Sumame»
Cardiff CF10 3NB 
Wales UK
«Addressl»
«Address_2»
«Address3»
«Postcode»
Tel Ff6n + 4 4 (0 )2 9  2 0 8 7  4 3 7 4  
Fax Ffacs + 4 4 (0 )2 9  2 0 8 7  4 8 5 9
The F a m i l y  S t u d y  o f  M y o p i a  Parc cathays
www.cardiff.ac.uk
Prifysgol Caerdydd 
Adeilad Redwood  
Rhodfa Edward VII
Caerdydd CF10 3NB 
Cymru Y Deymas Gyfunol
Date
Dear «Title» «Sumame»
Having had your eyes examined at Cardiff University Eye Clinic, we would like to 
invite you and your family to participate in the Family Study o f Myopia. Details 
about the research project are enclosed along with a questionnaire and consent form 
for you to complete should you decide to take part. Importantly all the information 
needed can be obtained by post so you would not need to travel.
The Family Study of Myopia is a research project being undertaken at Cardiff 
University. The study, which is funded by two Eye Research Charities, is working 
towards finding a cure for high myopia (a high degree of short sightedness) and is 
open to all high myopes and their families across the British Isles. The aim of the 
project is to identify the genes that cause high myopia, which will be the first step to 
finding a way to prevent its development.
If you would like to discuss the research further please do not hesitate to contact one 
of the researchers involved via the details on the information sheet.
Yours sincerely
Rosalind Creer MCOptom
The Family Study of Myopia research group
Optometry and Vision Sciences 
Cardiff University 
Redwood Building 
King Edward VII Avenue 
Cardiff 
CF10 3NB
Information about the research project
W e would like to invite you to take part in The Family Study of M yopia, a research  
project investigating the g en etic  factors that lead to the d eve lop m en t o f high myopia 
(a lso  known a s  short-sigh ted n ess).
W hat is th e  p u rp o se  of th e  s tu d y ?
The study is investigating how  m yopia is inherited from on e generation  to the next. Our 
aim is to d iscover the g e n e s  that m ake so m e  people m ore likely to b e c o m e  short-sighted  
than others. This will help our understanding of why m yopia occurs, and in the future 
m ay aid the develop m ent of treatm ents for the condition.
Why have I been  c h o se n ?
W e are seek in g  the participation of fam ilies from a cro ss  the U.K. and Ireland in which  
there are on e  or m ore individuals with high myopia. W e are looking for the help of about 
2 0 0  such  fam ilies in total.
W ho is o rg an is in g  th e  s tu d y ?
The study is organised  by research ers from the Departm ent of O ptom etry and Vision  
S c ie n c e s  at Cardiff University and the M edical G en etics Departm ent at the University of 
W ales C ollege of M edicine. The research is funded by two e y e  research  charities, the 
National Eye R esearch  Centre and the C ollege  of Optom etrists.
W hat w ould  it involve if I take p a rt?
• W e would ask  you to fill in a short questionnaire about your e y e s ig h t and your 
general health, and a lso  to identify other m em bers of your family w h o might be  
prepared to take part in the study (the m ore m em bers of your family w ho are willing 
to take part in the study the better, even  if th ese  relatives are not short sighted  
th em se lves).
• To en ab le  us to trace m yopia g e n e s  in your family, w e  would ask  you to provide two 
m outhw ash sam p les. T h ese  m ou th w ash es are ea sily  d o n e  by sw ishing so m e  saline  
around in your mouth for 2 0  se co n d s . The equipm ent and instructions will be posted  
to you if you agree  to take part. W e can a ssu re  you that th e se  sa m p les  will only be 
u sed  for studying m yopia g e n e s , and that all sa m p le s  will be coded  in order to 
protect your anonym ity
The F a m i l y  S tud yo f  M y o p i a
Please turn over...
• W e would ask  for your perm ission to contact your Optometrist/Optician for details of 
your spec tacle  or contact lens prescription and your ocular health.
Will my confidentiality be maintained?
W e take great care  to en su re  that the confidentiality of participating families is 
m aintained. All personal details a re  kept securely, and  the  findings from this research 
will not identify individuals.
How do I participate?
If you would like to take part, p lease  fill in the enclosed  questionnaire  and  consen t form 
and return them  to us in the  F reepost envelope provided. W e will con tac t you with 
details about the  m outhw ash sam ples a t a later date.
Contact for further information
If you have any further questions then we would be very happy to an sw er them  either by 
telephone on 029 20875063, by post a t the ad d re ss  overleaf or via em ail a t 
myopia@cardiff. ac. uk.
Many thanks,
Rosalind C reer
The Family Study of Myopia
Optometry and Vision Sciences
Cardiff University
Redwood Building
King Edward VII Avenue
Cardiff
CF10 3YJ
Study Questionnaire
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (P lease specify)
Surname .........................................................................................................
First nam es ........................................................................................................
Date of birth ........................................................................................................
Address ........................................................................................................
Tel. Number .........................................................................................................
P lease tick the box which you feel best describes your ethnic group:
□  White European □  American
□  Other European □  Afro-Caribbean
□  African □  Australasian
□  Asian □  Other (please specify)
1. At what age did you begin to wear spectacles? .................Yrs
2. What is the name and address of your current optician/optometrist?
3. Were you born prematurely? Yes □ N o D Don’t know n
4. Did you have any eye condition/disease at birth or in childhood?Yes □ N o D Don’t know n
If Yes, please give d eta ils ................................................................
5. Do you currently suffer from any eye condition or d isease?
If Yes, please give d eta ils ................................................................
Y es □ No n Don’t know n
6. Have you had any eye surgery?
If Yes, please give d eta ils ................................................................
Y es □ N o n Don’t know n
7. Do you take any medication for your eyes?
If Yes, please give deta ils ................................................................
Y es □ N o n Don’t know n
8. Do you take any medication for any other health condition?
If Yes, please give d eta ils ................................................................
Yes □ N o n Don’t know n
T h e F a m i l y  S t u d y  o f  M y o p i a
PQ(P1)
P lease  supply the nam es and addresses of any relatives who you think might be willing to participate 
in the research project. The participation of relatives who are not short-sighted is just as valuable as  
those that are. Similarly, the participation of your sp ou se  would be very helpful, if appropriate.
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (P lease  specify)
Surname ...........................................................................................................
First nam es ...........................................................................................................
Date of birth ...........................................................................................................
Address ...........................................................................................................
Tel. number .................................................................................................
Is this relative short-sighted? □  Yes □  No □  Don’t know
Please indicate their relationship to you:
□  Sister □  Brother □  Mother □  Father □  Daughter □  Son
□  Uncle □  Aunt □  Husband □  Wife □  Grandfather □  Grandmother
□  Other (please specify):................................................................
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (P lease specify)
Surname ...........................................................................................................
First nam es ...........................................................................................................
Date of birth ...........................................................................................................
Address ...........................................................................................................
Tel. number .................................................................................................
Is this relative short-sighted? □  Yes □  No □  Don’t know
Please indicate their relationship to you:
□  Sister □  Brother □  Mother □  Father □  Daughter □  Son
□  Uncle □  Aunt □  Husband □  Wife □  Grandfather □  Grandmother
□  Other (please specify):................................................................
Please continue on the next page..
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (Please specify)
Surname .................................................................................................
First names .................................................................................................
Date of birth .................................................................................................
Address .................................................................................................
Tel. number .................................................................................................
Is this relative short-sighted? □  Yes □  No □  Don’t know
Please indicate their relationship to you:
□  Sister □  Brother □  Mother □  Father □  Daughter □  Son
□  Uncle □  Aunt □  Husband □  Wife □  Grandfather □  Grandmother
□  Other (please specify):...............................................................
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (Please specify)
Surname .................................................................................................
First names .................................................................................................
Date of birth .................................................................................................
Address .................................................................................................
Tel. number .................................................................................................
Is this relative short-sighted? □  Yes □  No □  Don’t know
Please indicate their relationship to you:
□  Sister □  Brother □  Mother □  Father □  Daughter □  Son
□  Uncle □  Aunt □  Husband □  Wife □  Grandfather □  Grandmother
□  Other (please specify):................................................................
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (Please specify)
Surname .................................................................................................
First names .................................................................................................
Date of birth .................................................................................................
Address .................................................................................................
Tel. number ..........................................................
Is this relative short-sighted? □  Yes □  No
Please indicate their relationship to you:
□  Sister □  Brother □  Mother
□  Uncle □  Aunt □  Husband
□  Don’t know
□  Father □  Daughter □  Son
□  Wife □  Grandfather □  Grandmother
□  Other (please specify):
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (Please specify)
Surname ...........................................................................................................
First nam es ...........................................................................................................
Date of birth ...........................................................................................................
Address ...........................................................................................................
Tel. number .................................................................................................
Is this relative short-sighted? □  Yes □  No □  Don’t know
Please indicate their relationship to you:
□  Sister □  Brother □  Mother □  Father □  Daughter □  Son
□  Uncle □  Aunt □  Husband □  Wife □  Grandfather □  Grandmother
□  Other (please specify):...............................................................
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (Please specify)
Surname .................................................................................................
First names .................................................................................................
Date of birth .................................................................................................
Address .................................................................................................
Tel. number .................................................................................................
Is this relative short-sighted? □  Yes □  No □  Don’t know
Please indicate their relationship to you:
□  Sister □  Brother □  Mother □  Father □  Daughter □  Son
□  Uncle □  Aunt □  Husband □  Wife □  Grandfather □  Grandmother
□  Other (please specify):................................................................
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (Please specify)
Surname .................................................................................................
First names .................................................................................................
Date of birth .................................................................................................
Address .................................................................................................
Tel. number .................................................................................................
Is this relative short-sighted? □  Yes □  No □  Don’t know
Please indicate their relationship to you:
□  Sister □  Brother □  Mother □  Father □  Daughter □  Son
□  Uncle □  Aunt □  Husband □  Wife □  Grandfather □  Grandmother
□  Other (please specify):................................................................
Many thanks for your help
Conlons
—  OPTICIANS —
“Experience the Difference”
The Family Study of Myopia research project
Conlons Opticians is pleased to be helping researchers at Cardiff University in their work towards 
finding a cure for high myopia (a high degree of short sightedness). Their research project, The 
Family Study of Myopia, is funded by two Eye Research Charities and is open to all high myopes 
and their families across the U.K. The aim of the research is to identify the genes that cause high 
myopia, which will be the first step to finding a way to prevent its development.
If you are interested in taking part in the project or would like more information, please complete 
the section overleaf and return this card (no stamp required) stating how you would like to be 
contacted. Importantly, if you would like to take part, you would not need to travel, all of the 
information can be obtained by post.
Yours sincerely
John W. Welsby
John Welsby
M.D. Conlons Opticians
On beha lf of: Rosalind Creer
The Family Study o f  Myopia research group 
Tel. (029) 2087 5063 
email: myopia@ cardiff.ac.uk
Fold along this line
no stamp required
The F a m i l y  S t u d y o f M y o p i a
Rosalind Creer
The Family Study o f Myopia
Optometry and Vision Sciences
FREEPOST SWC4376
CARDIFF
CF10 3GZ
PQ1C
Optometry and Vision Sciences
Cardiff University
Redwood Building
King Edward VII Avenue
Cardiff
CF10 3YJ
Study Questionnaire
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (P lease specify)
Surname .........................................................................................................
First nam es .........................................................................................................
Date of birth .........................................................................................................
Address .........................................................................................................
Tel. Number .........................................................................................................
P lease tick the box which you feel best describes your ethnic group:
□  White European □  American
□  Other European □  Afro-Caribbean
□  African □  Australasian
□  Asian □  Other (please specify)
1. At what age did you begin to wear spectacles? .................Yrs
2. What is the name and address of your current optician/optometrist?
3. Were you born prematurely? Y es □ N o D Don’t know n
4. Did you have any eye condition/disease at birth or in childhood?Yes □ N o D Don’t know □
If Yes, please give deta ils................................................................
5. Do you currently suffer from any eye condition or d isease?
If Yes, please give deta ils................................................................
Y es □ N o n Don’t know n
6. Have you had any eye surgery?
If Yes, please give d eta ils ................................................................
Y es □ N o n Don’t know n
7. Do you take any medication for your eyes?
If Yes, please give d eta ils ................................................................
Y es □ N o n Don’t know n
8. Do you take any medication for any other health condition?
If Yes, please give d eta ils ................................................................
Y es □ N o n Don’t know □
The F a m i l y  S t u d y  of M y o p i a
PQ(P2)
We are currently in contact with vour:
□  Sister ................................................
□  Brother ................................................
□  Mother ................................................
□  Father ................................................
□  Daughter .................................................
□  Son .................................................
□  Other .................................................
Aunt Uncle Grandmother Grandfather Other(please specify)
] Other
Aunt Uncle Grandmother Grandfather Other(please specify)
] Other
Aunt Uncle Grandmother Grandfather Other(please specify)
P lease supply the nam es and ad d resses of any additional relatives who would be willing to participate 
in the research project. The participation of relatives who are not short-sighted is just a s  valuable as  
those that are.
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (P lease  specify)
Surname ...........................................................................................................
First nam es ...........................................................................................................
Date of birth ...........................................................................................................
Address ...........................................................................................................
Tel.number ...........................................................................................................
Is this relative short-sighted? □  Y es □  No □  Don’t know
P lease indicate their relationship to you:
□  Sister □  Brother □  Mother □  Father □  Daughter □  Son
□  Uncle □  Aunt □  Husband □  Wife □  Grandfather □  Grandmother
□  Other (please specify):....................................................
Please continue on next page..
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (Please specify)
Surname ...........................................................................................................
First nam es ...........................................................................................................
Date of birth ...........................................................................................................
Address ...........................................................................................................
Tel.number ..................................................................
Is this relative short-sighted? □  Y es □  No
P lease indicate their relationship to you:
□  Sister □  Brother □  Mother
□  Uncle □  Aunt □  Husband
□  Don’t know
□  Father □  Daughter □  Son
□  Wife □  Grandfather □  Grandmother
□  Other (p lease specify):
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (P lease specify)
Surname ...........................................................................................................
First nam es ...........................................................................................................
Date of birth ...........................................................................................................
Address ...........................................................................................................
Tel. number ................................................................
Is this relative short-sighted? □  Y es □  No
P lease indicate their relationship to you:
□  Sister □  Brother □  Mother
□  Uncle □  Aunt □  Husband
□  Other (p lease specify): 
****************************************************
Title □  Mr. □  Mrs. □  Ms. □  Miss
Surname ..................................................................
First nam es ..................................................................
Date of birth ..................................................................
Address ..................................................................
□  Don’t know
□  Father □  Daughter □  Son
□  Wife □  Grandfather □  Grandmother
it***********************************************************
□  Other (P lease  specify)
Tel.number ...........................................................................................................
Is this relative short-sighted? □  Y es □  No □  Don’t know
P lease indicate their relationship to you:
□  Sister □  Brother □  Mother □  Father □  Daughter □  Son
□  Uncle □  Aunt □  Husband □  Wife □  Grandfather □  Grandmother
□  Other (p lease specify):
Many thanks for your help, w e will contact you in the near future about the mouthwash sam ples
School of Optometry and Vision Sciences
Head of School Professor Tim Wess
Ysgol Optometreg a Gwyddorau Golygol
Pennaeth Yr Ysgol Yr Athro Tim Wess
CARDIFF
UNIVERSITY
PRIFYSGOL
C a eRD Y[§>
Cardiff University 
Redwood Building 
King Edward VII Avenue 
Cathays Park 
Cardiff CF10 3NB 
Wales UK
Tel Ff6n + 4 4 (0 )2 9  2 0 8 7  4 3 7 4  
Fax Ffacs + 4 4 (0 )2 9  2 0 8 7  4 8 5 9  
www.cardiff.ac.uk
The Fam ily S tudy of M yopia Prifysgol Caerdydd Adeilad Redwood  
Rhodfa Edward VII 
Parc Cathays
Caerdydd CF10 3NB 
Cymru Y Deymas Gyfunol
Consent Form for the Family Study of Myopia Please tick boxes
I a g r e e  that my O ptom etrist/O ptician can  b e  co n ta cted  for further d eta ils  about □  
my e y e s  and health.
I a g r e e  that other m em b ers of m y family m ay b e  a sk ed  to tak e part in th is study. □
I a g r e e  to provide m outh w ash  sa m p le s , which will b e  u se d  to trace  th e  p a s s a g e  [-j 
of m yopia g e n e s  through m y family.
I h a v e  b e e n  g iven  an information s h e e t  and h ave  b e e n  g iven  an  opportunity to □  
d is c u ss  th e  research .
I understand that my participation is voluntary and that I am  fre e  to w ithdraw at □  
any tim e without m y legal rights being a ffected .
I a g r e e  to take part in this study.
N am e D ate S ign atu re
N am e o f parent/guardian D ate S ign atu re
(if applicable)
R O SALIND CREER
R e se a r ch er ’s  n am e
Form: CO(P)
D ate S ignature
School of Optometry and Vision Sciences
Head of School Professor Tim Wess
Ysgol Optometreg a Gwyddorau Golygol
Pennaeth Yr Ysgol Yr Athro Tim Wess
Ca r d if f
UNIVERSITY
PRIFYSGOL
CaeRDY[§>
The F a m i l y  S t u d y  of M y o p i a
Cardiff University 
Redwood Building 
King Edward VII Avenue 
Cathays Park 
Cardiff CF10 3NB 
Wales UK
Tel Ff6n + 4 4 (0 )2 9  2 0 8 7  4 3 7 4  
Fax Ffacs + 4 4 (0 )2 9  2 0 8 7  4 8 5 9  
www.cardiff.ac.uk
Prifysgol Caerdydd 
Adeilad Redwood 
Rhodfa Edward VII 
Parc Cathays 
Caerdydd CF10 3NB 
Cymru Y Deyrnas Gyfunol
Dear
Your patient has kindly agreed to participate in the Family Study of Myopia. We would be very grateful if you would complete 
the enclosed form and return it in the envelope provided.
We would also be very grateful for your help with patient recruitment for our research, which aims to identify genetic factors 
influencing susceptibility to high myopia development.
Our research relies on discovering highly myopic brothers and sisters, ideally along with their extended 
family and your help will be extremely valuable to us.
You can help by informing any of your patients who meet the criteria about the study by providing them with one of the 
information packs provided. The criteria for inclusion are:
Prescription (using negative cylinder form and applying to each eye) 
Least minus meridian - 6.00DS or over 
Anisometropia less than 3.00DS 
No systemic pathology or syndromes known to cause myopia 
Over 7 years of age
We are collecting patient details in order to trace genes through families and will not be in any way involved in their future 
optometric care. Collection of DNA will be done by postal collection of a mouthwash sample, for which we will contact the 
patient directly. More details are displayed at our website http://www.cardiff.ac.uk/mvopia/.
If further information or more forms are required I can be contacted directly on tel. 00 44 2920 875063, at the above address 
or via email mvopia@cardiff.ac.uk.
Many thanks in anticipation of your assistance with our research.
Yours sincerely
Rosalind Creer MCOptom
Form OP1
Optometry and Vision Sciences 
Cardiff University 
Redwood Building 
King Edward VII Avenue 
Cardiff 
CF10 3NB
Optometric History Form (To be completed by optometrist)
Questionnaire and consent form returned by patient? Yes No
Patient details
Name
Address
D.O.B
Ocular details
Date of last eye examination.... 
Distance spectacle prescription
SPH CYL AXIS VA SPH CYL AXIS VA
RE LE
B.V.D.....................................................................................................
Patient ocular history (with particular reference to ocular problems or disease associated with myopia e.g. nuclear 
sclerotic cataract, keratoconus, retinal detachment etc.)
Patient general health (with particular reference to conditions associated with myopia)
The F a m i l y  S t u d y  o f M y o p i a
Form OP2
Optometry and Vision Sciences 
Cardiff University 
Redwood Building 
King Edward VII Avenue 
Cardiff 
CF10 3YJ
The F a m i l y  S t u d y  of M y o p i a
Thank you for your help with the Family Study of M yopia s o  far. W e are now in 
the p ro cess  of collecting m ou th w ash es and would be grateful if you would p lease  
follow the instructions below  to provide your sam p les .
Mouthwash Instructions
The m outhw ash is quick and painless, although it d o es  ta s te  quite  salty. If you 
swallow  any m outhw ash it will not harm you in any way.
You should have received two plastic containers, each with your name written on the 
side, containing sterile mouthwash solution.
We suggest that you do the mouthwash before breakfast and before brushing your 
teeth.
PLEASE FOLLOW THESE INSTRUCTIONS
1. Pour the mouthwash solution from one of the containers into your mouth.
2. Vigorously swish the solution around your mouth for at least 20 seconds.
3. Carefully spit the solution back into the plastic container.
4. Repeat steps 1-4 for a second sample.
5. Please post your 2 mouthwash samples to us, as soon as possible, in the 
stamped addressed envelope provided. (Please screw the caps on tightly)
Usually two mouthwash samples are sufficient for our analyses. However each 
individual is different, therefore if we find that there is not enough DNA in the 
samples we may contact you again to provide some more.
If you have any questions please contact Rosalind Creer or Jez Guggenheim on 
(029) 20 875063
Thank you for your time
A ppendix II
Optometry and Vision Sciences 
Cardiff University 
Redwood Building 
King Edward VII Avenue 
Cardiff 
CF10 3YJ
Study Questionnaire
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (Please specify)
Surname ....................................................................................................
First names .....................................................................................................
Date o f birth ....................................................................................................
Address ....................................................................................................
Tel. Number
1. At what age did you begin to wear spectacles? Yrs
2. Would you agree to your optician/optometrist being contacted for further details about your eyes and health?
Yes □ N o D
3. What is the name and address of your current optician/optometrist?
4. Were you bom prematurely? Yes □ N o D Don’t know n
5. Did you have any eye condition/disease at birth or in childhood?
If Yes, please give details................................................................................
Yes □ N o D Don’t know n
6. Do you currently suffer from any eye condition or disease?
If Yes, please give details................................................................................
Yes □ N o D Don't know n
7. Have you had any eye surgery?
If Yes, please give details................................................................................
Yes □ N o n Don’t know n
8. Do you take any medication for your eyes?
If Yes, please give details................................................................................
Yes □ N o n Don’t know n
9. Do you take any medication for any other health condition?
If Yes, please give details................................................................................
Yes □ N o n Don’t know n
10. Are there any other immediate family members who have not received a questionnaire? (see attached family tree,
those with a questionnaire are indicated) Yes □ N o n Don’t know n
11. If yes, would they be happy for us to contact them? Yes □ N o n Don’t know n
PQ1(IW)
The F a m i l y  S t u d y  of M y o p i a
If Yes, please list below and state their relationship to you.
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (Please specify)
Surname ..................................................................................
First names ..................................................................................
Date of birth ..................................................................................
Address ..................................................................................
Tel. Number
Please indicate their relationship to you:
Brother Sister Mother Father Son Daughter Aunt Uncle Other (Please specify)
If known, are they myopic (wear glasses to see in the distance)? Yes □  No □  Don’t know □
Title □  Mr. □  Mrs. □  Ms. □  Miss □  Other (Please specify)
Surname ..................................................................................
First names ..................................................................................
Date of birth .................................................................................
Address ..................................................................................
Tel. Number
Please indicate their relationship to you:
Brother Sister Mother Father Son Daughter Aunt Uncle Other (Please specify)
If known, are they myopic (wear glasses to see in the distance)? Yes □  No □  Don’t know □
I agree that the details I have provided may be used for this research study
Name:__________________________  Signature___________________________  Date
Name:__________________________  Signature______    Date
of parent/guardian (if applicable)
PQ(P1)
School of Optometry and Vision Sciences
Head of School Professor Tim Wess
Ysgol Optometreg a Gwyddorau Golygol
Pennaeth Yr Ysgol Yr Athro Tim Wess
Ca r d if f
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Cardiff University 
Redwood Building 
King Edward VII Avenue 
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Tel Ff&n + 4 4 (0 )2 9  2 0 8 7  4 3 7 4  
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The F a m i l y  S t u d y o f M y o p i a
Prifysgol Caerdydd 
Adeilad Redwood  
Rhodfa Edward VII 
Parc Cathays
Caerdydd CF10 3NB 
Cymru Y Deyrnas Gyfunol
Dear
W e would like to thank you very m uch for your help with our su rv ey  o f th e  inheritance of 
sh o rt-s ig h ted n ess  (m yopia). W e ’re very p le a se d  to have had su c h  a fan tastic  resp on se .
W e h ave  b e e n  ab le  to build up a detailed  picture of the pattern o f m yopia  inheritance in the 
com p lete  ex ten d ed  family, w hich h a s  sh ow n  that an important role is b e in g  p layed  by both 
g e n etic  factors and n on -gen etic  factors (su ch  a s  th e  am ount o f c lo s e  work carried out, 
perhaps).
A s w e  h ave  had su ch  a g o o d  r e sp o n se , w e  now  h o p e  to ex ten d  our r esea rch  to try and  
identify the g e n e s  that h ave  m ad e so m e  m em b ers of the fam ily b e c o m e  m yopic and others 
remain non-m yopic. Your family is ideal for this study, firstly b e c a u s e  it is s o  large, and 
seco n d ly  b e c a u s e  over 50%  of your relatives are m yopic, d o u b le  th e  am ou n t w e  would  
e x p e c t in the gen era l population.
With this in mind, w e  w ould like to invite you to o n e  of tw o fam ily g a th er in g s w e  are  
organising b etw een  o u rse lv es  and Adrian Murphy, o n e  in Kilkenny and th e  other in Dublin. 
Our aim is two-fold. To in vestigate  th e  connection  b etw een  s p e c ta c le  prescriptions and 
g e n e s  w e  n e e d  to take s o m e  e y e  m ea su rem en ts  from a s  m an y fam ily m em b ers a s  w e  
can. T h e s e  te s t s  will not only tell u s how  short-sighted  you and your relations are, but a lso  
which p r ec ise  feature of e a c h  p erso n ’s  e y e s  is resp on sib le  for ca u s in g  any  m yopia they  
m ay h ave. All o f the te s ts  are very sim ilar to th o se  you m ay h a v e  had d o n e  at the  
opticians. T h ey  are all quick and p a in less , and there is no n e e d  for any  e y e  drops. W e a lso  
n eed  a DNA sa m p le  from a s  m any m em b ers o f the fam ily a s  p o ss ib le . W e routinely obtain 
su ch  DNA sa m p le s  from a “sw ish  and spit m ou th w ash ”. T his in vo lves sim ply sw ishing a 
salt solution around your m outh and then  spitting it back  into a  tube. W e can  a ssu r e  you  
that all o f th e  DNA sa m p le s  w e  co llect will b e  co d ed  to protect your anonym ity. W e  
m aintain strict confidentiality and g ive our com p lete  a s su r a n c e  that your DNA sa m p les  will 
only b e  u sed  to in vestigate  m yopia g e n e s , and not for an y  other purpose.
The family ga therings will a lso  be  a  c h an c e  to m e e t up with your relatives. W e will provide 
a hot buffet and  drinks, and  th e re  will be  am ple  opportunity  to  chat.
You will find en clo sed  an  invitation and  reply en v elo p e . W e would be  grateful if you would 
com plete  th e  RSV P form and  return it to us in th e  en v e lo p e  provided a s  soon a s  possible, 
indicating w hether you wish to a ttend  (and if so , which v e n u e  would b e  m ost convenient, 
any  dietary requ irem ents and  w ho in your family is ab le  to  a ttend).
If you would like to a ttend  th e  family get-together, w e will s e n d  you a  co n se n t form, an 
instruction leaflet describ ing how to  carry out th e  m ou thw ash  p ro ced u re  and  two tubes of 
m outhw ash  solution, so  th a t you can  bring th e  m outhw ash  sa m p le s  along  on the  day. It 
would be  helpful if you could a lso  bring your d is tan ce  g la s s e s  with you.
W e would very m uch like a s  m any peop le  within th e  family a s  p o ssib le  to  a ttend  this social 
gathering but u n d ers tan d  if you a re  unab le  to. Should this b e  th e  c a s e  but you would still 
like to be involved with th e  study, p le a se  indicate this on the  form  in th e  s p a c e  provided. If 
you h av e  not s e n t your original q u estio n n aires  but would still like to  c o m e  and  join the 
study you a re  very w elcom e.
Your support in this project is greatly  ap p recia ted , Adrian M urphy an d  o u rse lv es  a re  
looking forward to  see in g  you on th e  21st or 2 2 nd February  2004. If you h av e  a  question 
abou t any a sp e c t of th e  study, w e would be delighted to  h ea r from you.
Yours sincerely
R osalind C reer
T he Family S tudy of Myopia re sea rch  group
The Family Study o f Myopia invites you to an 
evening o f food, drink & eye measuring!
The F am ily  S tu d y o f M y o p ia
Saturday 21st February 
Kilkenny River Court Hotel, The Bridge, John St, Kilkenny
or
Sunday 22nd February 
Royal Dublin Hotel, O’Connell St, Dublin
starting at: 5.30pm
RSVP
Please detach this section, tick box and return in envelope 
Name and address: ............................................................................
□  I am able to attend HU I am
□  I am unable to attend but would like to remain involved in the study 
Please indicate which gathering you would like to attend
□  K ilkenny  □  Dubl i n
Please state any dietary requirements here (e.g. Vegetarian) ..
School of Optometry and Vision Sciences
Head of School Professor Tim Wess
Ysgol Optometreg a Gwyddorau Golygol
Pennaeth Yr Ysgol Yr Athro Tim Wess
Ca r d if f
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The F a m i l y  S t u d y  of M y o p i a
Prifysgpl Caerdydd 
Adeilad Redwood 
Rhodfa Edward VII 
Parc Cathays
Caerdydd CF10 3NB 
Cymru Y Deyrnas Gyfunol
Dear
Thank you for your reply regarding the Family Study of Myopia and the family gathering. We are very pleased that 
you are able to attend. I have enclosed a map of the city centre showing the location of the Kilkenny River Court 
Hotel and a copy of the buffet menu. The party will be held in the Pembroke Suite. There is some parking available 
at the hotel and there are a number of car parks marked on the map, just in case you are not familiar with the city.
In order to trace the genes for myopia throughout the family we require DNA samples in the form of mouthwashes 
as explained in the previous information sheet. I have enclosed labelled mouthwash tubes, two for each person, 
and a set of instructions on how these samples should be taken. There is also a consent form for each person to 
sign. I would be grateful if you would take the samples first thing on the morning of the party and bring them with 
you along with the consent forms. If there is a family member who is unable to come but willing to provide some 
samples, please bring those along also. Again, we assure you that these samples will be coded for your anonymity 
and will be used for looking at genes for myopia only.
If you need any more information or have any questions please do not hesitate to contact us at the address above, 
by ‘phone on 00 44 (0) 2920 875063 or via email: myopia@cardiff.ac.uk
Thank you again for your help, we are looking forward to seeing you on the 21st February.
Yours sincerely
Rosalind Creer
The Family Study of Myopia research group
Ca r d if f
UNIVERSITY
PRIFYSGOL
CaeRDY[§>
School of Optometry and Vision Sciences
Head of School Professor Tim Wess
Ysgol Optometreg a Gwyddorau Golygol
Pennaeth Yr Ysgol Yr Athro Tim Wess
Cardiff University 
Redwood Building 
King Edward VII Avenue 
Cathays Park 
Cardiff CF10 3NB 
Wales UK
Tel Ffdn + 4 4 (0 )2 9  2 0 8 7  4 3 7 4
Fax Ffacs + 4 4 (0 )2 9  2 0 8 7  4 8 5 9
www.cardiff.ac.uk
Prifysgpl Caerdydd
Adeilad Redwood
Rhodfa Edward VII
Parc Cathays
Caerdydd CF10 3NB
Cymru V Deymas Gyfunol
Consent Form Please tick boxes
T h eF am i ly  S t u d y o f M y o p i a
I a g r e e  to provide m outh w ash  sa m p le s , which will b e  u sed  to trace  th e  p a s s a g e  [  
of m yopia g e n e s  through my family.
I a g r e e  to having e y e  m ea su r e m en ts  taken and th e  resu lts being u se d  for th e  
study.
I h ave  b een  given information regarding the study and h ave  b e e n  g iv en  th e  .— >
contact deta ils of the resea rch ers  in c a s e  I n eed  to d isc u ss  th e  r e sea rch  further.'— >
I understand that my participation is voluntary and that I am  free  to w ithdraw  
at any tim e without m y legal rights being affected . □
N am e D ate S ignature
N am e of parent/guardian D ate S ignature
(if applicable)
Form CO(IW)
Appendix III
Table A. Phenotypic data for Irish-Welsh family. An x indicates that this measurement was not taken or an appropriate value was not able to be calculated. Subject numbers in 
red represent those married-in individuals.
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26 -9.50 -1.00 150 -5.50 -0.75 30 -9.25 -3.05 164.49 -6.22 -1.34 19.71 27.82 26.18 43.97 43.65 y -9.50 -7.18
27 -3.25 -0.25 25 -2.50 -0.50 135 -2.79 -0.99 33.70 -2.12 -1.36 139.70 X X X X y -3.25 -4.42
28 -5.50 -1.50 150 -5.50 -1.25 15 -6.71 -2.46 159.58 -5.45 ' -1.33 6.96 27.17 26.63 42.09 42.57 y -5.50 -5.62
29 -1.25 - - -1.25 - - -1.96 -0.46 40.72 ~^ 1.66 -0.08 147.67 ^ X X X X y -T 2T -2.16
30 X X X X X X -0.16 -0.83 90.89 -0.25 -0.98 98.13 23.69 23.77 42.94 42.67 y -0.14 -1.04
31 -2.25 -0.50 120 -2.00 - - -2.53 -0.51 133.42 -2.47 -0.24 111.15 24.28 X 44.38 43.95 y -2.25 -2.98
32 -1.25 -0.25 85 -0.75 r-0.50 109 X x X x ' X X X X X X n -1.25 -2.05
34 0.00 - - 0.00 - X X X X X X X X X X y 0.00 -0.53
35 -3.75 -1.00 180 -4.50 - - -4.00 -0.79 175.83 -4.29 -0.67 35.70 25.36 25.31 45.50 45.49 y -3.75 -4.51
36 -3.00 -0.25 80 -2.75 -0.75 55 X X X X X X X X X X y -3.00 -3.84
37 0.00 - - 0.00 - X X X X X X X X X X n 0.00 -0.43
38 -2.50 - - -2.50 - - X X X X X X X X X X n -2.50 -3.17
39 0.00 - - 0.00 - - X X X X X X X X X X n 0.00 -0.40
40 0.00 - - 0.00 - - X X X X X X X X X X n 0.00 -0.39
41 -6.00 -1.75 90 -5.50 -1.75 100 X X X X X X X X X X y -6.00 -6.42
42 -2.00 -0.50 150 -2.00 -0.25 30 X X X X X X X X X X n -2.00 -2.87
43 -5.00 - - -5.00 - - X X X X X X X X X X y -5.00 -5.39
44 -1.00 - - -1.25 - - X X X X X X X X X X y -1.00 -1.83
45 -2.00 -0.75 90 -2.25 -0.50 70 X X X X X X X X X X y -2JD0 -2.85
46 0 - - 0 - - X X X X X X X X X X y 0.00 -0.36
47 -1.75 -0.75 102 -2.50 -0.25 90 r r .8 3 -1.00 108.75 -2.54 ~0.49 84.71 X X 43.38 43.16 y -1.75 -2.59
48 0.00 - - 0.00 - - X X X X X X X X X X n 0 -0.34
49 -6.00 -0.50 120 -3.25 -1.75 90 -7.08 -1.00 118.66 -5.08 -1.57 87.60 X X 43.92 43.50 y -6.00 -5.89
50 0.00 - - 0.00 - - X X X X X X X X X X n 0.00 -0.25
51 -6.00 -0.25 75 -2.00 -0.50 70 X X X X x X X X X X n -6.00 -5.88
52 i -1.50 -0.75 110 -1.00 -1.25 80 -1.94 -0.26 52.55 -1.37 -0.64 77.96 23.16 23.03 45.86 45.61 y -1.50 -2.18
53 , -4.50 -0.50 15 -4.00 -2.00 175 X X X x n X X X X X X y -4.50 -5.21
54 i -0.50 - -0.50 - - X X X X X X X X X X y -0.50 -1.31
55 -2.25 -2.00 115 -2.75 -1.25 50 X X X X X X X X X X y -2.25 -2.95
56 -1.25 - - -1.00 - x . X X X X X X X X X y -1.25 -1.87
57 -3.00 - - -0.75 - - X X X X X X X x X X y -3.00 -3.81
58 2.50 -1.75 130 1.50 - - 1.58 -2.27 126.86 2.19 J -1.61 ! 172.26 22.68 22.69 44.76 44.41 y 2.50 5.33
60 -1.75 -0.50 : 90 -1.75 - - -0.91 *-0.78 ^ 109.28 -0.94 -0.90 48.59 24.35 24.41 42.48 42.67 y -1.75 -2.46
-JL .4
62
X - - X - - X X X X X X X X X X y X X
0.00 - - 0.00 - - X X X X X X X X X X n 0.00 -0.22
63 -1.00 - - -1.50 - - -1.33 -0.70 93.54 -1.58 ^ -0.58 96.78 24.34 X 42.24 42.33 y -1.00 -1.64
64 t 0.00 - - 0.00 - - X X X X X X X x X X n 0.00 -0.19
65 0.00 - - 0.00 - - X X X X X X X x X X n 0.00 -0.17
69 ! -0.50
70 : 0.00
-0.50 160 -0.50 -0.75 45 -0.42 -0.82 127.86 -0.41 J -1.62 59.49 I23.94 24.17 43.58 43.39 y -0.50 -1.23
- - 0.00 - - X X X X X X X X X X y 0.00 -0.15
71 X - - X - - 0.33 [ -0.50 117.16 I 0.12 -0.79 93.41 23.50 X 42.94 43.14 y 0.31 3.68
72 0.00 - - 0.00 - - -0.33 -1.60 112.83 0.12 -1.58 78.21 24.42 24.34 42.51 42.20 y -0.29 -1.17
73 7.00 - - 6.50 - - 4.66 -0.85 58.61 3.93 -1.53 145.03 x ; 20.49 X X y 7.00 6.23
74 -0.50 - - -0.50 - - X X X X X X X X X X y -0.5^ -1.19
91 0.50 -0.50 135 0.00 -0.501 90 0.04 -3.83 22.89 0.31 -1.04 146.95 X X X X y 0.50 3.73
102 X - - X - - 0.25 -1.12 12.64 -0.04 -0.64 4 15.01 24.31 24.40 41.99 41.70 y 0.24 3.06
103 X - - X - - 0.16 -0.79 9.24 -0.22 -0.11 56.60 22.60 22.52 43.72 44.15 n 0.16 3.03
104 x - - X - - -0.04 -0.08 76.41 0.29 " -0.17 135.00 24.07 24.06 41.34 41.14 y -0.03 -0.64
105 0.00
0.00
- - 0.00 - - X X X X X X X x X X n 0.00 -0.03
106 - - 0.00 - - X X X X X X X X X X y 0.00 -0.02
108 X - - X - - 0.04 -1.00 134.43 -0.29 -0.53 7.47 23.76 x 43.48 43.45 y 0..05 2.96
112 -1.00 -2.25 12 -0.50 -3.50 164 -1.50 [ -2.46 21.49 -1.04 -3.28 H157.12 24.62 24.44 44.25 44.68 n -1.00 -1.62
113 0.00 - - 0.00 - - X X X x X X X X X X n 0.00 0.18
114 0.00 I - 0.00 - - X X X X X X X X X X n 0.00 0.19
115 -0.75 -0.75 I 180 -0.25 -1.25 5 X X X X X X X x X X y -0.75 -1.48
118 X - - X - - 0.70 -0.33 52.27 1.03 -0.64 76.44 23.71 23.51
X
42.35 42.56 y 0.65 4.03
119 1.50 -0.50 ; 10 1.25 -0.25 180 1.20 -0.48 179.88 1.12 -0.87 176.70 X X X y 1.50 4.60
125 i 1.25 - - 1.25 -0 25 115 1.00 -0.87 161.46 ; _9:.66 . -0.43 ! 38.87 _25.01 I 25.02 j 40.16 40.30 y 1.25 4.43
129 -3.25 -0.25 10 -3.25 -1.25 5 -3.12 -0.50 ' 176.89 -3.21 -1.20 8.12 24.88 24.65 43.70 44.60 y -3.25 -4.26
130 i 0.00 - - 0.00 - I - X X X X X X X X X X n 0.00 0.25
131 : -4.00 -0.75 ; 175 -4.50 -0.25 20 X X ^  X X X X X X X X n -4.00 -4.90
132 -3.00 - - -2.75 - - X X X X X X X ! x X X n -3.00 -3.59
133 : -4.25 -1.25 6 -5.50 -1.75 174 X X X x x X X : X X X y -4.25 -5.03
134 0.00 - - 0.00 - X X X X X X X X X X n 0.00 0.32
140 ! 0.00 - - 0.00 - - X X X X
? ' x X X ! x X X y 0.00 0.40
142 ’ -3.25 - - -2.75 -0.75 75 | -3.08 -050 [ 11863 I -2.87 I -0.58 82.60 X I 26.03 42.62 42.81 y -3.25 -3.87
143 0.25 : -0.25 180 ' 0.25 -0.50 10 X X X
144 0.00 - - 0.00 - - X X X
145 i -1.00 - - -1.00 - - X X X
150 | 0.00 - - 0 00 - - X X X
156 i 0.00 - - 0 00 - - X X X
163 : 0.00
. .1 ; - 0 00 - - X X X
164 i 0.00 - - 0.00 - - X X X
165 ! 0.00 - - 0.00 - - X X X
166 ; o.oo - - 0.00 - - X X X
167 I 0.00 - - 0.00 - - X X X
168 ! 0.00 - - 0.00 - - X X X
170 1 0.00........  - i - -0.50 - - X X X
173 | -5.75 | -0.25 13 -5.25 -0.50 55 -6.58 -0.45 169.83
174 7 ^ 0 0 “ - -7.00 -0.50“ 180 -7.00 -0.87 157.55
175 ! -1.75 - - -2.00 - - -2.62 -0.91 17.23
176 | -1.75 - - -2.00 - - -3.62 -0.62 177.95
177 I -2.75 j -0.50 95 -0.75 L -0.25 85 X X X
178 i -2.00 ; -3.00 175 -2.25 -2.75 15 -2.91 ^2.91 174.99
179 ; -3.00 I -0.25 90 -2.75 -0.25 90 -3.54 -0.33 146.03
180 j -2.00 -0.25 90 -2.50 -0.50 100 -2.33 -0.79 87.23
181 ; 0.00 - - 0.00 - - 0.54 -0.70 71.09
182 i 0.00 - - 0.00 - - 0.33 -0.53 73.52
187 | 0.25 ! -0.25 u 58 0.00 -0.25 92 X X X
189 i -2.50 | -1.50 150 -2.25 -0.25 110 X X X
190 ! 0.00 - - 0.00 - - X X X
193 i -4.25 ! -1.00 60 0.00 ■ ■ ....- — - X X X
194 ! x - - 0.00 -0.25 15 3.16 -1.06 166.72
195 0.25 i -0.50 180 j 0.00 - - X X X
196 j 0.00 - - 0.00 - - X X X
197 i 0.00 I -0.25 35 0.50 -0.25 90 X X X
198 ! -0.25 I -1.25 h 97 -0.25 -0.50 84 0.50 -1.21 88.39
199 I -2.50 ! -2.50 168 1.75 -3.75 10 -3.46 -3.94 ~ 157.08
201 X - - X - - 2.72 -2.65 110.28
202 X - - X - - 0.71 -0.54 33.33
203 | 0.00 - - 0.00 - - X X X
I 204 ; 0.00 - - 0.00 " - - 4.22 -2.16 155.85
-1.05
-0.74
-1.78
-112
6.44
-2.61
-0.29
-0787
-0.32
-0.47
178.37
170.45
162.25
x
18.83
145.23
89.67
95.14
111.81
x
-0.23 37.92
-2.08
-4.16
-100
93.40
20.67
87.81
-0.16 98.00
-1.75 111.00
 x
24782
26.10
24.14
24.10
24.41
23780
25.05
24.29
24.73
23.51
23.76
x
x
24.77 45.49
x 
x
X 
X 
X
 X
 X
X
X
 X
_x
X
45.52
X
2 4 4 4
x
43.30
43.70
44.15
43.81
43.91
44.09
x
24.77
23.60
x
4477
44.65
24.87 ! 40.91
24.90
x
39.27
x
x
X
X
24.13 40.24
44.45
44.47
42J09
41.14
39.59
x
x
X
X
41.42
x
X
X
23.72
22.78
23.63
x
45.33
44.42
42.54
45.23
44.51
x
x
23771 23.80
x
42.63
__x
42.77
0.25
0.00
-1.00
0.00
0.00
0.00
3.25
0.47
-1.56
0.48
0.57
0.99
0.00 1.05
0.00
0.00
1.07 
1.12 
0.00 1.19
0.00
000
-5.75
-7.00
-1.75
-2.75
- 2.00
-3.00
- 2.00
0.50
0.31
0.25
-2.50
0.00
-4.25
2.88
0.25
0.00
0.00
-0.25'
-2.50
2.48
0.65
0.00
3.84
1.23 
1.25 
-5.70 
-7.14 
-2.43 
-2.29 
-3.20 
-2.71 
-3.47 
- 2.66 
3.83 
3.7 i
3.44 
-3.05 
1.28 
-4.92 
5.34
3.44 
1.31“  
1.51 
-1.13 
-3.05
5.24 
4.18 
1.63 
5.91
205 j 0.00 - - 0.00 - - X X X X X X X X X X n 0.00 173 1
206 | 0.00 - - i o.oo - X X X X X X X X X X n 0.00 1.86 !
207 ; 0 - - ! 0 - - X X X X
. — 
X X X X X X n 0.00 1.91 I
208 8.50 -1.50 20 ; 9.oo -1.25 170 X X X X X X X X X X n 8.50 10.13 i
209 | 0 - - : o - _ X X X X X X X X ! x X n 0.00 1.94 !
210 ; -4.50 - - i -4.50 - - X I X X X X X X X x X n -4.50 -5.17 i
r~215 1 -3.00 - - ! -3.00 - - X f X X X X X X X i x X n ! -3.00 I -3.43 !
216 j -1.00 -1.25 180 I -1.25 -1.25 175 -1.12 ! -1.28 I 178.29 r -1.25 -1.96 170.94 X X I 43.50 43.59 y j -1.00 1 -1.49 i
217 j -1.00 - - j -1.00 - - -1.19 | -0.92 96.17 -1.37 -0.65 77.87 23.75 X I 43.95 44.41 y -1.00 ! -1.48 I
218 | 0 - - ! o - - x i X X X X X X X X X n : 0.00 2.04 i
219 j -3.00 -0.50 53 | -2.00 ^-1.25 115 "  x r  x X X X X X X X X n -3.00 -3.43 j
220 I 0.00 - - ! 0.00 - - X X X X X X X X i x X
_ p
n ! 0.00 ! 2.15 !
221 j 0.00 - - ; 0.00 - - i x I x X
.....'
X X X X X X X n ! 0.00 ! 2.18 !
228 j 1.00 -0.50u ....... . 90 I 0.75 -0.75 90 X X X X X X X X X X y 1.00 4.27 |
240 | 0.50 -1.00 180 : 0.25 -1.00 15 X X X X X X X X X X y 0.00 T 2.24 I
247 j -10.00 -3.00 15 -11.50 -1.25 180 X X X X X X X X X X j n 10.00 ! -7.40 I
257 ; 1.75 - - ! 1.75 r  - - 1.79 -0 33 97.48 2.00 -0.19 48.90 23.27 23.21 ! 41.67 41.78 n 1.75 4.96 !
258 ; 1.50 -1.00 10 i 2”6o~ -1.25 118 X X X X X X X X X X I n ! 1.50 4.69 i
259 : 0.00 - - I 0.00 - - 0.50 | -0.79 104.94 0.33 -0.32 86.99 X X ! X .. 43.86 “1— y ! 0.00 2.24
260 1.25 -1.25 105 | 1.00 -1.00 90 1.58 I -1.33 59.00 1.33 -0.42 169.33 23.55 23.61 i 41.93 41.88 n 1.25 4.56 I
261 -4.00 -0.75 5 ! -3.50 -0.75 165 ^  -4.25 i -0.85 27.55 -3.46 -0.68 125.36 26.65 26.13 ! 41.72 I 42.17
- r —
n -4.00 -4.87 !
262 ! X - ; x - - -1.29 | -1.37 117.54 0.22 -2.24 72.51 24.00 23.73 ! 42.94 I 42.81
-j—
y -1.16 '-1.85
263 0.00 - - ! o.oo - - 0.07 ! -0.53 120.62 0.37 -0.09 86.28 23.63 23.67 ; 42.01 42.01 y 0.06 3.00 1
264 0.00 - - 0.00 - - -0.12 j -0.17 136.36 0.21 -0.41 72.49 1 23.98 X ! 42.03 41.98 y -0.10 ! -1.04 I
269 0.00 - - ! 0.00 - - X X X X X X X X x X y 0.00 2.25 I
283 0.00 - - I 0.00 - - -0.08 j -0.37 107.66 0.00 0.00 0.00 23.94 24.15 42.43 42.15 y : -o.o6 I 0.70
285 0.00 - - 0.00 - - -0.66 ; -0.25 28.48 -0.25 -0.15 130.94 23.11 22.87 43.70 44.01 y -0.59 i 1.41 !
l_286 X - - X - - 0.00 j 0.00 0.00 0.16 -0.03 45.00 23.43 23.30 42.75 42.86 V 0.01 ! 2.88 i
h 287 0.00 - - 0.00 - - 0.58 i -0.12 82.53 1.12 -0.08 95.39 23.40 23.35 40.72 41.29 y 0.54 ! 3.87 j
'  288 0.00 - - 0.00 - - 0.62 I -0.62 91.28 0.33 -0.28 145.98 22.80 22.75 43.33 43.53 y I 0.57 ! 3.89
289 -1.50 -0.75 155 j -1.00 -0.25 170 -2.00 -0.45 126.14 -1.16 -0.46 126.89 X 24.81 42.92 42.67 y I -1.50 ! -2.16 I
290 i 0.00 - - 0.00 - - X X X X X X X X X X y j 0.00 2.32
291 0.00 - - j 0.00 - - X X X X X x X X X X y 0.00 2.44
292 0.00 - - I 0.00 - - X X X X X X X X X X y 0.00 2.46
293 j 0.00 - - i 0.00 - - X X X X X X X X X X y 0.00 i 2.49
294 0.00 - - I 0.00 - - X | X X X X X X X X X y 0.00 2.49 :
295 2.00 i -1.50 10 0.50 -0.50 160 2.37 -2.51 9.57 1.00 -1.09 161.94 22.38 X | 42.97 42.92 ! y ! 2.16 5.08 |
296 x - X - - -0.58 -0.81 , 156.80 -0.54 -1.12 159.78 23.73 X ! 44.28 44.31 j y -0.52 -1.32 !
297 x X - - 1.25 -1.18 95.09 1.22 -0.84 99.30 X X s x X y : 1.14 4.33
298 x - X - - 4.78 “-2.8V 171.94 4.47 -3.00 4.24 X X i x x  ! y i 4.35 5.99 j
302 0.00 i - - ..0~00 - - 0.21 -0.77 96.25 -0.13 -0.77 92.88 23.84 23.98 ] 42.75 42.86 ! y ! 0.20 3.03 |
305 -3.75 I - - -3.75 -0.25 135 -4.16 -0.52 1 142.23 -4.75 -0.90 19.79 X X j 42.49 42.30 ; y I -3.76 -4.71 !
312 0.00 ! - - 0.00 - - X x X X X X X X i x x y i 0.00 2.65 I
313 0.00 i - - ^0.00 - - X X X X X X X X x x y j 0.00 2.66 |
314 0.00 I - - 0.00 - - X X X X X X X X X X y I 0.00 2.72. j
315 0.00 I - - 0.00 - - X X X X X X X X x X S y I 0.00 2.72 I
316 0.00 | - - r 0.00 - - X X X X X X X X x X n I 0.00 2.75 !
317 o.oo j - - 0.00 “ - X X X x X X X X x x n ! 0.00 2.84 |

Trio 3
R:NV glasses 
L:NV glasses
O
R:-0.25/-0.50xl28
L:-0.25/-0.25x85
Trio 5
R:+1.00/-0.50x90 
L:+0.757-0.25x90
- O
R:unknown 
L: unknown
Trio 7
R-.+1.00DS 
L:+l.257-0.75x32
O
R:+1.00/-1.00xl80
L:+0.75/-0.75xl80
Trio 8
R:+2.25/-1.00xl 10 
L:+2.00/-l.00x90
O
R> 1.007-0.75x35 
L:-3.75DS
Trio 9
R:+0.25/-0.25x20
L:+0.25/-0.50xl70
O
R:-3.25DS
L:-3.25DS
R:-6.25/-1.75x15 
L:-6.75/-0.50xl 70
R:-7.00/-0.25xl0
L:-6.75/-0.25xl00
R:-7.50DS
L.-7.00DS
R:-7.75/-2.25xl50 
L:-6.507-4.00x180 R:-9.50DSL:-9.50DS
Trio 10
R:-0.25/-0.50xl0
L:-0.25/-0.25x40
R:-7.007-1.00xl80
L:-6.00/-1.25xl80
R:-7.50/-0.25x20
L:-6.75DS
Trio 11
R:-5.757-1.00x180 
L:-6.507-2.00x95
R-.-8.75/-l.25x145 
L:-7.507-0.50x50
R:-9.75/-2.00xl40 
L:-8.507-2.75x23
Trio 13
R:-9.50DS
L:-9.75DS
O
R:-0.75/-0.25x90
L:-0.75/-0.50x85
R:-9.75/-2.75x25 
L:-10.007-2.00x2
Trio 14
R:-l 0.007-0.50x135 
L:-9.757-1.00x150
O
R:+1.00/-1.25x50 
L:+0.75/-0.75xll5
R:-10.25/-l .75x45 
L:-8.507-1.75x125
Trio 15
R:-3.00/-2.00xl02 
L:-2.25/-2.00x85
O
R:-5.50/-l.00x90 
L:-8.50/-l.25x90
R:-7.25/-l.75x168 
L:-8.25/-0.75x25
Trio 16
R:+0.25/-0.50x90
L:+0.25/-0.75x60
O
R:-2.75/-l.00x60 
L:-3.007-0.50x30
R-.-7.25/-l .25x32 
L:-6.25/-l.25x140
Trio 17
R.plano (NV Rx) 
L: piano (NV Rx)
O
R:+1.00/-1.50xl05 
L:+1.007-1.25x85
R:-9.75/-0.75x85 
L:-8.257-0.75x85
Trio 18
R:+1.50/-2.00x90 
L:+1.507-1.00x108
O
Trio 19
R:+0.75/-1.00x120 
L:-0.75DS
R:-6.00/-1.50xl8( 
L:-4.507-0.75x75
O
R:+1.25/-0.75x55 
L:+l.257-0.75x105
R:-13.50DS
L:-11.25DS
R:-9.50/-0.50xl80
L:-12.75DS
Trio 20
R:-7.25/-0.75x90 
L.-5.507-0.50x85
- O
R:plano
L.plano
R:-6.50/-0.75xl80
L:-6.50/-0.75xl80
Trio Pedigrees. Trios recruited for association analysis.
Trio 21 Trio 22
R:NV Rx 
L.NV Rx
R:-20.75/-1.25x5
L:-20.00/-1.25xl20
R:unknown (NV Rx) 
L: unknown (NV Rx)
R:-6.50/-0.25xl40
L:-6.75/-0.75x30
O
R:-3.50/-0.75x95
L:-3.00/-1.00x75
R:-6.25/-2.00x90 
L:-7.00/-l.00x95
Trio 24
R:-5.00/-2.50x92 
L:-6.50/-2.00x65
R:-6.75/-0.75xl55 
L:-6.507-0.50x15
R:-12.00/-2.75x20 
L:-13.25/-2.25xl65
Trio 25 Trio 26
R:+0.75/-0.75xl05 
L:+0.507-0.75x80
R:-7.75/-0.75x25 
L:-6.25/-1.00xl 15
R:-4.75/-0.50xl 10 
L:-3.25/-l.50x100
O
R:-5.50/-0.50x90 
L:-4.00/-l.00x80
R:-12.00DS 
L:-l 1.50DS
R:-9.50/-0.25x5 
L:-9.757-0.25x10
Trio 27
R:-0.50/- 1.75x80 
L:-0.25/-2.25x85
O
R:-2.25/-2.00xl00 
L:-2.50/-l. 25x85
Trio 28
R:-16.25/-1.00x25 
L:-15.257-1.00x5
O
R:pl/-1.25x85 
L:pl/-0.25xl 65
Trio 29
R:+0.75/-l.00x87 
L:+l.257-0.50x100
O
R:-5.25/-0.75x90 
L:-5.00DS
Trio 30
R:-3.50/-0.75x50 
L:-4.757-0.75x15
O
Trio 31
R:-2.00/-0.50x105 
L:-l.507-0.25x180
R:-9.007-1.00x15 
L:-8.00/-0.75x160
R:-6.50DS
L:-6.75DS
R:-13.00DS 
L:-l 5.007-0.25x170
R:-6.50/-0.75xl5 
L:-7.507-0.25x110
R:-7.25DS
L:-7.25DS
R:-7.00/-0.25x20
L:-6.75DS
Trio 32
R:-6.50/-0.50xl0 
L:-4.507-0.75x85
O
Trio 33
R:-0.75/-0.50xl0
L:-0.75DS
R:-10.50/-0.25xl40
L:-8.25/-0.25xl00
R:-8.00/-3.50x165 
L:-l 1.007-1.25x15
R:-10.50/-0.50xl05
L:-10.50/-0.50x90
R:-7.00/-0.25xl65
L:-6.50/-0.75xl5
Trio 34
R:-3.75/-2.75x2 
L:-4.257-1.50x180
R:-10.25/-0.50x85 
L:-9.25/-0.50xl80
R:-6.00/-l.25x25 
L:-6.757-1.50x155
Trio 35
R:+1.25/-l.50x90 
L:+l.007-1.50x80
O
R:pl/-1.00x90 
L:-l.007-1.00x50
R:-9.25/-0.75xl35
L :-10.00/-l.00x150
Trio 36
R:-10.00/-0.75x44
L:-9.25/-1.00x8
O
R:plano
L:+0.50/-0.75xl70
R:-8.75/-0.50x45
L:-8.507-1.00x170
Trio pedigrees, contd.
Trio 37
R.unknovm 
L: unknown
O
R.unknown (NV Rx) 
L.unknown (NV Rx)
Trio 38
R-.+1.75DS
L:+1.00DS
O
R-.+2.00/-1.00x95 
L:+2.007-0.75x95
Trio 39
R:+0.25DS
L.+0.50DS
O
R:-l.25/-0.50x105 
L:-1.00/-0.75x80
R:-7.25/-0.50x20 
L:-9.25DS
R:-6.00/-l.50x170 
L:-6.00/-0.75xl0
R:-8.50/-0.25x95
L:-8.00DS
Trio 42
R:-5.75/-0.75x175 
L:-6.50/-0.75xl50
R:-6.75/-0.75xl0
L:-6.25/-1.00xl65
R:-6.75/-0.25xl70
L:-6.50/-0.50xl0
Trio 43
R:-5.75/-0.50x10 
L:-5.757-0.50x175
O
Trio 44
R:-1.75/-0.25xl25 R:+1.507-0.50xl35 
L:-l.257-0.50x45 L:-0.25/-0.50x65
O
R:+0.25/-0.50x82 
L:-2.507-0.75x65
R:-7.25DS
L:-6.75DS
R:-8.25/-l.25x165 
L:-10.507-0.75x175
Trio 47
R:-3.00/-0.75xl05 
L:-2.50/-l. 75x70
O
R:pl/-0.75x25
L:-0.25/-0.50xl55
Trio 48
R:+5.00/4.00x95 
L:+3.25/-2.75x90
O
R:-3.75/-0.75x100 
L:-0.257-0.50x70
Trio 49
R:+1.50/-0.25xl 10 
L:+l. 757-0.50x5
O
R:+1.00/-2.25x92 
L:+0.50/-l.75x80
R.-10.25/-3.75x180 
L:-8.75/4.25x155
R:-6.75/-0.50xl 10
L:-6.25/-0.25x75
R:-8.25/-0.75x90
L:-8.00/-0.50x80
Trio pedigrees contd.
Trio 40
R:+0.75/-0.75x90 
L:+0.50/-0.50xl00
O
Trio 41
R:-2.50/-l.00x175 R.4.00/- 1.25x90 
L:-2.00/-1.75xl80 L:-3.00/-l.50x180
O
R:-5.75/-0.50x30
L:-5.25/-0.25xl55
R:-8.00DS
L:-8.00DS
R:-8.25/-0.50xl 15 
L:-9.50/-0.50x65
Trio 45
R:-0.50/-l.75x75 
L:pl7-1.00x85
O
R:4.00/- 1.25x175 
L:-3.007-0.25x90
R:-12.50/-l.25x20 
L:-13.00/-0.50xll0
Trio 46
R:-1.00/-2.00x95 
L:-l.257-1.50x98
O
R:-0.75DS
L:-0.75/-0.50xl80
R:-6.00/-0.75x5 
L:-9.507-1.00x162
Trio 50
R:-8.00DS
L:-7.00DS
O
R:-0.75/-0.75xl50
L:+0.75/-2.75xl85
Trio 51
R:-8.00/-l.25x30 
L:-7.25/-1.00xl60
O
R:-2.25/-l.25x10 
L:-2.757-1.25x5
R:-6.50DS
L:-6.50DS
R :-6.75/-l.75x160
L:-5.507-1.75x10 (RD)
Trio 52
R:unknown
L:unknown
O
R: -3.25/-1.25x32 
L:-2.00/-2.00xl52
Trio 53
R:+1.50/-5.00x80 
L:+l.257-5.00x176
O
R:-1.00/-3.00xl70
L:-2.50/-2.50xl70
Trio 54
R:-0.25/-0.50x65
L:-0.25/-0.25x90
O
R:-3.75/-2.50x19 
L:-3.75/-3.00x162
Trio 55
R:+1.25/-3.00xl75 
L:+l.757-2.25x175
O
Trio 56
R:-2.00/-0.25x60
L:-2.50/-0.75xl50
R: unknown 
L :unknown
R:plano
L:plano
R:-6.50/-l.00x35 
L:-8.25DS
R:-7.00DS
L:-7.50DS
R:-8.25/-0.25xl0
L:-7.50/-0.25xl75
R:-9.00/-1.75x175 
L:-9.25/-1.25xl80
R:-7.00/-0.25x60
L:-7.00/-0.25x90
Trio 57
R:-4.00/-0.50x50 
L:-3.75/-l .00x110
R:-1.75DS
L:-1.75DS
Trio 58
R:plano
L:plano
R:-1.00DS
L:-1.00DS
Trio 59
R:-9.00/-1.50x5 
L:-l 1.00/-1.50x17(1
O
R:-0.50/-l.00x100 
L:-l .25/-2.00xl 17
Trio 60
R:-3.50/-0.50xl0: 
L:-3.757-0.75x90
O
R:-1.75DS
L:-1.75DS
Trio 61
R:+0.50/-0.50xl 10 
L:+0.50DS
O
R:-2.25DS
L:-7.00DS
R:-8.00/-0.25x20 
L:-7.507-0.50x20
R:-6.00/-0.25xl5 
L:-6.507-0.25x170
R:-7.00/-l.25x95 
L:-6.75/-l.25x105
R:-7.75/-0.25xl80
L:-8.00/-0.50xl80
R:-6.50/-l.75x175 
L:-7.007-1.50x15
Trio 62
R:-1.50DS 
L:-l.007-0.50x90
- O
R:-0.25DS
L:-0.75DS
Trio 63
R:-7.00/-0.75x5 
L:-5.757-1.00x180
O
Trio 64
R:-1.50/-0.75x5 
L:-l .507-1.00x170
R:-1.75/-2.50x92 
L:-1.25/-2.75x86
O
Trio 65
R:-4.507-0.75x145 
L:-l.007-1.50x50
R:NV Rx 
L:NV Rx
Trio 66
R:-16.75/-3.00xl2 
L:-17.00-2.00x110
R:-6.50/-0.50xl80
L:-6.00/-0.50xl5
O
R:-2.75/-l.25x95 
L:-3.25/-1.25xl00
R:-6.25/-0.25xl80 
L:-6.007-0.25x170
R:-9.50/-1.00x25 
L:-10.00/-0.25xl60
R:-9.25/-l.50x160 
L:-10.00/-l.50x180
R:-14.00/-2.00x50 
L:-14.25/-l.50x135
R:-9.25DS
L:-8.25/-0.25x90
Trio pedigrees contd.
Trio 67 Trio 68 Trio 69
R:-3.25/-0.50xl75
L:-1.25/-0.25x25
R:-7.25/-1.25xl5 
L:-8.00/-l.25x165
R:-0.50/-3.75x180 
L:-1.75/-2.50x165
R.-7.00/-3.50x180 
L:-7.00/-l.50x40
R:-4.75/-2.25x5
L:-4.75/-2.25xl80
O
R:-1.25/-0.50xl80
L:-0.75/-0.75xl80
R:-8.75/-0.75x5 
L:-9.00/-l.75x160
R-.-7.00/-l.00x20 
L:-7.25/-1.00xl50
R:-7.00DS
L:-7.25DS
Trio 74
R:-8.00/-l.00x60 
L:-4.75/-0.50x40
O
R:-2.25/-0.25xl00 
L:-l .757-0.25x100
Trio 75
R:-4.75/-0.50xl20 
L:-5.757-0.75x65
O
R:-1.25/-0.75xl70
L:-1.25/-0.75x5
Trio 76
R:pl/-0.25x90
L:pl/-0.50x90
O
R:-3.25DS 
L:-3.00/-0.25xl 70
R:-9.25DS
L:-8.75DS
R:-10.50/-0.75x40 
L:-11.007-0.50x150
R:-8.00/-0.25x55
L:-8.25/-0.50xl65
Trio 79
R:+0.25/-5.00xl77
L:+0.25/-4.00xl52
O
R:-2.50/-2.25x27
L:-1.00/-2.00xl60
Trio 80
R:-4.50/-2.00xl75
L:-5.25/-1.00xl75
Trio 81
R:-13.75/-l.50x180 
L:-9.25/-0.50xl70
R:-9.50/-1.25xl0
L:-9.00/-1.75xl60
O
R:pl/-0.25xl35 
L:-2.50/-l.25x90
R:-15.25/-0.75x30 
L:-l 1.007-3.50x160
R:-13.00DS
L:-14.25/-0.75x90
R:-8.00/-0.50xl00
L:-6.50/-0.50xl20
Trio pedigrees contd.
Trio 70
R:-0.25/-0.25x65
L:pl/-0.25x83
R:-8.00/-0.50xl00
L:-8.00/-0.50xl80
Trio72
R:+0.25/-l. 00x68 
L:-0.25DS
O
R:-2.00/-0.25x20 
L:-3.007-1.00x5
R:-10.75DS
L:-10.75DS
R:-6.75/-0.25xl80 
L:-7.007-0.50x180
Trio 77 Trio 78
R:pl/-1.25x105 
L:-0.75/-l.25x75
R:-7.00/-0.75xl80
L:-9.75DS
R:-9.75/-0.75xl0 
L:-l 1.507-1.00x155
O
R:-1.75/-0.25x5 
L:-3.007-0.25x170
R:-13.50/-0.50x20 
L:-12.007-1.00x180
R:-10.75/-0.75x75 
L:-9.50/-l. 00x85
Trio 82
R:pl/-0.50x90 
L:pl/-1.50x90
O
R:+0.75/-1.00xl80
L:pl/-0.25xl80
R:-8.00/-0.25xll5
L:-8.25/-0.25x60
Trio 83
R:+0.75/-0.50xl00 
L:+0.507-0.75x75
O
R:pl/-0.50x30 
L:pl/-0.25xl25
R:-8.25DS
L:-8.50/-0.25xl5
Trio 84
R:-9.50/-l. 50x50 
L:-9.50/-1.25xll0
O
R:-3.50/-0.50xl75 
L:-3.50/-0.50xl 80
Trio 85
R:-14.75/-l.75x80 
L:-12.507-2.50x140
- O
R:NV Rx 
L:NV Rx
Trio 86
R:-20.00/-1.00xl70 
L:-21.007-0.50x90
O
R:-0.25/-0.50xl60
L:-0.25/-0.25x45
R:-8.25/-0.50x40 
L:-8.007-1.00x140
R:-6.75/-0.50xl70
L:-7.00/-0.50x20
R:-9.75/-5.00xl80
L:-6.00/-5.50xl75
Trio 89
R:-1.00/-l.00x105 
L> 1.007-0.75x85
O
R:+1.25/-0.75xl0 
L:+l. 507-0.75x172
Trio 90
R:-5.75/-2.00xl80 
L:-5.757-1.50x172
O
Trio 91
R:plano
L:+0.25/-0.25xl65
R:-4.50/-2.75x7 
L:-5.007-4.25x3
R:-10.25/-0.25x90 
L:-9.507-0.50x85
R:-7.75/-l.00x10 
L:-7.757-0.50x170
R:-8.75/-2.25xl0 
L:-6.50/-2.75x162
R:-6.00/-5.50x9
L:-7.25/-5.00xl77
Trio 95
R:+0.50/-1.75xl5C 
L:+0.507-0.75x50
R:+6.00/-0.50x90 
L:+7.007-0.75x90
R:-13.25/-l.50x135 
L:-l 1.257-2.00x45
Trio 96
R:-6.75/-l.75x60 
L:-4.25/-l.00x160
O
R:-6.25/-2.00xl2 
L:-5.25/-l.50x160
R.-14.75/-1.25x70
L:-15.25DS
Trio 98
R:-5.00/-l.50x17 
L:-5.007-2.25x178
O
R:-3.00/-0.25x90 
L:-3.007-0.75x5
R:-10.00/-1.75x7
L:-10.00/-1.25xl65
Trio pedigrees, contd.
Trio 87
R:-4.50DS
L:plano
O
R:-3.25/-l.25x180 
L:-l.007-1.50x160
Trio 88
R:-4.25/-1.00xl00 
L:-4.75/-l. 00x60
O
R:-3.00/-0.50xl52 
L:-2.757-0.75x1
R:-16.00DS
L:-13.00DS
R:-7.007-l .25x130 
L:-7.007-0.50x80
Trio 93 Trio 94
R:-6.25/-0.75x67 
L:-6.507-0.75x85
R:-8.00/-0.50xl50 
L:-8.00/-l.25x30
R:-3.00/-2.25x90 
L:-3.25/-l. 75x90
R:+2.75/-2.25x88 
L:+l.757-0.75x63
R:-l 0.75/-1.25x12 
L:-13.25/-l.00x162
R:-7.75/-l .25x180 
L:-9.00/-0.75xl70
Trio 99 Trio 100
R:-13.50/-l.00x150 
L:-13.007-1.00x160
R:-20.50/-l.50x142 
L:-23.50DS
R:-10.00/-l.50x35 
L:-l 1.007-2.75x155
O
R:-0.25/-0.75xl30 
L:-0.50/-0.75x30
R:-27.50/-1.50xl5 
L:-27.50/-l.50x145
R:-12.25/-2.50x16
L:-l 3.007-0.75x18
Trio 101
R:-12.00/-0.75x20 
L:-l 1.50/-0.50xl40
O
R:+1.25/-0.75xl06
L:+0.75DS
Trio 102
R:-6.007-0.75x70 
L:-5.00/-l. 00x120
O
R-.-0.75DS
L:-0.25DS
Trio 103
R.-0.25/-0.50x170 
L:pl/-0.75xl80
R-.-12.25/-l.25x28 
L:-13.75/-l .25x165
R:-7.50/-0.50x55
L:-7.50/-0.25xl65
R:-6.25/-1.25xl70 
L:-6.75/-l .25x155
R:-8.00/-l.25x13 
L:-6.50/-1.00xl60
Trio 106
R:plano
L:pIano
R:-6.00/-0.25x80
L:-6.00/-0.50xl75
Trio 107
R:-9.25/-l.50x20 
L:-12.00/-2.00x5
O
R:+0.25/-0.50x10 
L:pl/-0.25x90
Trio 108
R:-12.00/-2.00x29 
L:-10.50/-l.00x145
O
R:-1.00/-0.25xl00 
L:-0.25/-0.75x70
R:-9.75/-0.50x85 
L:-10.50/-0.25x40
R:-8.75/-0.50x40 
L:-7.75/-0.25xl60
R:-7.50/-3.00x90 
L:-8.00/-2.25x85
Trio pedigrees, contd.
Trio 104
R:-7.50/-2.00x80 
L:-8.00/-l.25x65
O
R.-0.25/-0.50x125 
L:-0.25/-0.50x40
R:-8.00/-0.25xl80
L:-7.50DS
Trio 105
R:-2.25/-0.25xl80
L:-2.00/-0.25xl70
O
R:-2.25/-0.25xl65
L:-0.50/-0.25xl30
R:-7.00/-2.25x48
L:-9.00/-0.75xl55
Trio 110
R:-3.75DS
L:-1.75DS
R:-4.75DS
L:-3.25DS
Trio 116
R:+2.00/-0.75x80 
L:+2.007-0.75x90
O
R:-1.75/-0.75x90 
L:-1.507-0.75x70
R.-l 1.00/-1.50x60 
L:-14.75/-l .25x50
R:-6.50/-2.75x30 
L:-8.507-2.25x170
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